P00006620A05
Todarodes/NN pacificus/NN contains/VBZ much/RB more/DT retinochrome/NN than/IN Loligo/NN ,/, and/CC it/PRP is/VBZ more/RB abundant/JJ in/IN the/DT outer/JJ than/IN in/IN the/DT inner/JJ segments/NNS ./.
P00013085A09
Demethylglycodiazin/NN (/( 2-benzolsulfonamid/NN --/: 5-/CD (/( beta-hydroxyethoxy/NN )/) -pyrimidin/NN )/) ,/, which/WDT did/VBD not/RB inhibit/VBP endogenous/JJ ketogenesis/NN in/IN isolated/JJ liver/NN cells/NNS ,/, did/VBD not/RB affect/VBP lysosomal/JJ lipase/NN activity/NN ./.
P00026908A02
If/IN the/DT theory/NN is/VBZ correct/JJ ,/, it/PRP suggests/VBZ that/IN both/CC prophylaxis/NN and/CC management/NN of/IN the/DT acute/JJ condition/NN should/MD be/VBP possible/JJ by/IN means/NNS of/IN selective/JJ alpha-adrenoceptor/NN antagonism/NN ./.
P00042211A05
However/WRB ,/, in/IN undifferentiated/JJ areas/NNS of/IN transplanted/JJ tissue/NN ,/, we/PRP found/VBD ultrastructural/JJ evidence/NN that/IN immature/JJ pericytes/NNS of/IN capillaries/NNS can/MD differentiate/VBP into/IN preadipocytes/NNS ./.
P00058033A06
Antibodies/NNS in/IN sera/NNS from/IN rabbits/NNS immunized/VBN with/IN normal/JJ spleen/NN cells/NNS bound/VBD small/JJ but/CC significant/JJ amounts/NNS of/IN radiolabeled/JJ melanoma/NN antigens/NNS ./.
P00065903A11
The/DT similarity/NN between/IN the/DT protein/NN concentration/NN of/IN interstitial/JJ fluid/NN and/CC lymph/NN indicated/VBD that/IN the/DT endothelial/JJ lining/NN of/IN the/DT terminal/JJ lymphatics/NNS did/VBD not/RB restrict/VBP the/DT passage/NN of/IN macromolecules/NNS into/IN the/DT lymphatics/NNS ./.
P00097960A01
The/DT computed/JJ tomographic/JJ findings/NNS of/IN four/CD patients/NNS with/IN neoplastic/JJ disease/NN of/IN the/DT global/JJ rim/NN are/VBP discussed/VBN ./.
P00111772A04
S/NN --/: R/NN event/NN units/NNS consisted/VBD of/IN three/CD subtypes/NNS :/: stimulus-related/JJ ,/, response-related/JJ ,/, and/CC stimulus/NN --/: response-related/JJ units/NNS ./.
P00125829A03
The/DT survival/NN time/NN after/IN the/DT dissection/NN of/IN the/DT acoustic/JJ nerve/NN is/VBZ somewhat/RB more/RB than/IN seven/CD weeks/NNS ./.
P00139889A05
Glycerol-density-gradient/NN centrifugation/NN indicates/VBZ a/DT molecular/JJ weight/NN for/IN the/DT intact/JJ complex/NN of/IN about/RB 270000/CD ./.
P00163622A04
Consequently/RB ,/, the/DT diazepam-treated/JJ cells/NNS had/VBD a/DT higher/JJR chlorophyll/NN //SYM photosynthesis/NN ratio/NN --/: also/RB with/IN regard/NN to/TO respiration/NN in/IN order/NN to/TO calculate/VB the/DT gross/JJ photosynthesis/NN ./.
P00187164A02
The/DT pure/JJ mesenchymal/JJ tumor/NN is/VBZ usually/RB present/JJ at/IN birth/NN and/CC palpated/VBN as/IN a/DT mass/NN in/IN the/DT kidney/NN ./.
P00192861A02
The/DT pancreatic/JJ acinar/JJ cells/NNS of/IN zinc-deficient/JJ rats/NNS showed/VBD marked/JJ cellular/JJ alterations/NNS :/: a/DT reduction/NN in/IN zymogen/NN granules/NNS ,/, rupture/NN of/IN zymogen/NN granules/NNS ,/, basal/JJ accumulation/NN lipid/NN droplets/NNS ,/, prominent/JJ lysosome-like/JJ bodies/NNS ,/, focal/JJ degradation/NN of/IN the/DT cytoplasm/NN ,/, and/CC intracistenal/JJ granules/NNS within/IN the/DT dilated/JJ cisternae/NN of/IN the/DT endoplasmic/JJ reticulum/NN ./.
P00206818A03
The/DT results/NNS indicated/VBD that/IN ,/, (/( 1/CD )/) glucose-6-P/NN is/VBZ compartmentalized/VBN with/IN respect/NN to/TO the/DT enzymes/NNS involved/VBN in/IN glucose-60P/NN ,/, trehalose/NN and/CC glycogen/NN metabolism/NN ,/, (/( 2/CD )/) a/DT differences/NNS of/IN approximately/RB 0.6/CD mM/NN //SYM min/NN in/IN maximum/NN specific/JJ activity/NN of/IN glucokinase/NN compared/VBN to/TO glucose-6-P/NN phosphatase/NN is/VBZ required/VBN in/IN order/NN for/IN the/DT model/NN to/TO produce/VB end/NN product/NN carbohydrate/NN levels/NNS consistent/JJ with/IN those/PRP observed/VBN experimentally/RB ,/, (/( 3/CD )/) the/DT Km/NN of/IN glucokinase/NN for/IN glucose/NN strongly/RB influences/VBZ the/DT steady/JJ state/NN levels/NNS of/IN glucose/NN in/IN the/DT absence/NN of/IN external/JJ glucose/NN ,/, and/CC (/( 4/CD )/) changing/NN the/DT order/NN of/IN product/NN removal/NN in/IN the/DT reaction/NN catalyzed/VBN by/IN glucose-6-P/NN phosphatase/NN influences/VBZ the/DT level/NN of/IN glycogen/NN and/CC trehalose/NN ./.
P00219800A02
The/DT herpes/NN infection/NN was/VBD confirmed/VBN by/IN isolation/NN of/IN herpes/NN virus/NN from/IN the/DT CSF/NN (/( one/CD case/NN )/) ,/, from/IN the/DT brain/NN (/( one/CD case/NN )/) ,/, and/CC in/IN the/DT 5/CD remaining/JJ cases/NNS by/IN serology/NN ./.
P00263489A01
Computed/JJ tomography/NN scanners/NNS can/MD be/VBP calibrated/VBN to/TO provide/VB reproducible/JJ measurements/NNS for/IN a/DT quantitative/JJ analysis/NN of/IN lung/NN density/NN ./.
P00284170A07
There/EX was/VBD also/RB no/DT significant/JJ correlation/NN when/WRB prognostic/JJ factors/NNS were/VBD compared/VBN to/TO uptake/NN in/IN the/DT individual/JJ organ/NN systems/NNS except/IN that/IN T/NN cell/NN disease/NN was/VBD associated/VBN with/IN a/DT significantly/RB greater/JJR propensity/NN for/IN lymph/NN node/NN uptake/NN ./.
P00305839A04
These/DT results/NNS support/VBP the/DT assumption/NN that/IN with/IN increasing/JJ age/NN cellular/JJ immunity/NN is/VBZ clearly/RB reduced/VBN and/CC may/MD possibly/RB be/VBP associated/VBN with/IN an/DT increased/JJ incidence/NN of/IN neoplasia/NN ,/, infection/NN ,/, and/CC auto-immune/JJ disease/NN ./.
P00320526A03
Urinary/JJ tract/NN abnormalities/NNS were/VBD found/VBN in/IN 49/CD %/SYM of/IN patients/NNS with/IN the/DT Rokitansky/NN syndrome/NN ./.
P00338401A05
Maprotiline/NN appeared/VBD to/TO be/VB superior/JJ to/TO viloxazine/NN on/IN the/DT sleep/NN and/CC sadness/NN scales/NNS and/CC some/DT evidence/NN to/TO show/VB it/PRP to/TO be/VB better/JJR also/RB on/IN the/DT tension/NN scale/NN ./.
P00367052A05
The/DT results/NNS suggest/VBP that/IN cell-mediated/JJ immunology/NN plays/VBZ an/DT important/JJ role/NN for/IN the/DT lysozyme/NN synthesis/NN of/IN macrophages/NNS in/IN granuloma/NN ./.
P00393048A05
The/DT results/NNS indicate/VBP that/IN the/DT blocking/JJ action/NN of/IN the/DT gestagen/NN on/IN the/DT positive/JJ feedback/NN of/IN estradiol/NN on/IN LH/NN release/NN occurs/VBZ at/IN the/DT hypothalamus/NN or/CC higher/JJR CNS/NN centers/NNS ./.
P00422973A04
Many/PRP of/IN the/DT extra/JJ neurons/NNS are/VBP involved/VBN in/IN reproductive/JJ behavior/NN ./.
P00438202A06
The/DT hepatic/JJ heme/NN oxygenase/NN appears/VBZ to/TO have/VB characteristics/NNS essentially/RB similar/JJ to/TO those/PRP of/IN the/DT splenic/JJ heme/NN oxygenase/NN (/( Yoshida/NNP ,/, T./NNP ,/, and/CC Kikuchi/NNP ,/, G./NNP (/( 1978/CD )/) J./NN Biol./NN Chem./NN 253/CD ,/, 4224/CD and/CC 4230/CD )/) ./.
P00460828A02
Among/IN 96/CD patients/NNS who/WP underwent/VBD arthrotomy/NN ,/, the/DT arthroscopic/JJ diagnosis/NN was/VBD confirmed/VBN in/IN 96/CD per/IN cent/CD ./.
P00482467A06
Evening/NN cortisol/NN elevation/NN was/VBD twice/RB as/RB common/JJ in/IN patients/NNS with/IN diagnoses/NNS of/IN more/RB severe/JJ psychiatric/JJ illness/NN than/IN in/IN those/PRP with/IN minor/JJ disorders/NNS ./.
P00513294A03
As/IN for/IN side/NN effect/NN ,/, 1/CD case/NN developed/VBD eosinophilia/NN ,/, and/CC another/DT case/NN with/IN impaired/JJ liver/NN function/NN as/IN underlying/JJ disease/NN showed/VBD transitory/JJ exacerbated/JJ examination/NN values/NNS ./.
P00539639A01
Manula/NN compression/NN of/IN the/DT common/JJ carotid/JJ artery/NN after/IN a/DT complication/NN of/IN the/DT posterior/JJ approach/NN to/TO the/DT internal/JJ jugular/NN vein/NN resulted/VBD in/IN progressive/JJ AV/NN block/NN and/CC cardiac/JJ arrest/NN ./.
P00565754A03
The/DT most/RBS frequent/JJ lesions/NNS encountered/VBN included/VBD granuloma/NN in/IN 9.5/CD %/SYM ,/, focal/JJ areas/NNS of/IN necrosis/NN in/IN 14/CD %/SYM ,/, portal/NN triaditis/NN in/IN 17/CD %/SYM ,/, and/CC Kupffer/NN cell/NN hyperplasia/NN in/IN 33/CD %/SYM ./.
P00590425A02
It/PRP was/VBD observed/VBN that/IN the/DT matrix/NN and/CC fibrillary/JJ structure/NN became/VBD more/RB abundant/JJ in/IN the/DT mesangial/JJ cells/NNS and/CC also/RB in/IN the/DT epicytes/NNS ;/: it/PRP was/VBD noted/VBN that/IN the/DT Golgi/NN apparatus/NN was/VBD active/JJ and/CC the/DT granular/JJ endoplasmic/JJ reticulum/NN was/VBD very/RB enlarged/VBN ,/, partially/RB containing/VBG structures/NNS of/IN a/DT particular/JJ shape/NN ./.
P00608931A01
According/VBG to/TO studies/NNS carried/VBN out/RP using/VBG the/DT optical/JJ microscope/NN and/CC the/DT electron/NN microscope/NN quingestanol/NN acetate/NN ,/, which/WDT is/VBZ a/DT powerful/JJ progestagen/NN ,/, modified/VBD significantly/RB the/DT histology/NN and/CC the/DT histochemistry/NN of/IN the/DT endometrium/NN ./.
P00634556A04
The/DT cells/NNS contained/VBD coarse/JJ granular/JJ and/CC fibrillar/JJ material/NN in/IN the/DT cytoplasm/NN and/CC large/JJ granules/NNS in/IN the/DT nuclei/NNS ./.
P00675650A02
100/CD of/IN these/DT cases/NNS showed/VBD occlusion/NN in/IN the/DT ilio-femoral/JJ area/NN and/CC 6/CD in/IN the/DT axillary/JJ area/NN ./.
P00683476A01
Cells/NNS in/IN the/DT male/NN fowl/NN brain/NN which/WDT accumulate/VBP radioactivity/NN following/VBG 3H/NN testosterone/NN (/( T/NN )/) administration/NN were/VBD identified/VBN by/IN autoradiography/NN ./.
P00690888A15
The/DT data/NNS suggest/VBP that/IN the/DT inhibition/NN of/IN net/JJ fluid/NN transport/NN by/IN ouabain/NN is/VBZ indirect/JJ and/CC mediated/VBN by/IN changes/NNS in/IN intracellular/JJ ion/NN concentrations/NNS ./.
P00709534A01
History/NN and/CC clinical/JJ findings/NNS of/IN 18/CD cases/NNS of/IN adenosquamous/JJ carcinoma/NN of/IN the/DT skin/NN appendages/NNS found/VBN among/IN 135/CD cases/NNS of/IN primary/JJ carcinoma/NN of/IN the/DT vulva/NN seen/VBN at/IN the/DT University/NN of/IN Minnesota/NN Hospital/NN between/IN 1951/CD and/CC 1970/CD were/VBD analyzed/VBN ./.
P00735240A03
If/IN other/JJ diagnostic/JJ methods/NNS fail/VBP ,/, to/TO the/DT interest/NN of/IN an/DT early/JJ ascertainment/NN of/IN the/DT diagnosis/NN the/DT performance/NN of/IN a/DT test/NN excision/NN should/MD not/RB be/VBP delayed/VBN ./.
P00752233A03
The/DT light/JJ intervals/NNS are/VBP subjectively/RB estimated/VBN as/IN longer/JJR than/IN the/DT dark/JJ ones/NNS ./.
P00785612A05
The/DT Mayo-Smith/NN program/NN had/VBD a/DT much/RB larger/JJR number/NN of/IN disagreements/NNS with/IN the/DT clinical/JJ cardiologists/NNS ,/, and/CC was/VBD far/RB less/RB acceptable/JJ for/IN clinical/JJ use/NN in/IN their/PRP$ opinion/NN ./.
P00812305A03
With/IN increase/NN of/IN the/DT distance/NN and/CC reduction/NN of/IN the/DT time/NN of/IN contact/NN the/DT risk/NN of/IN meningococcus/NN infection/NN in/IN a/DT collective/JJ body/NN falls/VBZ to/TO the/DT zero/CD (/( no/PDT such/DT phenomenon/NN is/VBZ observed/VBN in/IN other/JJ droplet/NN infections/NNS )/) ./.
P00838772A03
A/DT major/JJ portion/NN of/IN total/JJ cytochrome/NN c/NN oxidase/NN (/( mitochondrial/JJ marker/NN )/) activity/NN was/VBD also/RB recovered/VBN in/IN this/DT fraction/NN ,/, with/IN the/DT remainder/NN sedimenting/NN between/IN 640/CD and/CC 6,000/CD g/NN ./.
P00853493A01
Permits/NNS to/TO maintain/VB the/DT articular/JJ gape/NN that/WDT is/VBZ necessary/JJ on/IN the/DT various/JJ angles/NNS of/IN rotation/NN of/IN the/DT joint/NN ,/, without/IN the/DT intervention/NN of/IN an/DT assistant/NN ,/, to/TO examine/VB on/IN a/DT remove-operated/JJ table/NN with/IN centring/NN on/IN telescopy/NN and/CC eventually/RB for/IN tomo-arthrography/NN ./.
P00869925A03
The/DT content/NN of/IN glycine/NN ,/, proline/NN and/CC dicarboxylicamino/JJ acids/NNS accounts/VBZ for/IN 83/CD %/SYM of/IN the/DT total/JJ resideus/NNS of/IN protein/NN C/NN and/CC it/PRP contains/VBZ 2.0/CD mol/NN of/IN P/NN //SYM mol/NN of/IN protein/NN ,/, most/RBS likely/JJ as/IN phosphoserine/NN ./.
P00876697A08
Maternal/JJ nutrition/NN immediately/RB before/IN delivery/NN has/VBZ considerable/JJ effect/NN on/IN the/DT circulating/JJ concentrations/NNS of/IN metabolites/NNS and/CC the/DT responses/NNS to/TO cold/NN of/IN the/DT newborn/NN ./.
P00901702A06
4/CD Following/VBG amphetamine/NN (/( 30/CD mg/NN )/) ,/, two/CD of/IN six/CD narcoleptic/JJ subjects/NNS had/VBD an/DT increase/NN in/IN plasma/NN growth/NN hormone/NN concentration/NN ./.
P00942722A01
The/DT metaphase/NN spindle/NN of/IN haploid/NN Dictyostelium/NN discoideum/NN (/( n/NN =/SYM 7/CD )/) is/VBZ 2/CD mum/NN long/JJ ./.
P00949648A06
The/DT literature/NN on/IN extrauterine/JJ pregnancy/NN is/VBZ reviewed/VBN briefly/RB ./.
P00963737A07
The/DT third/JJ type/NN of/IN cell/NN is/VBZ small/JJ ,/, and/CC can/MD not/RB yet/RB be/VBP identified/VBN ./.
P01003633A02
Our/PRP$ report/NN concerns/VBZ its/PRP$ use/NN in/IN 5/CD cases/NNS as/IN the/DT sole/JJ medical/JJ agent/NN for/IN dissolving/NN pelvic/JJ stones/NNS and/CC in/IN 6/CD others/NNS to/TO supplement/VB an/DT operation/NN and/CC dissolve/VB postoperative/JJ residual/JJ concretions/NNS ./.
P01013679A11
Without/IN involving/NN a/DT higher/JJR operative/JJ risk/NN ,/, the/DT open/JJ approach/NN to/TO mitral/JJ commissurotomy/NN offers/VBZ the/DT following/JJ main/JJ advantages/NNS :/: safe/JJ removal/NN of/IN intraatrial/JJ thrombi/NNS ,/, precise/JJ and/CC complete/JJ incision/NN of/IN the/DT fused/JJ commissures/NNS under/IN direct/JJ vision/NN ,/, avoidance/NN of/IN leaflet/NN tears/NNS ,/, separation/NN of/IN fused/JJ chordae/NN tendineae/NN and/CC incision/NN of/IN papillary/JJ muscles/NNS in/IN order/NN to/TO remove/VB subvalvular/JJ stenosis/NN ,/, debridement/NN of/IN calcium/NN from/IN leaflets/NNS ,/, and/CC repair/NN of/IN concomitant/JJ mitral/JJ regurgitation/NN by/IN valvuloplasty/NN ./.
P01035397A13
It/PRP was/VBD taken/VBN advantage/NN of/IN this/DT situation/NN to/TO remove/VB the/DT larvae/NNS with/IN a/DT pair/NN of/IN nippers/NNS ./.
P01067614A02
When/WRB such/DT cells/NNS are/VBP pulse-labeled/VBN with/IN [/( 3H/NN ]/) thymidine/NN during/IN the/DT peak/NN of/IN DNA/NN synthesis/NN on/IN day/NN 3/CD of/IN culture/NN ,/, then/RB cultured/VBN for/IN 3/CD more/DT days/NNS in/IN the/DT absence/NN of/IN isotope/NN ,/, labeled/JJ DNA/NN moves/VBZ slowly/RB into/IN the/DT Hirt/NN supernatant/NN cell/NN fraction/NN from/IN the/DT pellet/NN fraction/NN containing/VBG chromosomal/JJ DNA/NN ,/, and/CC then/RB into/IN the/DT culture/NN medium/NN ./.
P01082235A09
It/PRP is/VBZ conceivable/JJ that/IN the/DT great/JJ increase/NN in/IN resistance/NN duroing/VBG the/DT hypotonic/JJ period/NN was/VBD caused/VBN by/IN the/DT occlusion/NN of/IN the/DT gland/NN lumina/NNS ./.
P01115102A03
Rather/RB ,/, the/DT data/NNS suggest/VBP that/IN satisfaction/NN with/IN the/DT specific/JJ agency/NN is/VBZ the/DT chief/JJ determinant/NN of/IN overall/JJ satisfaction/NN ./.
P01141184A02
Celite/NN retains/VBZ all/DT interfering/JJ materials/NNS including/VBG Lipids/NNS whereas/IN the/DT chlorinated/JJ Insecticides/NNS are/VBP eluted/VBN from/IN the/DT column/NN with/IN n-hexane/NN ./.
P01164398A04
When/WRB the/DT mice/NNS were/VBD injected/VBN intraperitoneally/RB (/( i.p./NN )/) with/IN OK-432/NN at/IN 2/CD months/NNS of/IN age/NN ,/, they/PRP produced/VBD natural/JJ antibodies/NNS to/TO GCSAs/NNS or/CC to/TO PCl/NN antigen/NN ,/, unlike/IN untreated/JJ mice/NNS of/IN the/DT same/JJ strains/NNS at/IN the/DT same/JJ ages/NNS (/( negative/JJ controls/NNS )/) ,/, which/WDT produced/VBD no/DT antibodies/NNS ./.
P01180233A06
No/DT appreciable/JJ acidic/JJ mucosubstance/NN was/VBD demonstrated/VBN in/IN the/DT submandibular/JJ gland/NN mucous/NN tubules/NNS ./.
P01188237A10
The/DT integrity/NN of/IN the/DT postero-median/JJ part/NN of/IN the/DT frontal/JJ lobe/NN is/VBZ indespensable/JJ for/IN a/DT normal/JJ reaction/NN by/IN speech/NN to/TO stimuli/NNS received/VBN from/IN the/DT sensory/JJ areas/NNS ./.
P01212821A04
If/IN procured/VBN from/IN sensitized/JJ donors/NNS ,/, macrophage/NN migration/NN was/VBD inhibited/VBN by/IN the/DT corresponding/JJ antigen/NN ./.
P01243606A01
Recent/JJ progress/NN in/IN the/DT field/NN of/IN radioimmunology/NN ,/, especially/RB as/IN regards/VBZ prolactin/NN (/( PRL/NN )/) assay/NN ,/, as/RB well/RB as/IN the/DT use/NN of/IN new/JJ drugs/NNS have/VBP opened/VBN new/JJ perspectives/NNS for/IN a/DT better/RBR understanding/NN of/IN the/DT "/`` amenorrhoea-galactorrhea/NN syndrome/NN "/'' both/CC from/IN the/DT diagnostic/JJ and/CC therapeutic/JJ points/NNS of/IN view/NN ./.
P01273208A02
In/IN the/DT present/JJ study/NN five/CD normal/JJ adult/NN men/NNS were/VBD administered/VBN saline/NN and/CC two/CD doses/NNS of/IN of/IN haloperidol/NN (/( 0.25/CD mg/NN ,/, 0.5/CD mg/NN )/) intramuscularly/RB in/IN a/DT double-blind/JJ randomized/JJ block/NN design/NN ./.
P01279668A08
In/IN contrast/NN ,/, almost/RB all/DT (/( 98/CD %/SYM )/) two-cell/NN embryos/NNS cultured/VBN with/IN a/DT modified/JJ (/( chimeric/JJ phosphorothioate/NN //SYM phosphodiester/NN )/) antisense/NN c-myc/NN oligo/NN (/( 7.5/CD microM/NN )/) exhibited/VBD developmental/JJ arrest/NN at/IN the/DT eight-cell/NN //SYM morula/NN stage/NN ,/, whereas/IN no/DT developmental/JJ arrest/NN occurred/VBD following/VBG incubation/NN with/IN high/JJ concentrations/NNS of/IN the/DT modified/JJ sense/NN complement/NN (/( 30/CD microM/NN )/) ./.
P01288403A05
Many/JJ treatments/NNS have/VBP been/VBN proposed/VBN ,/, but/CC the/DT follow-up/NN is/VBZ often/RB inadequate/JJ ./.
P01293316A08
Empirically/RB ,/, we/PRP found/VBD L/NN =/SYM constant.LVW-0.28/NN (/( r/NN =/SYM 0.43/CD ,/, P/NN </SYM 0.01/CD )/) ./.
P01307725A04
However/WRB ,/, in/IN the/DT work/NN reported/VBN here/RB ,/, we/PRP found/VBD that/IN treatment/NN with/IN 2-deoxyglucose/NN (/( 2-DOG/NN )/) irreversibly/RB altered/VBD the/DT cells/NNS :/: when/WRB poisoned/JJ human/NN neutrophils/NNS were/VBD then/RB permeabilized/VBN ,/, the/DT cells/NNS failed/VBD to/TO degranulate/VB well/RB in/IN response/NN to/TO Ca2+/NN ,/, and/CC their/PRP$ sensitivity/NN to/TO Ca2+/NN could/MD not/RB be/VBP recovered/VBN by/IN the/DT readdition/NN of/IN ATP/NN ./.
P01315770A01
The/DT smg-25A/NN //SYM rab3A/NN protein/NN (/( smg/NN p25A/NN )/) ,/, a/DT member/NN of/IN the/DT small/JJ GTP-binding/JJ protein/NN superfamily/NN ,/, has/VBZ a/DT C-terminal/JJ structure/NN of/IN Cys-Ala-Cys/NNS which/WDT is/VBZ post-translationally/RB processed/VBN :/: both/DT cysteine/NN residues/NNS are/VBP geranylgeranylated/VBN followed/VBN by/IN the/DT carboxyl/NN methylation/NN of/IN the/DT C-terminal/JJ cysteine/NN residue/NN ./.
P01319709A07
Our/PRP$ data/NNS suggest/VBP that/IN the/DT incidence/NN of/IN angioedema/NN associated/VBN with/IN lisinopril/NN is/VBZ greater/JJR than/IN that/PRP associated/VBN with/IN captopril/NN or/CC enalapril/NN ./.
P01331546A01
A/DT prospective/JJ study/NN examining/VBG the/DT incidence/NN of/IN dimercaptosuccinic/JJ acid/NN (/( DMSA/NN )/) abnormalities/NNS in/IN children/NNS at/IN the/DT time/NN of/IN acute/JJ urinary/JJ tract/NN infection/NN ,/, the/DT progression/NN of/IN these/DT abnormalities/NNS following/VBG treatment/NN and/CC their/PRP$ correlation/NN with/IN the/DT presence/NN of/IN vesicoureteral/JJ reflux/NN is/VBZ reported/VBN ./.
P01335473A06
This/PRP explains/VBZ the/DT inhibition/NN of/IN ACTH-stimulated/JJ cortisol/NN synthesis/NN by/IN midazolam/NN (/( 50/CD %/SYM inhibitor/NN dose/NN (/( IC50/NN )/) 22/CD mumol/NN //SYM l/NN )/) ./.
P01344159A04
Effectiveness/NN in/IN the/DT therapeutic/JJ intervention/NN on/IN ischaemic/JJ injury/NN bore/VBD an/DT inverse/JJ relation/NN with/IN the/DT degree/NN of/IN PIS/NN or/CC the/DT "/`` risk/NN region/NN "/'' ./.
P01358974A03
To/TO evaluate/VB the/DT immunogenic/JJ potential/NN of/IN IL-2-releasing/JJ neoplastic/JJ cells/NNS ,/, we/PRP used/VBD an/DT expression/NN vector/NN to/TO introduce/VB the/DT cDNA/NN coding/VBG for/IN murine/JJ IL-2/NN into/IN TS/NN //SYM A/NN cells/NNS ./.
P01369116A01
The/DT introduction/NN of/IN new/JJ technology/NN and/CC increased/JJ effort/NN from/IN around/IN the/DT world/NN is/VBZ driving/VBG the/DT completion/NN of/IN the/DT human/NN gene/NN map/NN ./.
P01376918A07
The/DT phosphorylatable/JJ serines/NNS detected/VBN by/IN the/DT SMI/NN antibodies/NNS are/VBP part/NN of/IN Ser-Pro/NN motifs/NNS and/CC can/MD be/VBP phosphorylated/VBN by/IN a/DT protein/NN kinase/NN activity/NN that/WDT can/MD be/VBP used/VBN to/TO induce/VB a/DT paired/JJ helical/JJ filament-like/JJ state/NN in/IN human/NN brain/NN tau/NN in/FW vitro/FW ./.
P01384656A03
Two/CD genes/NNS of/IN interest/NN are/VBP localized/VBN near/IN the/DT breakpoints/NNS ,/, the/DT transferrin/NN receptor/NN gene/NN and/CC the/DT ETS2/NN proto-oncogene/NN ./.
P01388785A08
She/PRP died/VBD with/IN sepsis/NN after/IN several/JJ viral/JJ and/CC bacterial/JJ infections/NNS ./.
P01402199A03
Three/CD days/NNS later/RB ,/, the/DT perforation/NN of/IN noncoronary/JJ sinus/NN of/IN Valsalva/NN into/IN the/DT right/JJ atrium/NN was/VBD noted/VBN and/CC she/PRP developed/VBD progressive/JJ heart/NN failure/NN due/JJ to/TO the/DT massive/JJ left-to-right/NN shunt/NN ./.
P01406835A08
The/DT two/CD regimens/NNS produced/VBD comparable/JJ objective/NN responses/NNS ,/, but/CC the/DT regimen/NN including/VBG interferon/NN had/VBD a/DT greater/JJR effect/NN in/IN prolonging/NN the/DT time/NN to/TO treatment/NN failure/NN (/( P/NN </SYM 0.001/CD )/) and/CC the/DT duration/NN of/IN complete/JJ response/NN (/( P/NN =/SYM 0.03/CD )/) ./.
P01416824A01
Teicoplanin/NN was/VBD compared/VBN with/IN vancomycin/NN for/IN the/DT prophylaxis/NN of/IN experimental/JJ Enterococcus/NN faecalis/NN endocarditis/NN in/IN rats/NNS ./.
P01421106A05
These/DT and/CC other/DT findings/NNS suggest/VBP that/IN kinetic/JJ compression/NN injuries/NNS of/IN the/DT adult/NN spinal/JJ cord/NN can/MD result/VBP in/IN regeneration-associated/JJ gene/NN expression/NN in/IN intrinsic/JJ CNS/NN neurons/NNS ./.
P01434269A02
Most/PRP of/IN the/DT patients/NNS with/IN renal/JJ cell/NN carcinoma/NN in/IN the/DT last/JJ 10/CD years/NNS were/VBD examined/VBN in/IN Chiba/NNP prefecture/NN ,/, which/WDT has/VBZ a/DT population/NN of/IN about/RB five/CD million/CD and/CC 25/CD active/JJ urological/JJ offices/NNS ./.
P01439452A08
In/IN patients/NNS treated/VBN with/IN streptokinase/NN ,/, the/DT hemorrhage/NN was/VBD probably/RB due/JJ to/TO a/DT more/RB than/IN 80/CD %/SYM decrease/NN in/IN plasma/NN fibrinogen/NN ./.
P01448457A08
In/IN contrast/NN to/TO the/DT effect/NN of/IN carbohydrate-rich/JJ meals/NNS ,/, an/DT enteric/JJ augmentation/NN of/IN insulin/NN release/NN seems/VBZ to/TO be/VB of/IN minor/JJ and/CC possibly/RB of/IN no/DT importance/NN during/IN ingestion/NN of/IN protein-rich/JJ meals/NNS ./.
P01452940A14
Left/JJ ventricular/JJ diastolic/JJ function/NN assessed/VBN by/IN the/DT relaxation/NN time/NN constant/NN was/VBD prolonged/VBN ,/, the/DT peak/JJ filling/JJ rate/NN was/VBD decreased/VBN and/CC left/JJ ventricular/JJ stiffness/NN was/VBD increased/VBN in/IN the/DT supraventricular/JJ tachycardia/NN group/NN ./.
P01457715A09
The/DT patient/NN died/VBD in/IN a/DT few/JJ hours/NNS ,/, with/IN the/DT diagnosis/NN of/IN hypovolaemic/JJ shock/NN caused/VBN by/IN a/DT burst/JJ AAA/NN ./.
P01467526A06
Of/IN the/DT other/JJ 12/CD patients/NNS (/( all/DT sibling/JJ donors/NNS )/) ,/, 11/CD received/JJ TBI/NN plus/CC Cy/NN plus/CC another/DT agent/NN :/: VP16/NN ,/, carboplatinum/NN ,/, or/CC AZQ/NN ./.
P01472366A04
Median/JJ survival/NN time/NN with/IN respect/NN to/TO cancer/NN death/NN was/VBD 18/CD months/NNS in/IN the/DT take/JJ group/NN ,/, as/IN compared/VBN with/IN over/RB 74/CD months/NNS in/IN the/DT non-take/NN group/NN (/( p/NN =/SYM 0.06/CD )/) ./.
P01481504A03
Bradyarrhythmia/NN was/VBD found/VBN to/TO occupy/VB a/DT major/JJ place/NN in/IN the/DT pathogenesis/NN of/IN cerebrovascular/JJ disorders/NNS ./.
P01486017A13
Interestingly/RB ,/, the/DT number/NN of/IN CRF/NN receptors/NNS are/VBP increased/VBN in/IN cortical/JJ areas/NNS of/IN Alzheimer/NNP brains/NNS ./.
P01490680A07
Preliminary/JJ data/NNS suggest/VBP release/NN after/IN oral/JJ glucose/NN despite/IN localization/NN of/IN the/DT GLPI/NN containing/JJ cells/NNS predominantly/RB in/IN the/DT ileum/NN and/CC colon/NN ./.
P01505424A02
Risk/NN behaviours/NNS that/WDT could/MD have/VBP predisposed/VBN him/PRP to/TO HIV/NN infection/NN are/VBP discussed/VBN ./.
P01514474A04
Proper/JJ positioning/NN of/IN the/DT patient/NN and/CC placement/NN of/IN a/DT unilateral/JJ eye/NN shield/NN are/VBP the/DT first/JJ steps/NNS in/IN management/NN ./.
P01523257A04
In/IN Experiment/NN 2/CD ,/, injections/NNS of/IN either/CC 0/CD ,/, 0.25/CD ,/, or/CC 0.50/CD mg/NN //SYM kg/NN pimozide/NN were/VBD given/VBN every/DT 12/CD hours/NNS to/TO rats/NNS subjected/VBN to/TO the/DT activity-stress/NN paradigm/NN ./.
P01536727A03
The/DT two/CD groups/NNS of/IN patients/NNS did/VBD not/RB differ/VBP significantly/RB in/IN sex/NN distribution/NN ,/, age/NN of/IN onset/NN of/IN disease/NN ,/, duration/NN of/IN disease/NN ,/, number/NN of/IN relapses/NNS and/CC histological/JJ findings/NNS ./.
P01541558A09
The/DT association/NN is/VBZ apparently/RB not/RB a/DT classic/JJ antibody-antigen/NN interaction/NN but/CC may/MD result/VBP from/IN other/JJ mechanisms/NNS ./.
P01555593A02
Its/PRP$ fate/NN was/VBD then/RB followed/VBN using/VBG a/DT sensitive/JJ enzyme/NN immunoassay/NN for/IN cystatin/NN alpha/NN ./.
P01564746A03
In/IN addition/NN ,/, the/DT pretrichial/JJ modification/NN of/IN it/PRP can/MD be/VBP used/VBN without/IN alteration/NN in/IN the/DT hairline/NN ./.
P01578842A04
The/DT control/NN group/NN consisted/VBD of/IN 35/CD volunteers/NNS whose/WDT ages/NNS ranged/VBD from/IN 18/CD to/TO 50/CD years/NNS ./.
P01583457A12
Under/IN conditions/NNS of/IN high/JJ input/NN pressure/NN and/CC high/JJ output/NN pressure/NN ,/, power/NN output/NN increased/VBD by/IN 20/CD %/SYM compared/VBN to/TO hypoxic/JJ hearts/NNS without/IN coronary/JJ perfusion/NN ./.
P01592637A06
The/DT remaining/JJ 29/CD patients/NNS were/VBD treated/VBN according/VBG to/TO the/DT above/JJ protocol/NN ./.
P01597274A08
A/DT conservative/JJ clinical/JJ haemorrhage/NN control/NN attempt/NN is/VBZ possible/JJ in/IN exceptional/JJ cases/NNS only/RB ./.
P01606931A05
By/IN Week/NN 4/CD of/IN conditioning/NN ,/, although/IN the/DT insulin/NN and/CC glucose/NN indices/NNS continued/VBD to/TO decrease/VB in/IN the/DT exercised/JJ ponies/NNS ,/, there/EX was/VBD no/DT significant/JJ difference/NN between/IN the/DT groups/NNS ./.
P01616444A01
The/DT seminiferous/JJ tubular/JJ compartment/NN of/IN the/DT human/NN testis/NN occupies/VBZ about/IN two/CD thirds/NNS of/IN the/DT volume/NN of/IN the/DT organ/NN and/CC is/VBZ supported/VBN by/IN loose/JJ connective/JJ tissue/NN containing/VBG the/DT Leydig/NN cells/NNS ./.
P01620907A03
Mean/JJ length/NN of/IN postoperative/JJ stay/NN was/VBD extended/VBN from/IN 7.8/CD to/TO 10.7/CD days/NNS in/IN those/PRP developing/VBG infection/NN (/( P/NN less/RB than/IN 0.05/CD )/) ./.
P01625403A06
The/DT average/JJ ages/NNS of/IN the/DT sources/NNS ,/, those/PRP who/WP were/VBD infected/VBN secondly/RB and/CC those/PRP who/WP had/VBD given/VBN chemoprophylaxis/NN were/VBD 44.8/CD ,/, 32.2/CD and/CC 7.7/CD years/NNS of/IN age/NN respectively/RB ./.
P01630025A07
This/DT case/NN was/VBD of/IN interest/NN with/IN respect/NN to/TO blood/NN cell/NN differentiation/NN and/CC immunological/JJ findings/NNS ./.
P01639726A02
Similar/JJ to/TO other/JJ mammals/NNS ,/, the/DT input/NN //SYM output/NN (/( I/NN //SYM O/NN )/) functions/NNS of/IN 2f1-f2/NN show/VBP non-monotonicities/NNS and/CC notches/NNS at/IN f1/NN levels/NNS between/IN 40-70/CD dB/NN SPL/NN ./.
P01648117A02
The/DT baseline/NN hormonal/JJ pattern/NN revealed/VBD low/JJ glucocorticoid/NN levels/NNS (/( 17-hydroxyprogesterone/NN ,/, plasma/NN and/CC urinary/JJ cortisol/NN ,/, cortisol/NN secretion/NN rate/NN )/) ,/, as/RB well/RB as/IN androgen/NN (/( testosterone/NN and/CC dehydroepiandrosterone/NN sulfate/NN )/) and/CC estrogen/NN (/( 17-beta-estradiol/NN )/) levels/NNS ,/, since/IN the/DT defect/NN is/VBZ present/JJ at/IN both/CC adrenal/JJ and/CC gonadal/JJ levels/NNS ./.
P01652125A07
Both/CC an/DT elevation/NN of/IN ambient/JJ osmolality/NN to/TO 600-750/CD mOsm/NN //SYM kg/NN and/CC disruption/NN of/IN the/DT cytoskeleton/NN by/IN cytochalasin/NN B/NN (/( 0.1/CD mmol/NN //SYM l/NN )/) reduce/VBP initial/JJ FITC-albumin/NN uptake/NN by/IN 50/CD %/SYM -60/CD %/SYM in/IN a/DT non-additive/JJ fashion/NN ./.
P01659998A01
The/DT spin-lattice/NN relaxation/NN of/IN the/DT tyrosine/NN radical/NN D./NN in/IN Photosystem/NN II/CD particles/NNS was/VBD studied/VBN at/IN 4.2/CD K/NN in/IN samples/NNS in/IN which/WDT flash-induced/JJ oscillations/NNS of/IN the/DT oxidation/NN state/NN of/IN the/DT Mn-cluster/NN of/IN the/DT oxygen/NN evolving/JJ system/NN were/VBD abolished/VBN by/IN addition/NN of/IN ANT2P/NN ,/, leaving/VBG Fe2+/NN //SYM Fe3+/NN oscillations/NNS intact/JJ ./.
P01668590A04
The/DT neurosecretory/JJ structures/NNS were/VBD found/VBN only/RB in/IN the/DT caudal/JJ portion/NN ./.
P01679042A05
The/DT heat/NN shock/NN response/NN is/VBZ discussed/VBN with/IN regard/NN to/TO the/DT possible/JJ importance/NN of/IN transcriptional/JJ regulation/NN of/IN mycobacterial/JJ genes/NNS in/FW vivo/FW ./.
P01692303A01
In/IN order/NN to/TO elucidate/VB the/DT relationship/NN between/IN the/DT structure/NN and/CC function/NN of/IN proteins/NNS encoded/VBN for/IN by/IN the/DT Ly-6/NN gene/NN complex/NN ,/, a/DT cDNA/NN was/VBD constructed/VBN for/IN a/DT Ly-6.2/NN specificity/NN and/CC then/RB monoclonal/JJ antibodies/NNS (/( mAb/NN )/) generated/VBN to/TO bacterially/RB synthesized/JJ protein/NN ./.
P01700197A01
Migration/NN of/IN microvessel/NN endothelial/JJ cells/NNS (/( MEC/NN )/) in/IN response/NN to/TO angiogenic/JJ stimuli/NNS is/VBZ a/DT key/JJ aspect/NN of/IN angiogenesis/NN ,/, whether/IN in/IN physiologic/JJ or/CC pathologic/JJ situations/NNS ./.
P01707938A01
The/DT effect/NN of/IN interferons/NNS (/( IFNs/NNS )/) on/IN growth/NN inhibition/NN and/CC carcinoembryonic/JJ antigen/NN (/( CEA/NN )/) secretion/NN by/IN 14/CD established/JJ human/NN colorectal/JJ carcinoma/NN cell/NN lines/NNS was/VBD studied/VBN in/FW vitro/FW ./.
P01715895A02
We/PRP have/VBP now/RB investigated/VBN the/DT intracellular/JJ mechanisms/NNS involved/VBN in/IN RVV-stimulated/JJ GH/NN release/NN by/IN concomitant/JJ administration/NN of/IN RVV/NN with/IN known/JJ intracellular/JJ mediators/NNS in/IN rat/NN pituitary/NN cells/NNS ./.
P01719762A06
This/DT change/NN in/IN the/DT levels/NNS of/IN CFTR/NN mRNA/NN is/VBZ correlated/VBN with/IN the/DT morphological/JJ differentiation/NN that/WDT occurs/VBZ in/IN Caco2/NN cells/NNS during/IN culture/NN ./.
P01728238A07
There/EX have/VBP been/VBN 51/CD late/JJ deaths/NNS ,/, 45/CD cardiac/JJ ./.
P01737343A03
In/IN terms/NNS of/IN changing/NN the/DT R/NN group/NN ,/, maximum/NN cytotoxic/JJ effects/NNS were/VBD conferred/VBN by/IN alicyclic/JJ substituents/NNS ./.
P01746895A02
TAG-72/NN was/VBD detected/VBN in/IN the/DT serum/NN of/IN a/DT significant/JJ percentage/NN of/IN patients/NNS whose/WDT CEA/NN levels/NNS were/VBD negative/JJ which/WDT underscores/VBZ the/DT possibility/NN of/IN exploiting/NN the/DT complementarity/NN of/IN the/DT two/CD tumor/NN markers/NNS in/IN the/DT diagnosis/NN of/IN gastrointestinal/JJ (/( G.I./NN )/) carcinoma/NN ./.
P01756258A01
Deregulated/JJ expression/NN of/IN the/DT RAS/NN oncogene/NN is/VBZ associated/VBN with/IN tumorigenic/JJ transformation/NN of/IN mammary/JJ cells/NNS ./.
P01760749A05
On/IN a/DT given/JJ day/NN ,/, an/DT animal/NN was/VBD infused/VBN with/IN methylphenidate/NN ,/, tyrosine/NN ,/, or/CC methylphenidate/NN plus/CC tyrosine/NN ./.
P01765260A09
Intercrosses/NNS of/IN heterozygous/JJ females/NNS and/CC hemizygous/JJ males/NNS yielded/VBD 5.5/CD %/SYM aneuploidy/NN for/IN Rb/NN (/( X.2/NN )/) 2Ad/NN and/CC 5.4/CD %/SYM for/IN Rb/NN (/( X.9/NN )/) 6H/NN ./.
P01783790A04
The/DT older/JJR women/NNS were/VBD more/RB interested/VBN in/IN educating/NN their/PRP$ children/NNS ./.
P01793488A08
The/DT resulting/JJ cell/NN lines/NNS (/( UV5P1/NN ,/, 5P1R1/NN ,/, and/CC 5P1R3/NN )/) expressed/VBD arylhydrocarbon/NN hydroxylase/NN activity/NN ./.
P01798278A09
Thus/RB ,/, active/JJ O2/NN species/NNS may/MD contribute/VBP to/TO vascular/JJ responses/NNS in/IN pathophysiological/JJ situations/NNS associated/VBN with/IN their/PRP$ formation/NN (/( e.g./IN inflammation/NN ,/, ischemia/NN //SYM reperfusion/NN ,/, etc./NN )/) and/CC to/TO the/DT physiological/JJ regulation/NN of/IN vascular/JJ tone/NN produced/VBN by/IN changes/NNS in/IN O2/NN tension/NN (/( e.g./IN reactive/JJ hyperemia/NN ,/, hypoxic/JJ vasoconstriction/NN ,/, etc/NN )/) ./.
P01812676A03
More/RB frequently/RB ,/, however/WRB ,/, the/DT behavior/NN is/VBZ associated/VBN with/IN additional/JJ behavior/NN problems/NNS or/CC is/VBZ part/NN of/IN other/JJ psychopathological/JJ syndromes/NNS ,/, e.g./IN conduct/NN disorder/NN ./.
P01822479A02
This/DT article/NN addresses/VBZ the/DT health/NN problems/NNS and/CC care/NN needs/NNS of/IN young/JJ children/NNS in/IN American/JJ cities/NNS and/CC summarizes/VBZ the/DT nursing/JJ knowledge/NN and/CC skills/NNS needed/VBN for/IN urban/JJ nursing/JJ practice/NN ./.
P01831450A06
These/DT results/NNS demonstrate/VBP advantages/NNS of/IN oscillatory/JJ behavior/NN of/IN glycolysis/NN in/IN the/DT regulation/NN of/IN carbohydrate/NN utilization/NN and/CC the/DT maintenance/NN of/IN a/DT high/JJ [/( ATP/NN ]/) //SYM [/( ADP/NN ]/) ratio/NN ./.
P01848936A01
Treatment/NN of/IN splenic/JJ leukocytes/NNS from/IN Cornell/NN K/NN strain/NN male/NN chickens/NNS (/( homozygous/JJ at/IN the/DT B15/NN locus/NN of/IN the/DT major/JJ histocompatibility/NN complex/NN )/) with/IN ovine/JJ corticotropin-releasing/JJ factor/NN (/( oCRF/NN )/) ,/, before/IN their/PRP$ co-incubation/NN with/IN naive/JJ chicken/NN adrenal/JJ cells/NNS ,/, resulted/VBD in/IN an/DT increase/NN in/IN corticosterone/NN production/NN ./.
P01858031A06
When/WRB cyclooxygenase/NN blockade/NN with/IN indomethacin/NN completely/RB prevented/VBD KC/NN production/NN of/IN PGE2/NN in/IN (/( -/SYM )/) arginine/NN culture/NN ,/, TNF-alpha/NN production/NN was/VBD upregulated/VBN (/( p/NN less/RB than/IN 0.001/CD vs/CC (/( -/SYM )/) arginine/NN ;/: p/NN not/RB significant/JJ vs/CC (/( +/SYM )/) arginine/NN )/) ./.
P01867839A08
This/PRP indicates/VBZ that/IN the/DT timing/NN of/IN allowed/JJ sleep/NN has/VBZ less/PRP of/IN an/DT immediate/JJ effect/NN on/IN circadian/JJ rhythms/NNS than/IN the/DT timing/NN of/IN the/DT external/JJ light-dark/NN cycle/NN ./.
P01881968A02
Beginning/VBG 7/CD to/TO 10/CD weeks/NNS after/IN the/DT start/NN of/IN cohabitation/NN ,/, each/DT female/NN was/VBD tested/VBN for/IN aggression/NN toward/IN an/DT unfamiliar/JJ female/NN at/IN weekly/RB intervals/NNS for/IN 3/CD weeks/NNS ./.
P01891364A05
Methylation/NN interference/NN experiments/NNS were/VBD used/VBN to/TO identify/VB purine/NN residues/NNS involved/VBN in/IN this/DT protein-DNA/NN interaction/NN ./.
P01900481A04
Luteinizing/JJ hormone/NN (/( LH/NN )/) concentrations/NNS remained/VBD suppressed/VBN ./.
P01909013A05
An/DT additional/JJ eight/CD cases/NNS manifested/VBD otitis/NN media/NNS or/CC eustachian/JJ tube/NN dysfunction/NN ./.
P01917874A07
Our/PRP$ results/NNS provide/VBP support/NN for/IN the/DT existence/NN of/IN a/DT cellular/JJ repressor/NN in/IN B./NN subtilis/NN that/WDT is/VBZ functionally/RB homologous/JJ to/TO the/DT E./NN coli/NN LexA/NN repressor/NN and/CC suggest/VBP that/IN the/DT mechanism/NN by/IN which/WDT B./NN subtilis/NN RecA/NN protein/NN (/( like/IN RecA/NN of/IN E./NN coli/NN )/) becomes/VBZ activated/VBN to/TO promote/VB the/DT induction/NN of/IN the/DT SOS/NN response/NN is/VBZ also/RB conserved/VBN ./.
P01927617A07
Long/JJ term/NN results/NNS are/VBP analyzed/VBN as/RB well/RB ./.
P01940987A02
Contrast-enhanced/JJ T1-weighted/JJ MRI/NN revealed/VBD the/DT characteristic/JJ basal/JJ meningeal/JJ inflammation/NN of/IN TbM/NN and/CC its/PRP$ focal/JJ spreading/NN into/IN adjacent/JJ brain/NN ./.
P01945815A08
Trauma/NN in/IN the/DT maxillary/JJ region/NN have/VBP caused/VBN fracture/NN of/IN the/DT implants/NNS in/IN 5/CD patients/NNS ./.
P01960280A03
Thresholds/NNS were/VBD estimated/VBN using/VBG two/CD different/JJ adaptive/JJ procedures/NNS and/CC the/DT method/NN of/IN constant/JJ stimuli/NNS ./.
P01965027A03
While/IN 204/CD children/NNS presented/VBD gastrointestinal/JJ symptoms/NNS with/IN diarrhoea/NN ,/, 12/CD had/VBD subclinical/JJ signs/NNS ,/, 26/CD presented/VBD only/RB respiratory/JJ symptoms/NNS and/CC 22/CD had/VBD no/DT clinical/JJ symptomatology/NN ./.
P01974569A02
TIL/NN were/VBD produced/VBN by/IN culturing/NN Thy-1-enriched/JJ single/JJ cell/NN suspensions/NNS from/IN a/DT variety/NN of/IN murine/JJ tumors/NNS in/IN exogenous/JJ IL-2/NN along/JJ with/IN irradiated/JJ tumor/NN cells/NNS and/CC splenocytes/NNS ./.
P01984233A04
We/PRP prospectively/RB studied/VBD 55/CD insulin-dependent/JJ diabetic/JJ patients/NNS enrolled/VBN before/IN 9/CD weeks/NNS '/POS gestation/NN through/IN two/CD consecutive/JJ pregnancies/NNS :/: sequence/NN 1/CD and/CC sequence/NN 2/CD ./.
P01988764A08
A/DT comprehensive/JJ individualized/JJ treatment/NN program/NN is/VBZ often/RB required/VBN in/IN the/DT care/NN of/IN individuals/NNS with/IN tic/NN disorders/NNS ./.
P01998718A07
N-Bromosuccinimide/NN treatment/NN for/IN modification/NN of/IN tryptophan/NN residues/NNS caused/VBD a/DT loss/NN of/IN the/DT activity/NN ,/, although/IN the/DT inhibitory/JJ sugar/NN exhibited/VBD no/DT protective/JJ effect/NN against/IN this/DT treatment/NN ./.
P02003809A05
It/PRP is/VBZ ,/, however/WRB ,/, one/CD simple/JJ but/CC effective/JJ approach/NN ,/, and/CC is/VBZ available/JJ to/TO any/DT GP/NN ./.
P02017712A01
A/DT complete/JJ and/CC comprehensive/JJ assessment/NN is/VBZ the/DT first/JJ step/NN towards/IN rational/JJ management/NN of/IN the/DT elderly/JJ patient/NN ./.
P02032225A06
Addition/NN of/IN 1/CD ,/, 25/CD (/( OH/NN )/) 2D3/NN to/TO the/DT platinum/NN resulted/VBD in/IN marginal/JJ to/TO marked/JJ enhancement/NN of/IN growth/NN inhibition/NN over/IN that/PRP observed/VBN with/IN either/DT platinum/NN alone/JJ ./.
P02046848A01
SEP/NN (/( somatosensory/JJ evoked/JJ potential/NN )/) monitoring/NN was/VBD carried/VBN out/RP on/IN seven/CD patients/NNS with/IN vertebro-basilar/JJ aneurysms/NNS during/IN balloon/NN occlusion/NN test/NN ,/, during/IN operation/NN ,/, or/CC after/IN operation/NN ./.
P02051572A06
In/IN the/DT 6/CD mg.kg-1/NN group/NN ,/, mean/NN arterial/JJ pressure/NN ,/, heart/NN rate/NN and/CC cardiac/JJ index/NN decreased/VBD significantly/RB ,/, but/CC no/DT significant/JJ changes/NNS in/IN cardiac/JJ variables/NNS were/VBD observed/VBN in/IN the/DT 2/CD mg.kg-1/NN group/NN ./.
P02060914A02
The/DT project/NN incorporated/VBD cooperative/JJ arrangements/NNS between/IN the/DT mental/JJ health/NN system/NN and/CC vocational/JJ rehabilitation/NN and/CC occupational/JJ education/NN agencies/NNS ./.
P02070492A05
Analysis/NN of/IN polydG*polydC/NN revealed/VBD a/DT similar/JJ adduct/NN pattern/NN to/TO that/PRP obtained/VBN with/IN lucidin-modified/JJ DNA/NN ./.
P02085108A01
Test/NN measures/NNS of/IN field-dependence-independence/NN and/CC impulsiveness-control/NN were/VBD obtained/VBN from/IN two/CD groups/NNS of/IN diabetic/JJ children/NNS and/CC their/PRP$ parents/NNS ,/, the/DT children/NNS being/VBG in/IN optimal/JJ (/( O/NN ,/, n/NN =/SYM 12/CD )/) or/CC poor/JJ (/( P./NN n/NN =/SYM 27/CD )/) metabolic/JJ control/NN and/CC ,/, according/VBG to/TO the/DT judgment/NN of/IN clinicians/NNS ,/, showing/VBG optimal/JJ or/CC poor/JJ psychological/JJ adaptation/NN ./.
P02089961A09
The/DT altered/JJ distributions/NNS of/IN these/DT metals/NNS suggested/VBD tissue/NN injury/NN and/CC impairment/NN of/IN red/JJ cell/NN and/CC vessel/NN wall/NN functions/NNS ./.
P02104950A06
The/DT importance/NN of/IN quality/NN as/RB well/RB as/IN length/NN of/IN life/NN as/IN health/NN outcomes/NNS has/VBZ led/VBN to/TO the/DT development/NN of/IN cost-utility/NN analysis/NN ./.
P02114041A07
These/DT data/NNS show/VBP that/IN early/JJ after/IN start/NN of/IN treatment/NN the/DT proportion/NN of/IN tumor/NN cells/NNS remains/VBZ constant/NN in/IN contrast/NN to/TO radiation/NN alone/JJ where/WRB the/DT fraction/NN of/IN tumor/NN cells/NNS decreases/VBZ because/IN of/IN influx/NN of/IN granulocytes/NNS and/CC macrophages/NNS into/IN the/DT tumor/NN ./.
P02123079A03
Six/CD patients/NNS relapsed/VBD during/IN follow-up/NN ,/, all/PRP of/IN whom/WP had/VBD been/VBN sober/JJ less/RB than/IN 5/CD years/NNS ./.
P02132188A09
Alterations/NNS in/IN BBM/NN lipid/NN composition/NN may/MD be/VBP related/VBN to/TO the/DT enhanced/JJ permeability/NN to/TO glucose/NN in/IN animals/NNS fed/VBN S/NN ,/, while/IN the/DT similarity/NN of/IN BBM/NN fatty/JJ acid/NN composition/NN in/IN diabetic/JJ and/CC control/NN animals/NNS fed/VBN P/NN may/MD be/VBP related/VBN to/TO the/DT similar/JJ glucose/NN uptake/NN ./.
P02145207A02
The/DT agarose/NN technique/NN and/CC electrophoresis/NN on/IN cellulose-acetate/NN foil/NN methods/NNS were/VBD chosen/VBN because/IN a/DT small/JJ quantity/NN of/IN the/DT maternal/NN available/JJ for/IN examination/NN ./.
P02157914A02
Radioligand/NN binding/JJ assay/NN using/VBG 3H-prazosin/NN as/IN an/DT alpha/NN 1-adrenoceptor/NN ligand/NN and/CC 3H-yohimbine/NN as/IN an/DT alpha/NN 2-adrenoceptor/NN ligand/NN ,/, clearly/RB demonstrated/VBD alpha/NN 1/CD and/CC alpha/NN 2/CD receptors/NNS present/JJ in/IN both/CC rat/NN and/CC human/NN adrenal/JJ gland/NN membranes/NNS ./.
P02161814A06
Furthermore/RB ,/, double-labeling/JJ studies/NNS combining/VBG in/FW situ/FW hybridization/NN and/CC immunocytochemistry/NN using/VBG CD30/NN (/( BerH2/NN )/) and/CC CD15/NN (/( LeuM1/NN )/) as/IN markers/NNS of/IN RS/NN cells/NNS ,/, as/RB well/RB as/IN pan/NN B-marker/NN (/( L26/NN )/) and/CC pan/NN T-marker/NN ,/, CD45RO/NN (/( UCHL1/NN )/) ,/, were/VBD performed/VBN to/TO demonstrate/VB the/DT phenotype/NN of/IN EBV/NN DNA-positive/JJ cells/NNS ,/, confirming/VBG that/IN EBV/NN DNA/NN was/VBD present/JJ in/IN RS/NN cells/NNS but/CC not/RB in/IN lymphocytes/NNS ./.
P02173930A03
The/DT replicative/JJ form/NN of/IN polyoma/NN DNA/NN sequences/NNS was/VBD observed/VBN in/IN SEWA/NN tumors/NNS grown/VBN in/IN ascites/NN fluids/NNS but/CC not/RB in/IN cells/NNS maintained/VBN as/IN solid/JJ tumors/NNS ./.
P02182667A02
Isolates/NNS were/VBD identified/VBN by/IN serogrouping/NN or/CC as/IN enterotoxigenic/JJ E./NN coli/NN (/( ETEC/NN )/) ,/, enteroinvasive/JJ E./NN coli/NN (/( EIEC/NN )/) ,/, enteropathogenic/JJ E./NN coli/NN (/( EPEC/NN )/) adhesin/NN factor/NN (/( EAF/NN )/) E./NN coli/NN ,/, or/CC Shiga-like-toxin/NN (/( SLT/NN )/) -producing/JJ E./NN coli/NN by/IN DNA/NN hybridization/NN ./.
P02187410A07
The/DT dot/NN blot/NN technique/NN yielded/VBD results/NNS within/IN 48/CD h/NN and/CC can/MD be/VBP used/VBN as/IN a/DT fast/JJ and/CC sensitive/JJ method/NN of/IN detection/NN for/IN SLTEC/NN in/IN foods/NNS and/CC calf/NN fecal/JJ samples/NNS ./.
P02196946A07
Subjects/NNS were/VBD excluded/VBN if/IN they/PRP had/VBD damaged/JJ target/NN organs/NNS ,/, secondary/JJ hypertension/NN ,/, diabetes/NN mellitus/NN ,/, a/DT cholesterol/NN concentration/NN greater/JJR than/IN 8/CD mmol/NN //SYM l/NN ,/, or/CC a/DT history/NN of/IN malignant/JJ hypertension/NN ./.
P02201903A04
Maintenance/NN of/IN M1/NN and/CC M2/NN is/VBZ dependent/JJ on/IN the/DT presence/NN of/IN LA/NN ,/, which/WDT provides/VBZ capsid/NN and/CC cap-pol/NN for/IN M/NN dsRNA/NN maintenance/NN ./.
P02211417A02
Steers/NNS (/( 530/CD kg/NN )/) were/VBD fed/VBN a/DT 50/CD :/: 50/CD roughage/NN :/: concentrate/NN diet/NN at/IN 1.5/CD times/IN their/PRP$ NEm/NN requirement/NN ./.
P02221412A06
We/PRP suggest/VBP that/IN preoxygenation/NN with/IN 3-min/NN breathing/NN of/IN 100/CD %/SYM O2/NN offers/VBZ more/DT protection/NN against/IN hypoxia/NN due/JJ to/TO prolonged/JJ apnea/NN after/IN induction/NN of/IN anesthesia/NN in/IN the/DT elderly/NN than/IN does/VBZ four/CD maximal/JJ breaths/NNS of/IN 100/CD %/SYM O2/NN ./.
P02235912A01
A/DT rapid/JJ and/CC reliable/JJ method/NN for/IN the/DT purification/NN of/IN rat/NN liver/NN glucokinase/NN was/VBD developed/VBN ./.
P02245618A06
Comparing/VBG mean/NN differences/NNS ,/, Qsp/NN //SYM Qt/NN 1/CD was/VBD significantly/RB different/JJ only/RB from/IN Qsp/NN //SYM Qt/NN 3/CD (/( p/NN less/RB than/IN .01/CD )/) ./.
P02254843A04
A/DT significant/JJ negative/JJ relationship/NN existed/VBD between/IN the/DT amount/NN of/IN information/NN received/VBN about/IN sex/NN and/CC the/DT experience/NN of/IN a/DT pregnancy/NN before/IN age/NN 18/CD years/NNS among/IN the/DT sample/NN group/NN mothers/NNS only/RB ./.
P02264205A04
It/PRP was/VBD found/VBN that/IN in/IN group/NN 1/CD patients/NNS the/DT indices/NNS of/IN central/JJ (/( mean/NN arterial/JJ pressure/NN ,/, cardiac/JJ and/CC stroke/NN indices/NNS ,/, total/JJ peripheral/JJ vascular/JJ resistance/NN ,/, work/NN of/IN the/DT left/JJ ventricle/NN )/) and/CC intracardiac/JJ (/( time/NN of/IN circulation/NN of/IN blood/NN in/IN the/DT heart/NN cavities/NNS and/CC lungs/NNS )/) hemodynamics/NNS were/VBD on/IN the/DT upper/JJ normal/JJ values/NNS and/CC in/IN occasional/JJ cases/NNS exceeded/VBD it/PRP ./.
P02273434A01
A/DT case/NN is/VBZ presented/VBN in/IN which/WDT the/DT Nd/NN :/: YAG/NN laser/NN obviated/VBD the/DT need/NN for/IN a/DT major/JJ thoracic/JJ procedure/NN ./.
P02283534A05
Rapid/JJ reduction/NN of/IN contraction-induced/JJ autogenetic/JJ inhibition/NN was/VBD also/RB observed/VBN in/IN homonymous/JJ gamma-motoneurons/NNS ./.
P02293226A04
GS/NN also/RB plays/VBZ a/DT role/NN in/IN the/DT NKC-IFN-IL-2/NN regulatory/JJ system/NN ,/, inhibits/VBZ the/DT growth/NN of/IN tumor/NN cells/NNS ,/, and/CC antagonizes/VBZ the/DT suppression/NN of/IN ADCC/NN and/CC NK/NN cytotoxicities/NNS in/IN mice/NNS with/IN surgical/JJ stress/NN ./.
P02302758A06
For/IN HOEtNU/NN O6-/NN (/( 2-hydroxyethyl/NN )/) guanine/NN was/VBD found/VBN to/TO be/VB 63/CD %/SYM of/IN N-7-/NN (/( 2-hydroxyethyl/NN )/) guanine/NN ./.
P02307370A06
In/IN contrast/NN to/TO the/DT binding/JJ data/NNS ,/, no/DT cross/NN activation/NN of/IN transcription/NN is/VBZ detectable/JJ in/IN cultured/JJ cell/NN lines/NNS ./.
P02317180A06
Our/PRP$ study/NN suggests/VBZ that/IN tympanometry/NN can/MD be/VBP a/DT valuable/JJ tool/NN in/IN managing/NN aerotitis/NN media/NN in/IN the/DT aeromedical/JJ environment/NN ./.
P02326692A01
Spines/NNS from/IN 832/CD deceased/JJ patients/NNS with/IN a/DT terminal/JJ diagnosis/NN of/IN malignant/JJ neoplasm/NN were/VBD examined/VBN grossly/RB ,/, microscopically/RB and/CC radiographically/RB for/IN evidence/NN of/IN tumor/NN ./.
P02335845A01
Exercise/NN electrocardiography/NN with/IN or/CC without/IN thallium-201/NN scintigraphy/NN was/VBD performed/VBN (/( pre-hospital/NN discharge/NN )/) in/IN 66/CD asymptomatic/JJ survivors/NNS of/IN a/DT first/JJ inferior/JJ myocardial/JJ infarction/NN (/( IMI/NN )/) ./.
P02340488A07
Careful/JJ cytological/JJ review/NN of/IN 51/CD patients/NNS with/IN MDS/NN or/CC ANLL/NN and/CC various/JJ cytogenetic/JJ anomalies/NNS was/VBD performed/VBN for/IN comparison/NN :/: vacuolated/JJ granulocytes/NNS were/VBD a/DT very/JJ uncommon/JJ finding/NN ./.
P02349957A03
The/DT interstitial/JJ fibrosis/NN was/VBD proven/VBN to/TO be/VB the/DT most/RBS important/JJ morphological/JJ parameter/NN ,/, and/CC the/DT most/RBS important/JJ clinical/JJ parameters/NNS were/VBD the/DT serum/NN creatinine/NN concentration/NN and/CC the/DT creatinine/NN clearance/NN ./.
P02364285A01
We/PRP studied/VBD whether/IN plasticity-induced/JJ callosal/JJ transfer/NN exists/VBZ after/IN the/DT critical/JJ period/NN for/IN sensitivity/NN of/IN visual/JJ cortex/NN cells/NNS in/IN kittens/NNS postnatally/RB monocularly/RB deprived/VBN and/CC in/IN which/WDT interocular/JJ competition/NN was/VBD cancelled/VBN by/IN chiasm/NN transection/NN during/IN adulthood/NN ./.
P02369120A05
The/DT 1H/NN assignments/NNS for/IN tobramycin/NN are/VBP similar/JJ to/TO those/PRP previously/RB reported/VBN for/IN rings/NNS I/CD and/CC III/CD of/IN kanamycin/NN A/NN ./.
P02374058A08
The/DT 6/CD rabbits/NNS (/( 12/CD TMJs/NNS )/) demonstrated/VBD consistent/JJ microvascular/JJ differences/NNS ./.
P02383817A06
Levels/NNS of/IN physical/JJ activity/NN during/IN leisure/NN time/NN of/IN the/DT injured/JJ pupils/NNS were/VBD related/VBN to/TO activity/NN levels/NNS in/IN the/DT whole/JJ population/NN ./.
P02393587A08
Group/NN 2/CD included/VBD patients/NNS with/IN ventricular/JJ tachycardia/NN of/IN noncoronary/JJ genesis/NN ./.
P02398235A07
A/DT summary/NN score/NN (/( number/NN of/IN individual/JJ game/NN scores/NNS above/IN the/DT 95th/JJ percentile/NN )/) of/IN 4/CD or/CC more/PRP detected/VBD 60/CD %/SYM of/IN hyperactive/JJ subjects/NNS with/IN a/DT false/JJ positive/NN rate/NN of/IN 5/CD %/SYM ./.
P02411925A06
In/IN the/DT animals/NNS with/IN adhesions/NNS adhesiolysis/NN was/VBD performed/VBN and/CC 6/CD %/SYM dextran/NN 70/CD or/CC saline/NN was/VBD left/VBN in/IN the/DT peritoneal/JJ cavity/NN ./.
P02420715A05
This/DT conductance/NN was/VBD abrogated/VBN upon/IN disaggregating/NN the/DT complexes/NNS with/IN a/DT monovalent/JJ hapten/NN (/( epsilon-N-DNP-L-lysine/NN )/) ./.
P02429497A01
The/DT frequency/NN of/IN occurrence/NN of/IN the/DT adrenergic/JJ ,/, cholinergic/JJ ,/, 5-hydroxytryptamine/NN (/( 5-HT/NN )/) -/SYM ,/, substance/NN P/NN (/( SP/NN )/) -/SYM ,/, methionine-enkephalin/NN (/( met-Enk/NN )/) -/: and/CC somatostatin/NN (/( SOM/NN )/) -immunoreactive/JJ fibres/NNS innervating/VBG the/DT smooth/JJ muscle/NN of/IN the/DT large/JJ intestine/NN in/IN Hirschsprung/NN and/CC control/NN children/NNS was/VBD compared/VBN ./.
P02433793A08
Although/IN no/DT significant/JJ decrease/NN in/IN myocardial/JJ ATP/NN took/VBD place/NN ,/, 31/CD of/IN 38/CD patients/NNS needed/VBD inotropic/JJ support/NN to/TO wean/VB them/PRP off/IN bypass/NN ./.
P02442509A10
The/DT most/RBS common/JJ adverse/JJ effects/NNS are/VBP those/PRP expected/VBN from/IN a/DT potent/JJ arteriolar/JJ dilator/NN :/: ankle/NN swelling/NN ,/, headache/NN ,/, dizziness/NN ,/, flushing/NN ,/, etc/NN ./.
P02446859A11
No/PDT such/DT lesions/NNS were/VBD present/JJ among/IN control/NN rats/NNS ./.
P02455592A03
All/DT three/CD interferons/NNS have/VBP direct/JJ antitumor/NN activity/NN in/FW vivo/FW for/IN 38C13/NN lymphoma/NN at/IN high/JJ doses/NNS ;/: however/WRB ,/, none/CD of/IN these/DT interferons/NNS has/VBZ independent/JJ antitumor/NN activity/NN for/IN SL2/NN in/FW vivo/FW ./.
P02459828A07
Addition/NN of/IN histamine/NN (/( 10/CD (/( -6/CD )/) -10/CD (/( -5/CD )/) M/NN )/) induced/VBD an/DT increase/NN in/IN the/DT frequency/NN of/IN contractions/NNS and/CC enhanced/VBD the/DT basal/JJ tone/NN particularly/RB in/IN human/NN samples/NNS ./.
P02468677A07
This/DT intercellular/JJ contact-dependent/JJ depolarization/NN (/( ICDD/NN )/) was/VBD unaffected/VBN by/IN valinomycin/NN ;/: it/PRP was/VBD abolished/VBN by/IN substituting/NN Na+/NN in/IN the/DT external/JJ medium/NN with/IN a/DT nondiffusible/JJ cation/NN (/( choline/NN )/) ,/, which/WDT shows/VBZ that/IN ICDD/NN was/VBD sustained/VBN by/IN Na+/NN influxes/NNS ,/, probably/RB mediated/VBN by/IN stretch-activated/JJ (/( s.a./NN )/) cation/NN channels/NNS ./.
P02476870A05
Specific/JJ in/FW vivo/FW T-lymphocyte/NN subpopulation/NN depletion/NN was/VBD accomplished/VBN by/IN multiple/JJ intraperitoneal/JJ administrations/NNS of/IN cytotoxic/JJ monoclonal/JJ antibodies/NNS to/TO mice/NNS prior/RB to/TO and/CC following/VBG BLM/NN administration/NN ./.
P02480823A09
The/DT variations/NNS observed/VBN with/IN pH/NN and/CC ionic/JJ strength/NN can/MD be/VBP primarily/RB attributed/VBN to/TO screened/JJ coulombic/JJ interactions/NNS ./.
P02489642A07
The/DT glycosaminoglycan/NN chains/NNS after/IN chondroitinase/NN AC/NN II/CD hydrolysis/NN were/VBD seen/VBN on/IN gel/NN as/IN polydispersed/JJ ,/, broad/JJ alcian/NN blue/JJ staining/JJ material/NN (/( Mr/NN =/SYM 20,000-60,000/CD dalton/NN )/) while/IN chains/NNS were/VBD totally/RB hydrolyzed/VBN by/IN chondroitinase/NN ABC/NN ./.
P02499460A02
The/DT patients/NNS were/VBD 52/CD men/NNS who/WP had/VBD sustained/VBD a/DT myocardial/JJ infarction/NN at/IN an/DT age/NN of/IN 50/CD years/NNS or/CC less/PRP and/CC the/DT controls/NNS ,/, selected/VBN from/IN a/DT random/JJ population/NN sample/NN ,/, were/VBD matched/VBN to/TO the/DT patients/NNS for/IN age/NN and/CC sex/NN ./.
P02508498A06
Arginine/NN vasopressin/NN (/( AVP/NN )/) rose/VBD from/IN base/NN line/NN after/IN HS/NN (/( P/NN =/SYM 0.11/CD vehicle/NN experiments/NNS ,/, P/NN =/SYM 0.04/CD cortisol/NN experiments/NNS )/) ,/, and/CC AVP/NN responses/NNS were/VBD greater/JJR in/IN the/DT cortisol/NN experiments/NNS than/IN in/IN the/DT vehicle/NN experiments/NNS (/( delta/NN AVP/NN =/SYM 21.9/CD +/-/SYM 10.9/CD vs./CC 3.1/CD +/-/SYM 0.9/CD pg/NN //SYM ml/NN ,/, P/NN =/SYM 0.05/CD )/) ./.
P02517998A02
It/PRP is/VBZ administered/VBN by/IN the/DT South/NN African/JJ Association/NN of/IN Retail/NN Pharmacists/NNS ,/, and/CC directed/VBN at/IN all/DT segments/NNS of/IN the/DT population/NN ,/, with/IN the/DT aim/NN of/IN promoting/NN a/DT drug-abuse/NN free/JJ society/NN ./.
P02531658A04
U1/NN A/NN protein/NN can/MD also/RB bind/VBP the/DT loop/NN sequence/NN when/WRB it/PRP is/VBZ part/NN of/IN an/DT artificial/JJ RNA/NN which/WDT can/MD not/RB form/VBP a/DT stable/JJ hairpin/NN structure/NN ./.
P02540050A04
In/IN order/NN to/TO evaluate/VB the/DT effect/NN of/IN enalapril/NN on/IN sympathetic/JJ stimulation/NN 10/CD mild/JJ to/TO moderate/JJ hypertensive/JJ patients/NNS were/VBD studied/VBN during/IN static/JJ (/( hand/NN grip/NN )/) and/CC dynamic/JJ exercise/NN (/( bicycle/NN ergometer/NN )/) ,/, after/IN 2/CD weeks/NNS of/IN placebo/NN and/CC after/IN 1/CD month/NN of/IN treatment/NN with/IN 20-40/CD mg/NN enalapril/NN once/RB daily/RB ./.
P02543984A10
The/DT results/NNS provide/VBP direct/JJ ,/, in/FW vivo/FW evidence/NN to/TO support/VB the/DT hypothesis/NN that/IN reactive/JJ oxygen/NN metabolites/NNS play/VBP a/DT causal/JJ role/NN in/IN the/DT myocardial/JJ "/`` stunning/NN "/'' seen/VBN after/IN brief/JJ ischemia/NN ./.
P02555701A07
Analysis/NN of/IN a/DT variety/NN of/IN E5/NN missense/NN mutants/NNS revealed/VBD a/DT strong/JJ correlation/NN between/IN their/PRP$ phenotypes/NNS in/IN the/DT acute/JJ transformation/NN assays/NNS following/VBG infection/NN and/CC in/IN the/DT stable/JJ focus-forming/JJ assay/NN following/VBG transfection/NN ./.
P02564792A04
Furthermore/RB ,/, we/PRP found/VBD no/DT de/FW novo/FW methylation/NN in/IN this/DT region/NN ./.
P02569540A12
Serotonin/NN was/VBD the/DT only/RB transmitter/NN identified/VBN in/IN cultured/JJ but/CC not/RB in/IN freshly/RB dissociated/JJ cells/NNS ./.
P02578927A03
The/DT lumbar/JJ response/NN was/VBD abnormal/JJ in/IN 2.95/CD %/SYM of/IN legs/NNS ,/, while/IN the/DT Erb/NN response/NN was/VBD always/RB within/IN normal/JJ limits/NNS ./.
P02583119A07
Insertion/NN of/IN a/DT spacer/NN between/IN TATAAATA/NN and/CC the/DT cap/NN site/NN resulted/VBD in/IN accumulation/NN of/IN U2/NN RNA/NN with/IN an/DT extended/JJ 5/CD '/SYM end/NN ,/, indicating/VBG that/IN the/DT TATAAATA/NN element/NN is/VBZ responsible/JJ for/IN selection/NN of/IN the/DT initiation/NN site/NN ./.
P02597857A01
A/DT family/NN study/NN was/VBD carried/VBN out/RP in/IN two/CD groups/NNS of/IN patients/NNS fulfilling/VBG RDC/NN for/IN schizoaffective/JJ disorder/NN :/: in/IN one/CD ,/, a/DT full/JJ affective/JJ and/CC a/DT full/JJ schizophrenic/JJ syndrome/NN were/VBD simultaneously/RB present/JJ ;/: in/IN the/DT other/PRP ,/, affective/JJ and/CC schizophrenic/JJ features/NNS appeared/VBD within/IN a/DT polymorphic/JJ and/CC rapidly/RB changing/JJ clinical/JJ picture/NN ,/, with/IN depersonalization/NN //SYM derealization/NN and/or/CC confusion/NN ./.
P02607648A07
The/DT further/JJ analysis/NN of/IN C-AP/NN using/VBG this/DT method/NN would/MD promise/VBP the/DT establishment/NN of/IN clinical/JJ assessment/NN of/IN the/DT enzyme/NN ./.
P02621564A02
One/CD is/VBZ a/DT self-emulsifying/JJ type/NN ,/, and/CC the/DT other/PRP is/VBZ an/DT oil/NN dispersing/JJ type/NN ./.
P02631814A03
The/DT reason/NN for/IN this/DT episode/NN was/VBD detected/VBN through/IN imaging/JJ techniques/NNS --/: echocardiography/NN and/CC isotopic/JJ studies/NNS ,/, and/CC consisted/VBD on/IN infarct/NN expansion/NN with/IN early/JJ evolution/NN for/IN apical/JJ aneurysm/NN ./.
P02641810A01
A/DT retrospective/JJ analysis/NN of/IN survival/NN time/NN was/VBD carried/VBN out/RP in/IN 29/CD progressive/JJ systemic/JJ sclerosis/NN patients/NNS treated/VBN with/IN immunosuppressive/JJ drugs/NNS and/CC in/IN 15/CD patients/NNS who/WP underwent/VBD another/DT mode/NN of/IN treatment/NN ./.
P02651209A04
The/DT staining/JJ intensity/NN ,/, cytoplasmic/JJ granulations/NNS ,/, and/CC length/NN of/IN hypophysial/JJ gonadotrophs/NNS (/( B2/NN cells/NNS )/) were/VBD increased/VBN (/( P/NN less/RB than/IN 0.05/CD )/) due/JJ to/TO LHRH/NN treatment/NN ./.
P02656541A06
Seventy-two/CD percent/NN of/IN the/DT patients/NNS entered/VBN into/IN the/DT study/NN had/VBD confirmed/JJ myocardial/JJ infarction/NN (/( 39/CD %/SYM anterior/JJ ,/, 39/CD %/SYM inferior/JJ ,/, 22/CD %/SYM other/JJ locations/NNS )/) and/CC 85/CD %/SYM of/IN all/DT individuals/NNS treated/VBN tolerated/VBD the/DT full/JJ intravenous/JJ dose/NN of/IN 15/CD mg/NN of/IN metoprolol/NN ./.
P02661306A10
Metastasising/NN in/IN the/DT skeletal/JJ structure/NN can/MD be/VBP overlooked/VBN in/IN only/RB 2/CD out/IN of/IN 555/CD patients/NNS (/( 0.36/CD %/SYM )/) ./.
P02670763A08
Less/RB optimal/JJ combinations/NNS of/IN sensitivity/NN and/CC specificity/NN were/VBD found/VBN for/IN differential/JJ glomerular/JJ filtration/NN rate/NN renography/NN ,/, differential/JJ effective/JJ renal/JJ plasma/NN flow/NN renography/NN ,/, and/CC selective/JJ renal/JJ vein/NN renin/NN ratios/NNS ,/, each/PRP performed/VBN after/IN a/DT single/JJ dose/NN of/IN captopril/NN ./.
P02675648A06
The/DT remaining/JJ 10/CD patients/NNS were/VBD pleased/VBN with/IN their/PRP$ operation/NN ./.
P02680518A04
These/DT proteins/NNS potentially/RB modulate/VBP phagocyte/NN function/NN ./.
P02685133A13
Ten/CD patients/NNS had/VBD dissecting/JJ aneurysms/NNS and/CC 5/CD had/VBD atherosclerotic/JJ thoracic/JJ aneurysms/NNS ./.
P02690039A05
We/PRP are/VBP more/RB likely/RB to/TO develop/VB a/DT greater/JJR understanding/NN for/IN the/DT end-stage/NN structure/NN if/IN we/PRP have/VBP had/VBD a/DT glimpse/NN of/IN the/DT blueprints/NNS for/IN its/PRP$ design/NN ./.
P02700156A04
389/CD serum/NN specimens/NNS of/IN suspected/JJ Dengue/NN Fever/NN patients/NNS including/VBG 226/CD HI/NN (/( +/SYM )/) paired/JJ sera/NNS and/CC 163/CD HI/NN (/( -/SYM )/) paired/JJ sera/NNS which/WDT were/VBD collected/VBN from/IN 1/CD to/TO 150/CD days/NNS after/IN onset/NN of/IN the/DT disease/NN in/IN 1988/CD have/VBP been/VBN assayed/VBN for/IN IgM/NN antibodies/NNS to/TO Dengue/NN type/NN I/CD virus/NN ./.
P02705576A12
The/DT low/JJ expenditure/NN in/IN trained/JJ groups/NNS did/VBD not/RB ,/, however/WRB ,/, relate/VBP to/TO changes/NNS in/IN facultative/JJ BAT/NN thermogenesis/NN ./.
P02714623A08
Whole/JJ serum/NN was/VBD separated/VBN over/IN a/DT neutral/JJ G-200/NN column/NN ,/, and/CC all/DT activity/NN eluted/VBN at/IN the/DT void/JJ volume/NN indicated/VBD an/DT apparent/JJ molecular/JJ weight/NN equal/JJ to/TO or/CC greater/JJR than/IN 250/CD kDa/NN ./.
P02723855A04
Measurement/NN of/IN mandibular/JJ opening/NN revealed/VBD a/DT mean/NN increase/NN of/IN 5.9/CD mm/NN ./.
P02738747A01
Spirometry/NN was/VBD performed/VBN on/IN 136/CD male/NN industrial/JJ workers/NNS experienced/VBN in/IN undergoing/NN pulmonary/JJ function/NN testing/NN for/IN the/DT purpose/NN of/IN studying/NN the/DT effects/NNS of/IN the/DT use/NN of/IN noseclips/NNS on/IN forced/JJ vital/JJ capacity/NN (/( FVC/NN )/) maneuvers/NNS ./.
P02748331A01
The/DT major/JJ regions/NNS coding/VBG for/IN the/DT transfer/NN RNA/NN genes/NNS in/IN the/DT mitochondrial/JJ DNA/NN of/IN K./NN lactis/NN were/VBD studied/VBN ./.
P02753117A10
It/PRP is/VBZ suggested/VBN that/IN muscarinic/JJ cholinergic/JJ mechanisms/NNS in/IN the/DT basal/JJ forebrain/NN may/MD be/VBP involved/VBN in/IN the/DT pathogenesis/NN of/IN neural/JJ dysfunction/NN associated/VBN with/IN locomotor/NN activity/NN in/IN man/NN ./.
P02767253A07
Peroperative/JJ cultures/NNS revealed/VBD small/JJ numbers/NNS of/IN staphylococcus/NN epidermidis/NN in/IN eleven/CD patients/NNS ,/, and/CC none/CD of/IN them/PRP developed/VBD graft/NN infection/NN ./.
P02781562A02
Desethylamiodarone/NN ,/, a/DT metabolite/NN ,/, whose/WDT role/NN in/IN the/DT etiology/NN of/IN amiodarone-induced/JJ pulmonary/JJ toxicity/NN has/VBZ been/VBN unclear/JJ ,/, also/RB possesses/VBZ antiarrhythmic/JJ activity/NN and/CC could/MD potentially/RB be/VBP used/VBN as/IN an/DT antiarrhythmic/JJ drug/NN itself/PRP ./.
P02785815A06
Results/NNS showed/VBD that/IN this/DT gene/NN was/VBD transiently/RB activated/VBN in/IN the/DT very/RB early/JJ embryonic/JJ stage/NN and/CC in/IN the/DT pupal/JJ stage/NN ,/, suggesting/VBG that/IN sarcocystatin/NN A/NN participates/VBZ in/IN morphogenesis/NN of/IN larval/JJ and/CC adult/NN structures/NNS of/IN Sarcophaga/NN ./.
P02794326A01
Acute/JJ corneal/JJ hydrops/NN ,/, a/DT condition/NN secondary/JJ to/TO keratoconus/NN ,/, can/MD be/VBP difficult/JJ to/TO diagnose/VB unless/IN examination/NN is/VBZ also/RB performed/VBN on/IN the/DT fellow/JJ eye/NN ./.
P02804028A02
Antiretinal/JJ antibodies/NNS were/VBD measured/VBN by/IN indirect/JJ immunofluorescence/NN and/CC passive/JJ haemagglutination/NN ,/, and/CC circulating/JJ immune/JJ complexes/NNS were/VBD measured/VBN by/IN polyethylene/NN glycol/NN precipitation/NN and/CC Clq/NN binding/NN ./.
P02808299A08
The/DT results/NNS obtained/VBN indicate/VBP that/IN the/DT menaquinone/NN acts/VBZ between/IN the/DT two/CD b-type/NN cytochromes/NNS in/IN an/DT electron/NN transport/NN chain/NN ./.
P02822335A03
Computed/JJ tomography/NN and/CC magnetic/JJ resonance/NN have/VBP with/IN few/JJ exceptions/NNS added/VBN little/JJ to/TO the/DT primary/JJ diagnosis/NN ./.
P02830733A04
It/PRP is/VBZ concluded/VBN that/IN conservative/JJ management/NN after/IN withdrawal/NN of/IN hormonal/JJ contraception/NN my/MD be/VBP the/DT preferable/JJ treatment/NN for/IN hepatic/JJ adenoma/NN and/CC focal/JJ nodular/JJ hyperplasia/NN ./.
P02839309A03
HDL-Au/NN was/VBD not/RB internalized/VBN ./.
P02847748A01
A/DT quantitative/JJ study/NN of/IN the/DT relationship/NN between/IN structure/NN and/CC receptor/NN binding/JJ affinity/NN of/IN a/DT series/NN of/IN 16/CD beta-carbolines/NNS showed/VBD the/DT influence/NN of/IN lipophilic/JJ character/NN and/CC hydrogen/NN bonding/JJ capability/NN of/IN substituents/NNS in/IN position/NN 3/CD ./.
P02863875A03
If/IN a/DT fetus/NN is/VBZ identified/VBN with/IN a/DT treatable/JJ disorder/NN in/FW utero/FW ,/, and/CC if/IN that/DT disorder/NN can/MD affect/VBP fetal/JJ development/NN ,/, then/RB treatment/NN during/IN fetal/JJ life/NN is/VBZ potentially/RB beneficial/JJ ./.
P02874639A03
The/DT effects/NNS were/VBD quantified/VBN by/IN the/DT sister/NN chromatid/NN exchange/NN (/( SCE/NN )/) assay/NN ./.
P02896446A04
The/DT changes/NNS are/VBP essentially/RB reversible/JJ after/IN treatment/NN ,/, although/IN recovery/NN may/MD take/VBP several/JJ months/NNS ./.
P02912515A01
Gang/NN formation/NN is/VBZ common/JJ among/IN adolescents/NNS ,/, and/CC the/DT sociological/JJ dynamics/NNS of/IN this/DT phenomenon/NN have/VBP been/VBN studied/VBN in/IN depth/NN ./.
P02917372A10
During/IN hemorrhagic/JJ shock/NN arterial/JJ oxygen/NN tension/NN (/( PaO2/NN )/) increased/VBD from/IN 78.0/CD to/TO 94.0/CD torr/NN (/( P/NN less/RB than/IN 0.005/CD )/) ,/, lymph/NN flow/NN (/( QL/NN )/) decreased/VBD from/IN 7.2/CD to/TO 5.2/CD ml/NN //SYM h/NN (/( P/NN less/RB than/IN 0.05/CD )/) and/CC lymph/NN protein/NN clearance/NN (/( L/NN //SYM P.QL/NN )/) from/IN 4.6/CD to/TO 3.3/CD ml/NN //SYM h/NN (/( P/NN less/RB than/IN 0.05/CD )/) ./.
P02921962A05
Conclusions/NNS are/VBP drawn/VBN concerning/VBG the/DT significance/NN of/IN these/DT processes/NNS for/IN midwife/NN managers/NNS ./.
P02937736A02
In/IN the/DT presence/NN of/IN oxidizable/JJ substrates/NNS ,/, bacteria/NN reduce/VBP this/DT pigment/NN to/TO a/DT colorless/JJ product/NN ,/, leukopyocyanin/NN ./.
P02943618A06
Our/PRP$ results/NNS ,/, interpreted/VBN in/IN light/NN of/IN studies/NNS from/IN the/DT other/JJ laboratories/NNS ,/, suggest/VBP the/DT existence/NN of/IN multiple/JJ abnormalities/NNS in/IN the/DT BB/NN rat/NN ,/, including/VBG the/DT presence/NN of/IN T/NN cells/NNS as/IN effector/NN or/CC helper/NN cells/NNS that/WDT augment/VBP onset/NN of/IN disease/NN and/CC the/DT absence/NN of/IN a/DT regulatory/JJ T/NN cell/NN circuit/NN that/WDT could/MD prevent/VBP the/DT disease/NN ./.
P02955176A04
Bmax/NN in/IN the/DT C57BL/NN //SYM 6J/NN mice/NNS were/VBD lower/JJR than/IN in/IN the/DT other/JJ strains/NNS of/IN young/JJ animals/NNS (/( 7-15/CD weeks/NNS )/) but/CC remained/VBD relatively/RB constant/JJ throughout/IN life/NN (/( measured/VBN up/IN to/TO 104/CD weeks/NNS of/IN age/NN )/) ./.
P02966134A04
The/DT study/NN represents/VBZ a/DT prospective/JJ assessment/NN and/CC included/VBD 52/CD men/NNS and/CC 32/CD women/NNS with/IN a/DT mean/NN age/NN of/IN 43/CD years/NNS ./.
P02977341A02
2./CD These/DT proteoglycan/NN preparations/NNS contained/VBN about/IN equal/JJ amounts/NNS of/IN heparan/NN sulfate/NN and/CC chondroitin/NN sulfates/NNS ./.
P02982847A05
DNase/NN I/CD protection/NN experiments/NNS revealed/VBD that/IN cAMP-CRP/NN binds/VBZ to/TO the/DT cya/NN DNA/NN region/NN between/IN +11/CD and/CC -20/CD ,/, in/IN which/WDT a/DT consensus/NN CRP/NN binding/JJ sequence/NN is/VBZ present/JJ ./.
P02986944A13
Clonidine/NN (/( 10/CD (/( -5/CD )/) M/NN )/) ,/, similarly/RB perfused/VBN for/IN 15/CD min/NN ,/, had/VBD no/DT effect/NN ./.
P02989238A04
As/IN a/DT percentage/NN of/IN total/JJ starch/NN intake/NN ,/, total/JJ tract/NN and/CC ruminal/JJ starch/NN digestion/NN increased/VBD (/( linear/JJ ,/, P/NN less/RB than/IN .01/CD )/) while/IN postruminal/JJ starch/NN digestion/NN decreased/VBD (/( linear/JJ ,/, P/NN less/RB than/IN .01/CD )/) with/IN corn/NN level/NN ./.
P02999437A05
Although/IN the/DT minor/JJ differences/NNS between/IN these/DT proteins/NNS may/MD be/VBP sufficient/JJ to/TO account/VB for/IN the/DT poor/JJ growth/NN of/IN Ad2+ND5/NN in/IN monkey/NN cells/NNS ,/, the/DT most/RBS striking/JJ difference/NN between/IN helper-competent/JJ Ad2+ND2/NN and/CC helper-defective/JJ Ad2+ND5/NN is/VBZ in/IN the/DT production/NN of/IN the/DT SV40-specific/JJ protein/NN after/IN infection/NN of/IN monkey/NN cells/NNS ./.
P03008317A03
Especially/RB the/DT high/JJ incidence/NN of/IN reinfection/NN with/IN CMV/NN (/( 88.0/CD %/SYM )/) and/CC HSV/NN (/( 81.0/CD )/) at/IN high/JJ prednisolone/NN dosage/NN compared/VBN to/TO the/DT lower/JJR incidence/NN (/( CMV/NN 54.5/CD %/SYM ,/, HSV/NN 44.1/CD %/SYM )/) at/IN low/JJ prednisolone/NN dosage/NN was/VBD apparent/JJ ./.
P03021299A02
This/DT study/NN investigated/VBD the/DT effect/NN ,/, on/IN time/NN to/TO onset/NN and/CC duration/NN of/IN analgesia/NN ,/, of/IN pH/NN adjustment/NN of/IN 0.25/CD per/IN cent/CD bupivacaine/NN immediately/RB prior/RB to/TO injection/NN into/IN the/DT epidural/JJ space/NN in/IN parturients/NNS ./.
P03029658A01
Previous/JJ studies/NNS with/IN neutrophils/NNS from/IN newborn/NN infants/NNS compared/VBN to/TO neutrophils/NNS from/IN healthy/JJ adults/NNS have/VBP documented/VBD increased/JJ respiratory/JJ burst/NN activity/NN including/VBG enhanced/JJ superoxide/NN anion/NN (/( O2-/NN )/) production/NN ,/, nitroblue/NN tetrazolium/NN dye/NN reduction/NN ,/, and/CC hexose/NN monophosphate/NN shunt/NN activity/NN ./.
P03038195A01
The/DT mechanism/NN of/IN respiratory/JJ burst/NN was/VBD studied/VBN by/IN modulating/NN membrane/NN surfaces/NNS with/IN lipophilic/JJ ions/NNS in/IN guinea-pig/NN polymorphonuclear/JJ leukocytes/NNS and/CC their/PRP$ subcellular/JJ membranes/NNS ./.
P03054266A02
It/PRP can/MD be/VBP accompanied/VBN by/IN acute/JJ diffuse/JJ or/CC localised/JJ abdominal/JJ pain/NN and/CC it/PRP could/MD also/RB appear/VBP to/TO be/VB an/DT acute/JJ appendicitis/NN or/CC an/DT intussusception/NN ./.
P03073687A04
No/DT significant/JJ loss/NN of/IN adsorption/NN capacity/NN was/VBD observed/VBN after/IN sterilization/NN and/CC storage/NN of/IN immunoadsorbents/NNS ./.
P03086582A06
These/DT findings/NNS show/VBP that/IN it/PRP is/VBZ safe/JJ to/TO administer/VB undiluted/JJ hypertonic/JJ elemental/JJ diets/NNS by/IN constant/JJ nasogastric/JJ infusion/NN to/TO patients/NNS with/IN inflammatory/JJ bowel/NN disease/NN ./.
P03107356A01
Methylcobalamin/NN (/( CH3-B12/NN )/) was/VBD administrated/VBN in/IN a/DT dose/NN of/IN 6/CD mg/NN per/IN day/NN (/( group/NN A/NN ,/, 16/CD cases/NNS )/) or/CC 12/CD mg/NN per/IN day/NN (/( group/NN B/NN ,/, 23/CD cases/NNS )/) for/IN 16/CD weeks/NNS to/TO patients/NNS with/IN oligozoospermia/NN ./.
P03112430A06
The/DT daily/JJ caloric/JJ intake/NN was/VBD 0.21/CD to/TO 0.22/CD kcal/NN //SYM g/NN body/NN weight/NN ./.
P03122751A03
In/IN the/DT particulate/JJ fraction/NN ,/, IFN-gamma/NN decreased/VBD protein/NN kinase/NN C/NN activity/NN within/IN 1/CD hr/NN but/CC it/PRP reappeared/VBD after/IN 24/CD hr/NN ,/, whereas/IN IFN-beta/NN decreased/VBD the/DT activity/NN during/IN the/DT inhibition/NN of/IN cell/NN growth/NN ./.
P03133111A07
Neutralization/NN (/( Winn/NN type/NN )/) tests/NNS showed/VBD that/IN peritoneal/JJ T/NN lymphocytes/NNS possessed/VBD tumor/NN cytotoxicity/NN and/CC that/IN the/DT antitumor/NN capacity/NN was/VBD reduced/VBN by/IN in/FW vivo/FW treatment/NN with/IN anti/JJ I-Ad/NN monoclonal/JJ antibody/NN simultaneously/RB with/IN and/CC 1/CD day/NN prior/RB to/TO MMC-Meth/NN A/NN injection/NN ./.
P03143388A07
There/EX were/VBD no/DT statistically/RB significant/JJ differences/NNS among/IN the/DT three/CD groups/NNS for/IN any/PRP of/IN the/DT quantitative/JJ parameters/NNS ./.
P03149527A12
Sequencing/NN of/IN purified/JJ lectins/NNS and/CC cDNA/NN clones/NNS indicates/VBZ that/IN at/IN least/JJS 4/CD distinct/JJ genes/NNS code/VBP for/IN what/WP appears/VBZ to/TO be/VB a/DT family/NN of/IN HL-14/NN ./.
P03168884A01
The/DT author/NN provides/VBZ some/DT material/NN for/IN reflection/NN on/IN the/DT issue/NN of/IN developing/NN leadership/NN in/IN the/DT health/NN sector/NN ;/: in/IN this/DT case/NN ,/, in/IN the/DT specific/JJ area/NN of/IN nursing/NN ./.
P03180204A04
She/PRP had/VBD marked/JJ symptomatic/JJ improvement/NN ,/, no/DT further/JJ heart/NN failure/NN ,/, and/CC a/DT full-term/NN ,/, normal/JJ delivery/NN ./.
P03191946A02
A/DT number/NN of/IN monoclonal/JJ antibodies/NNS which/WDT have/VBP been/VBN shown/VBN to/TO be/VB capable/JJ of/IN inducing/NN T/NN cell/NN activation/NN and/CC which/WDT have/VBP been/VBN previously/RB considered/VBN to/TO recognize/VB distinct/JJ proteins/NNS all/PRP reacted/VBN with/IN the/DT same/JJ transfected/JJ gene/NN product/NN ./.
P03204008A09
There/EX were/VBD five/CD instances/NNS of/IN leukopenia/NN and/CC fever/NN ./.
P03219063A04
A/DT factor/NN analysis/NN was/VBD performed/VBN on/IN the/DT SDMI/NN and/CC six/CD levels/NNS of/IN sexual/JJ decision/NN making/NN were/VBD defined/VBN :/: Object/NN Constancy/NN ,/, Ambivalence/NN ,/, Need/NN for/IN Merger/NN ,/, Need/NN Gratification/NN ,/, Low/JJ Self-esteem/NN ,/, and/CC Narcissistic/JJ Gratification/NN ./.
P03231884A04
We/PRP suggest/VBP that/IN the/DT total/JJ sum/NN of/IN other/JJ anions/NNS such/JJ as/IN proteins/NNS ,/, phosphate/NN ,/, pyruvate/NN ,/, citrate/NN ,/, free/JJ fatty/JJ acids/NNS and/CC aminoacids/NNS ,/, as/RB well/RB as/IN sodium-hydrogen/NN exchange/NN could/MD account/VBP for/IN this/DT acidosis/NN ./.
P03261110A02
In/IN most/DT thymic/JJ tissues/NNS from/IN patients/NNS with/IN MG/NN ,/, a/DT maturating/JJ tendency/NN of/IN lymphocytes/NNS was/VBD generally/RB observed/VBN ./.
P03280907A01
Imipenem/NN is/VBZ a/DT new/JJ carbapenem/NN antibiotic/NN that/IN has/VBZ an/DT extremely/RB broad/JJ spectrum/NN of/IN antibacterial/JJ activity/NN ./.
P03292334A04
Two/CD proteolytic/JJ bands/NNS in/IN rat/NN gastric/JJ mucosa/NN that/WDT migrated/VBD concurrently/RB with/IN human/NN slow-moving/JJ proteinase/NN reacted/VBD with/IN antihuman/NN slow-moving/JJ proteinase/NN reacted/VBD with/IN antihuman/NN slow-moving/JJ proteinase/NN ./.
P03304329A01
A/DT method/NN is/VBZ described/VBN for/IN the/DT preparation/NN of/IN monolayer/NN smears/NNS from/IN paraffin-embedded/JJ tissue/NN ./.
P03315639A03
There/EX was/VBD no/DT significant/JJ correlation/NN between/IN concentrations/NNS of/IN serum/NN Tg/NN and/CC triiodothyronine/NN (/( T3/NN )/) ,/, thyroxine/NN (/( T4/NN )/) ,/, fasting/JJ plasma/NN glucose/NN (/( FPG/NN )/) ,/, and/CC hemoglobin/NN A1c/NN (/( HbA1c/NN )/) ./.
P03328560A01
Considerable/JJ progress/NN has/VBZ been/VBN made/VBN in/IN the/DT morphologic/JJ study/NN of/IN pituitary/NN due/JJ to/TO the/DT availability/NN of/IN angioscan/NN programs/NNS ./.
P03341541A05
A/DT positive/JJ test/NN result/NN was/VBD defined/VBN as/IN pain/NN with/IN sodium/NN hydroxide/NN but/CC not/RB with/IN saline/JJ solution/NN or/CC hydrochloric/JJ acid/NN infusion/NN ./.
P03351882A02
This/DT brief/JJ article/NN attempts/VBZ to/TO explain/VB how/WRB to/TO decode/VB such/DT references/NNS and/CC thus/RB get/VB to/TO the/DT reports/NNS ./.
P03362871A08
Distinct/JJ mechanisms/NNS ,/, therefore/RB ,/, regulate/VBP the/DT expression/NN of/IN proenkephalin/NN mRNA/NN and/CC prodynorphin/NN mRNA/NN in/IN rat/NN hippocampus/NN ./.
P03374408A08
This/DT method/NN will/MD be/VBP applicable/JJ routinely/RB for/IN the/DT definite/JJ identification/NN of/IN atypical/JJ strains/NNS of/IN Campylobacter/NN species/NNS and/CC other/JJ gram-negative/JJ bacteria/NN difficult/JJ to/TO identify/VB biochemically/RB ./.
P03385813A05
Sixteen/CD mongrel/NN dogs/NNS were/VBD anesthetized/VBN and/CC bled/VBN by/IN increments/NNS of/IN 3/CD %/SYM of/IN their/PRP$ total/JJ blood/NN volume/NN until/IN the/DT onset/NN of/IN sustained/JJ hypotension/NN or/CC a/DT 25/CD %/SYM blood/NN loss/NN ./.
P03397743A01
The/DT authors/NNS reviewed/VBD the/DT clinical/JJ and/CC radiographic/JJ results/NNS of/IN 31/CD bipolar/JJ hip/NN arthroplasties/NNS performed/VBN for/IN avascular/JJ necrosis/NN in/IN 24/CD patients/NNS ./.
P03403456A06
R/NN resulted/VBD in/IN increased/JJ arterial/JJ lactate/NN concentrations/NNS compared/VBN with/IN C/NN and/CC SW/NN at/IN base/NN line/NN but/CC was/VBD not/RB different/JJ from/IN SW/NN at/IN 4/CD wk/NN ./.
P03409486A11
Further/JJ biochemical/JJ investigations/NNS revealed/VBD that/IN the/DT antioxidative/JJ enzyme/NN ,/, catalase/NN ,/, was/VBD significantly/RB increased/VBN to/TO 137/CD +/-/SYM 12.7/CD U/NN //SYM mg/NN protein/NN in/IN the/DT heat-shocked/JJ hearts/NNS while/IN the/DT control/NN value/NN was/VBD 64.8/CD +/-/SYM 8.3/CD U/NN //SYM mg/NN protein/NN ./.
P03421612A07
The/DT implications/NNS of/IN these/DT findings/NNS for/IN ethical/JJ practice/NN and/CC for/IN the/DT theoretical/JJ interpretation/NN of/IN phallometric/JJ assessment/NN data/NNS were/VBD discussed/VBN ./.
P03440467A02
No/DT differences/NNS between/IN the/DT relative/JJ peak/JJ areas/NNS of/IN the/DT various/JJ fatty/JJ acids/NNS were/VBD observed/VBN as/IN regards/VBZ the/DT two/CD detectors/NNS used/VBN except/IN that/IN response/NN of/IN the/DT electron/NN capture/NN dectector/NN to/TO the/DT hydroxy/NN acid/NN derivatives/NNS exceeded/VBD that/PRP to/TO the/DT non-hydroxy/NN acid/NN derivatives/NNS by/IN 20/CD %/SYM ./.
P03456347A04
The/DT relative/JJ incorporation/NN of/IN fibronectin/NN and/CC collagen/NN into/IN the/DT matrix/NN also/RB increases/VBZ in/IN response/NN to/TO TGFbeta/NN ./.
P03480807A04
Only/RB those/DT cells/NNS in/IN which/WDT the/DT stimulation/NN evoked/VBD excitation/NN (/( alone/JJ or/CC mixed/VBN with/IN inhibition/NN )/) responded/VBD to/TO the/DT inhibitors/NNS ./.
P03492926A03
We/PRP tested/VBD for/IN a/DT specific/JJ interaction/NN of/IN albumin/NN with/IN the/DT ablumenal/JJ surface/NN of/IN the/DT capillary/NN wall/NN ./.
P03503041A01
Actions/NNS of/IN muscles/NNS that/WDT pass/VBP over/IN more/RB than/IN one/CD joint/NN are/VBP mainly/RB described/VBN with/IN respect/NN to/TO movements/NNS in/IN the/DT joints/NNS that/WDT are/VBP crossed/VBN ./.
P03511102A06
No/DT positive/JJ correlation/NN was/VBD found/VBN between/IN the/DT amount/NN of/IN periodontal/JJ tissue/NN support/NN and/CC the/DT magnitude/NN of/IN the/DT forces/NNS developed/VBN during/IN biting/NN with/IN maximal/JJ strength/NN in/IN habitual/JJ occlusion/NN either/CC totally/RB or/CC locally/RB ,/, although/IN there/EX was/VBD a/DT strong/JJ tendency/NN (/( r/NN =/SYM 0.54/CD ;/: 0.6/CD greater/JJR than/IN P/NN greater/JJR than/IN 0.5/CD )/) towards/IN decreasing/JJ total/JJ maximal/JJ bite/NN force/NN with/IN decreasing/JJ total/NN remaining/JJ periodontal/JJ ligament/NN area/NN ./.
P03521517A04
MTP-1403/NN markedly/RB improved/VBD the/DT oral/JJ glucose/NN tolerance/NN test/NN in/IN the/DT genetically/RB diabetic/JJ KK/NN mice/NNS ./.
P03538922A02
Forty-six/CD patients/NNS with/IN proved/JJ MPV/NN bites/NNS and/CC incoagulable/JJ blood/NN ,/, indicating/VBG systemic/JJ envenoming/NN ,/, were/VBD randomly/RB allocated/VBN for/IN treatment/NN with/IN Thai/JJ Red/JJ Cross/NN (/( TRC/NN )/) ,/, Thai/JJ Government/NN Pharmaceutical/NN Organization/NN (/( GPO/NN )/) ,/, or/CC Twyford/NN Pharmaceutical/NN monospecific/JJ antivenoms/NNS ./.
P03544648A06
The/DT patients/NNS again/RB asked/VBD for/IN an/DT analgesic/NN after/IN an/DT average/NN of/IN 4.6/CD h/NN in/IN the/DT oxycodone/NN group/NN and/CC after/IN an/DT average/NN of/IN 6.1/CD h/NN in/IN the/DT diclofenac/NN group/NN ./.
P03550454A10
This/PRP suggests/VBZ the/DT importance/NN of/IN choosing/NN an/DT appropriate/JJ Nt/NN as/RB well/RB as/IN method/NN for/IN the/DT estimation/NN of/IN mu/NN ./.
P03556435A04
The/DT species/NN composition/NN bore/VBD considerable/JJ resemblance/NN to/TO that/PRP of/IN house/NN dust/NN (/( although/IN the/DT density/NN of/IN mites/NNS was/VBD far/RB lower/JJR )/) and/CC the/DT mites/NNS have/VBP probably/RB been/VBN transported/VBN from/IN homes/NNS via/IN clothing/NN and/CC pets/NNS ./.
P03572797A10
The/DT similarity/NN between/IN the/DT behavioral/JJ effects/NNS of/IN the/DT beta/NN adrenergic/JJ agonists/NNS and/CC those/PRP of/IN proven/JJ antidepressant/NN drugs/NNS provides/VBZ evidence/NN consistent/JJ with/IN the/DT contention/NN that/IN centrally/RB acting/JJ beta/NN adrenergic/JJ agonists/NNS might/MD possess/VBP antidepressant/NN activity/NN ./.
P03584468A01
The/DT metabolism/NN of/IN human/NN IgE/NN was/VBD studied/VBN in/IN normals/NNS ,/, severe/JJ atopics/NNS ,/, and/CC patients/NNS with/IN the/DT hyperimmunoglobulin/NN E-recurrent/JJ infection/NN (/( HIE/NN ;/: Job/NN 's/POS )/) syndrome/NN to/TO determine/VB whether/IN IgE/NN metabolism/NN is/VBZ altered/VBN in/IN patients/NNS with/IN marked/JJ elevation/NN of/IN serum/NN IgE/NN ./.
P03595783A05
Vasopressin/NN increased/VBD the/DT excitability/NN of/IN impaled/JJ neurons/NNS without/IN substantially/RB altering/NN membrane/NN potential/NN or/CC resistance/NN ./.
P03601381A12
The/DT overall/JJ results/NNS --/: considering/VBG both/CC objective/JJ and/CC subjective/JJ factors/NNS --/: showed/VBD good/JJ to/TO excellent/JJ results/NNS in/IN 12/CD patients/NNS of/IN group/NN I/CD (/( 52/CD %/SYM )/) ,/, in/IN 8/CD patients/NNS of/IN group/NN II/CD (/( 62/CD %/SYM )/) ,/, and/CC in/IN 31/CD patients/NNS of/IN group/NN III/CD (/( 84/CD %/SYM )/) ./.
P03619130A01
One/CD hundred/CD and/CC fifty-two/CD children/NNS affected/VBN by/IN respiratory/JJ syndromes/NNS ,/, probably/RB due/JJ to/TO allergy/NN ,/, underwent/VBD skin/NN testing/NN to/TO a/DT range/NN of/IN extracts/NNS including/VBG several/JJ different/JJ species/NNS of/IN mites/NNS ./.
P03651151A01
Effects/NNS of/IN oral/JJ administration/NN of/IN elastase/NN on/IN changes/NNS in/IN contractile/JJ responses/NNS of/IN smooth/JJ muscle/NN cells/NNS of/IN the/DT aorta/NN and/CC pulmonary/JJ artery/NN were/VBD studied/VBN in/IN rabbits/NNS fed/VBN a/DT high-cholesterol/NN diet/NN ./.
P03656193A09
Simultaneously/RB gastric/JJ pressure/NN was/VBD increased/VBN primarily/RB by/IN a/DT reduction/NN in/IN the/DT tonic/JJ vagal/JJ drive/NN to/TO the/DT intramural/JJ non-adrenergic/JJ ,/, non-cholinergic/JJ inhibitory/JJ neurones/NNS in/IN the/DT corpus/NN region/NN ./.
P03668318A06
An/DT Arrhenius/NN analysis/NN of/IN heat/NN survival/NN curves/NNS of/IN the/DT different/JJ CFU-S/NN allowed/VBD us/PRP to/TO estimate/VB only/RB one/CD activation/NN energy/NN (/( Ea/NN )/) in/IN the/DT inactivation/NN process/NN of/IN foetal/JJ liver/NN and/CC regenerating/JJ spleen/NN CFU-S/NN ,/, and/CC two/CD Ea/NN in/IN the/DT case/NN of/IN steady-state/NN marrow/NN and/CC spleen/NN CFU-S/NN and/CC regenerating/JJ marrow/NN CFU-S/NN ./.
P03680049A09
(/( 3/CD )/) Phospholipids/NNS were/VBD labeled/VBN with/IN [/( 32P/NN ]/) orthophosphate/NN which/WDT was/VBD mostly/RB incorporated/VBN into/IN phosphatidylinositol/NN 4/CD ,/, 5-bisphosphate/NN (/( PIP2/NN )/) ,/, phosphatidylinositol/NN 4-phosphate/NN ,/, phosphatidylinositol/NN ,/, and/CC phosphatidic/JJ acid/NN ./.
P03699194A05
The/DT phenol/NN fraction/NN thus/RB obtained/VBN was/VBD subjected/VBN to/TO thin/JJ layer/NN chromatography/NN (/( TLC/NN )/) (/( cyclohexane-ethyl/NN acetate/NN =/SYM 2/CD :/: 1/CD ,/, V/NN //SYM V/NN and/CC chloroform-ethyl/NN ether/NN =/SYM 4/CD :/: 1/CD ,/, V/NN //SYM V/NN )/) ./.
P03710141A02
The/DT analyses/NNS were/VBD done/VBN separately/RB in/IN each/PRP of/IN the/DT ethnic/JJ groups/NNS categorized/VBN according/VBG to/TO the/DT parents/NNS '/POS country/NN of/IN birth/NN (/( Europe/NNP ,/, Asia/NNP ,/, North/NN Africa/NNP ,/, and/CC Israel/NNP //SYM mixed/JJ origin/NN )/) in/IN order/NN to/TO identify/VB the/DT nature/NN and/CC sources/NNS of/IN any/DT heterogeneity/NN among/IN the/DT groups/NNS ./.
P03716018A07
During/IN treatment/NN with/IN low-strength/NN anthralin/NN ,/, the/DT mast/JJ cell/NN changes/NNS underwent/VBD regression/NN ./.
P03732727A02
Many/JJ patients/NNS had/VBD a/DT poor/JJ left/JJ ventricular/JJ function/NN ./.
P03738742A02
A/DT 3/CD mm/NN thick/JJ ,/, tube-form/NN applicator/NN of/IN noble/JJ metal/NN which/WDT is/VBZ closed/VBN at/IN the/DT front/NN side/NN is/VBZ implanted/VBN into/IN the/DT tumor/NN by/IN a/DT stereotaxic/JJ technique/NN and/CC firmly/RB screwed/VBN together/RB with/IN the/DT osseous/JJ calotte/NN ./.
P03750242A07
The/DT study/NN also/RB showed/VBD that/IN doctors/NNS had/VBD difficulty/NN in/IN identifying/NN the/DT reversibility/NN of/IN airflow/NN obstruction/NN in/IN patients/NNS in/IN whom/WP they/PRP correctly/RB predicted/VBD obstruction/NN ./.
P03766705A07
Parotid/NN glands/NNS receiving/VBG 7.5-15.0/CD Gy/NN were/VBD atrophic/JJ at/IN 16-22/CD weeks/NNS after/IN irradiation/NN and/CC showed/VBD no/DT recovery/NN by/IN 40/CD weeks/NNS ./.
P03782626A01
Lying/NN in/IN 4th-/NN ,/, 7th-/NN ,/, and/CC 10th-grade/NN boys/NNS was/VBD measured/VBN through/IN parent/NN and/CC teacher/NN reports/NNS ./.
P03794055A01
After/IN a/DT lower/JJR hemi-cervical/JJ spinal/JJ cord/NN injury/NN ,/, a/DT patient/NN presented/VBD with/IN a/DT left/JJ hemiplegia/NN and/CC on/IN the/DT same/JJ side/NN a/DT unilateral/JJ chest/NN wall/NN paradoxical/JJ motion/NN mimicking/VBG a/DT flail/NN chest/NN ./.
P03805448A06
Two/CD possible/JJ causes/NNS for/IN depressed/JJ N/NN digestibility/NN of/IN 60/CD degrees/NNS C/NN silage/NN were/VBD 1/CD )/) the/DT ratio/NN of/IN poorly/RB digested/JJ nonamino/JJ acid/NN N/NN to/TO highly/RB digested/JJ amino/JJ acid/NN N/NN was/VBD higher/JJR in/IN 60/CD degrees/NNS C/NN silage/NN than/IN in/IN 35/CD degrees/NNS C/NN or/CC unheated/JJ silage/NN ,/, and/CC 2/CD )/) amino/JJ acid/NN N/NN in/IN 60/CD degrees/NNS C/NN silage/NN was/VBD digested/VBN less/RB than/IN amino/JJ acid/NN N/NN in/IN 35/CD degrees/NNS C/NN or/CC unheated/JJ silage/NN ./.
P03822838A02
Experiments/NNS were/VBD carried/VBN out/RP in/IN E./NN coli/NN DNA/NN polymerase/NN I/CD Klenow/NN fragment/NN enzyme/NN system/NN ./.
P03836440A01
Computed/JJ tomograms/NNS (/( CT/NN )/) in/IN twenty/CD cases/NNS of/IN renal/JJ tuberculosis/NN (/( TB/NN )/) were/VBD reviewed/VBN in/IN comparison/NN with/IN intravenous/JJ urograms/NNS ./.
P03858299A04
Enamel/NN demineralization/NN experiments/NNS conducted/VBN in/FW vitro/FW confirmed/VBD the/DT significance/NN of/IN the/DT results/NNS of/IN the/DT computer/NN simulations/NNS ,/, thus/RB providing/VBG evidence/NN for/IN a/DT correlation/NN between/IN the/DT known/JJ metabolic/JJ activity/NN of/IN plaque/NN (/( organic/JJ acid/NN composition/NN )/) ,/, physical/JJ chemistry/NN of/IN plaque/NN ,/, and/CC caries/NN susceptibility/NN ./.
P03874151A05
IL-1/NN generation/NN was/VBD determined/VBN by/IN the/DT ability/NN of/IN supernatants/NNS from/IN 2-day/NN cultured/JJ adherent/JJ cells/NNS stimulated/VBN by/IN lipopolysaccharide/NN to/TO enhance/VB proliferation/NN of/IN PHA-stimulated/JJ mice/NNS thymocytes/NNS ./.
P03879038A08
Bovine/JJ rhodopsin/NN ,/, on/IN the/DT other/JJ hand/NN ,/, had/VBD a/DT single/JJ Mr/NN component/NN and/CC focused/VBD in/IN a/DT major/JJ band/NN at/IN pH/NN 6.2/CD ./.
P03895372A03
After/IN two/CD months/NNS ,/, the/DT resulting/JJ porencephalic/JJ cyst/NN had/VBD been/VBN transformed/VBN into/IN glial/JJ tissue/NN of/IN very/JJ high/JJ echogenicity/NN ./.
P03906866A04
Some/PRP of/IN the/DT relevant/JJ enzymatic/JJ metabolic/JJ reactions/NNS are/VBP also/RB discussed/VBN ./.
P03920038A09
The/DT investigation/NN demonstrates/VBZ the/DT great/JJ relevance/NN of/IN persistent/JJ treatment/NN for/IN prevention/NN of/IN exacerbations/NNS as/RB well/RB as/IN for/IN interval/NN periods/NNS ./.
P03935156A01
Spectroscopic/JJ studies/NNS on/IN the/DT trans-7/NN ,/, 8-dihydroxy-anti-9/NN ,/, 10-epoxy-7/NN ,/, 8/CD ,/, 9/CD ,/, 10-tetrahydrobenzo/NN [/( a/NN ]/) pyrene-/NN (/( anti-BPDE-/NN )/) modified/JJ synthetic/JJ polynucleotide/NN solutions/NNS reveal/VBP interesting/JJ sequence-dependent/JJ stereoselective/JJ covalent/JJ binding/NN of/IN anti-BPDE/NN to/TO DNA/NN ./.
P03941248A05
Differences/NNS between/IN these/DT findings/NNS and/CC those/PRP reported/VBN for/IN Western/JJ samples/NNS reflect/VBP cultural/JJ differences/NNS between/IN Yoruba/NNP and/CC Western/JJ societies/NNS ./.
P03955986A04
Ninety-three/CD percent/NN of/IN patients/NNS were/VBD transported/VBN to/TO a/DT hospital/NN where/WRB first/JJ treatment/NN was/VBD given/VBN within/IN six/CD hours/NNS after/IN the/DT accident/NN ./.
P03961186A06
These/DT standards/NNS are/VBP of/IN particular/JJ value/NN in/IN subtle/JJ or/CC early/JJ cases/NNS in/IN which/WDT the/DT thinning/NN of/IN the/DT epiphysis/NN may/MD not/RB be/VBP apparent/JJ upon/IN simple/JJ observation/NN ./.
P03975972A03
The/DT series/NN included/VBD 217/CD cases/NNS of/IN cerebral/JJ thrombosis/NN ,/, 54/CD of/IN cerebral/JJ hemorrhage/NN ,/, and/CC 35/CD of/IN TIA/NN ./.
P03981021A07
None/CD of/IN the/DT patients/NNS with/IN underlying/JJ conditions/NNS survived/VBD after/IN receiving/VBG inappropriate/JJ therapy/NN as/IN compared/VBN with/IN 50/CD %/SYM who/WP were/VBD previously/RB healthy/JJ ./.
P03996727A05
The/DT extent/NN of/IN their/PRP$ action/NN depended/VBD on/IN their/PRP$ structural/JJ similarity/NN to/TO the/DT cyclohexyl/NN of/IN retinal/NN ./.
P04013578A02
The/DT focus/NN was/VBD manifested/VBN by/IN group/NN morbidity/NN among/IN the/DT cattle-tending/JJ personnel/NN of/IN a/DT dairy/NN farm/NN ./.
P04018776A10
Enhanced/JJ extramedullary/JJ erythropoiesis/NN was/VBD observed/VBN in/IN all/DT cases/NNS ./.
P04029403A05
Biopsies/NNS were/VBD taken/VBN from/IN the/DT tumour/NN and/CC from/IN adjacent/JJ '/`` normal/JJ '/'' mucosa/NN and/CC from/IN both/DT resection/NN edges/NNS ./.
P04040179A04
Nongerm/NN cell/NN malignancies/NNS in/IN mixed/JJ germ/NN cell/NN tumors/NNS following/VBG chemotherapy/NN may/MD be/VBP more/RB common/JJ than/IN previously/RB described/VBN ./.
P04050971A07
In/IN airways/NNS ,/, the/DT nonciliated/JJ bronchiolar/JJ epithelial/JJ (/( Clara/NN )/) cell/NN was/VBD the/DT predominant/JJ cell/NN affected/VBN ./.
P04056049A10
The/DT slopes/NNS of/IN the/DT resting/JJ heart/NN rate/NN vs./CC the/DT plasma/NN concentration/NN of/IN l-pindolol/NN were/VBD significantly/RB less/RB than/IN zero/CD and/CC were/VBD significantly/RB correlated/VBN to/TO the/DT pretreatment/NN heart/NN rate/NN ,/, which/WDT supports/VBZ the/DT hypothesis/NN that/IN intrinsic/JJ sympathetic/JJ tone/NN largely/RB determines/VBZ the/DT effect/NN of/IN pindolol/NN on/IN the/DT resting/JJ heart/NN rate/NN ./.
P04067078A03
The/DT second/JJ tone/NN ,/, F2/NN ,/, was/VBD located/VBN above/IN CF/NN ./.
P04073450A05
Hyperventilation/NN ,/, with/IN hand/NN bagging/NN ,/, was/VBD successful/JJ in/IN treating/NN five/CD out/IN of/IN six/CD episodes/NNS of/IN PFC/NN (/( 83/CD %/SYM )/) ,/, without/IN complication/NN ./.
P04091585A01
Follow/NN up/RP of/IN 40/CD girls/NNS with/IN premature/JJ thelarche/NN showed/VBD that/IN where/WRB this/DT disorder/NN occurred/VBD before/IN age/NN 2/CD years/NNS it/PRP usually/RB regressed/VBN completely/RB ,/, thus/RB representing/VBG a/DT transient/JJ and/CC isolated/JJ phenomenon/NN ./.
P06091809A02
The/DT so-called/JJ "/`` gaiting/JJ mechanism/NN "/'' of/IN calcium/NN channels/NNS plays/VBZ a/DT more/RB essential/JJ part/NN in/IN the/DT changes/NNS in/IN the/DT basal/JJ tone/NN of/IN precapillary/JJ sphincters/NNS influenced/VBN by/IN calcium/NN antagonists/NNS ,/, whereas/IN voltage-controlled/JJ and/CC receptor-operated/JJ calcium/NN channels/NNS are/VBP responsible/JJ for/IN variations/NNS in/IN the/DT adrenergic/JJ tone/NN of/IN precapillary/JJ sphincters/NNS ./.
P06101125A03
The/DT iris/NN could/MD be/VBP adequately/RB evaluated/VBN and/CC the/DT retina/NN could/MD be/VBP visualized/VBN after/IN surgery/NN in/IN 36/CD cases/NNS ./.
P06117377A04
Furthermore/RB ,/, propranolol/NN significantly/RB potentiated/VBD the/DT vasoconstriction/NN caused/VBN by/IN intra-arterial/JJ norepinephrine/NN and/CC attenuated/VBD the/DT vasodilator/NN action/NN of/IN isoproterenol/NN ./.
P06138056A01
The/DT effect/NN of/IN vasodilation/NN (/( with/IN nifedipine/NN )/) or/CC beta-adrenergic/JJ receptor/NN blockade/NN (/( with/IN propranolol/NN ,/, alprenolol/NN or/CC metoprolol/NN )/) on/IN the/DT rate/NN of/IN rise/NN of/IN oxygen/NN uptake/NN and/CC heart/NN rate/NN were/VBD studied/VBN in/IN 14/CD healthy/JJ subjects/NNS after/IN a/DT step-wise/JJ increase/NN of/IN workload/NN from/IN a/DT light/JJ to/TO a/DT moderate/JJ exercise/NN intensity/NN ./.
P06149528A04
In/IN the/DT hyperinsulinemic/JJ hypoglycemic/JJ infants/NNS ,/, an/DT increase/NN in/IN total/JJ endocrine/JJ cell/NN volume/NN was/VBD found/VBN ;/: however/WRB ,/, the/DT typical/JJ features/NNS of/IN nesidioblastosis/NN were/VBD also/RB found/VBN in/IN the/DT controls/NNS ./.
P06166392A01
Leukocytes/NNS and/CC mast/JJ cells/NNS of/IN rat/NN peritoneal/JJ exudate/NN (/( PE/NN )/) were/VBD fused/VBN in/FW vitro/FW with/IN actively/RB growing/JJ mouse/NN cells/NNS ./.
P06172374A08
Anti-RCGC-PK1/NN serum/NN showed/VBD no/DT reactivity/NN with/IN highly/RB purified/JJ xenogeneic/JJ mucins/NNS nor/CC with/IN syngeneic/JJ small/JJ bowel/NN mucin/NN ./.
P06184021A06
The/DT relevance/NN of/IN this/DT observation/NN to/TO be/VB clinical/JJ features/NNS of/IN rheumatoid/JJ arthritis/NN is/VBZ discussed/VBN ./.
P06193901A02
The/DT isomers/NNS of/IN HCH/NN were/VBD separated/VBN by/IN adsorption/NN chromatography/NN on/IN silica/NN gel/NN ./.
P06198531A02
Since/IN there/EX is/VBZ no/DT part/NN of/IN the/DT history/NN ,/, physical/JJ examination/NN or/CC noninvasive/JJ laboratory/NN findings/NNS that/WDT is/VBZ specific/JJ ,/, a/DT tentative/JJ criteria/NNS for/IN diagnosis/NN of/IN pulmonary/JJ thromboembolism/NN is/VBZ proposed/VBN based/VBN a/DT scoring/JJ system/NN ./.
P06207601A03
Five/CD had/VBD no/DT symptoms/NNS ,/, nine/CD had/VBD ambiguous/JJ symptoms/NNS ,/, and/CC six/CD had/VBD pericardial/JJ tamponade/NN ./.
P06213410A01
Posttranslational/JJ transfer/NN of/IN most/DT precursor/NN proteins/NNS into/IN mitochondria/NNS is/VBZ dependent/JJ on/IN energization/NN of/IN the/DT mitochondria/NNS ./.
P06226696A05
Total/JJ clinical/JJ recovery/NN occurred/VBD at/IN the/DT end/NN of/IN 6/CD months/NNS ./.
P06245686A03
The/DT pH/NN dependence/NN can/MD be/VBP analysed/VBN in/IN terms/NNS of/IN a/DT pKa/NN of/IN 6.2/CD in/IN the/DT oxidised/JJ form/NN and/CC a/DT pKa/NN of/IN 7.3/CD in/IN the/DT reduced/JJ form/NN ./.
P06262408A03
The/DT response/NN pattern/NN obtained/VBN with/IN optimum/NN concentrations/NNS of/IN these/DT preparations/NNS was/VBD very/RB similar/JJ to/TO that/PRP seen/VBN with/IN the/DT B/NN cell/NN mitogen/NN ,/, LPS/NN ./.
P06273649A01
The/DT identification/NN of/IN female/NN carriers/NNS of/IN Fabry/NN 's/POS disease/NN is/VBZ important/JJ for/IN genetic/JJ counselling/NN since/IN prenatal/JJ diagnosis/NN of/IN affected/JJ fetuses/NNS is/VBZ possible/JJ ./.
P06290264A03
It/PRP caused/VBD biphasic/JJ kinetics/NNS of/IN inhibition/NN which/WDT could/MD be/VBP potentiated/VBN by/IN ATP/NN ./.
P06300763A04
The/DT nucleotide/NN sequence/NN of/IN the/DT longest/JJS cDNA/NN contained/VBN in/IN pGET2/NN was/VBD determined/VBN ./.
P06309961A04
Using/VBG Epstein-Barr/NN virus/NN activation/NN or/CC coculture/NN with/IN irradiated/JJ adult/NN T/NN cells/NNS in/IN the/DT presence/NN of/IN influenza/NN virus/NN to/TO identify/VB precursor/NN B/NN cells/NNS for/IN anti-viral/JJ antibody/NN production/NN ,/, newborns/NNS were/VBD found/VBN to/TO have/VB a/DT decreased/JJ number/NN of/IN influenza-specific/JJ B/NN cells/NNS as/IN compared/VBN with/IN adults/NNS ./.
P06314491A06
Our/PRP$ more/RB recent/JJ studies/NNS support/VBP the/DT notion/NN that/IN loperamide/NN has/VBZ an/DT effect/NN on/IN specific/JJ transport/NN systems/NNS rather/RB than/IN non-specific/JJ passive/JJ diffusional/JJ processes/NNS ./.
P06327443A07
It/PRP also/RB may/MD provide/VBP a/DT newer/JJR conceptual/JJ basis/NN for/IN a/DT more/RB rational/JJ development/NN of/IN future/JJ compounds/NNS to/TO antagonize/VB the/DT lethal/JJ effects/NNS of/IN cyanide/NN ./.
P06337311A07
The/DT vast/JJ majority/NN of/IN cutaneous/JJ basal/JJ cell/NN and/CC squamous/JJ cell/NN carcinomas/NNS are/VBP easily/RB cured/VBN no/DT matter/NN what/WP the/DT treatment/NN modality/NN ./.
P06343057A02
Moderate/JJ hyperthyroidism/NN increased/VBD the/DT rate/NN of/IN glucose/NN turnover/NN ,/, whereas/IN hypothyroidism/NN was/VBD without/IN effect/NN ./.
P06349442A07
The/DT procoagulant/NN material/NN was/VBD identified/VBN as/IN a/DT cell-associated/JJ tissue/NN thromboplastin/NN ,/, acting/VBG via/IN the/DT extrinsic/JJ coagulation/NN pathway/NN ./.
P06361809A01
A/DT multiclinic/JJ ,/, collaborative/JJ study/NN has/VBZ been/VBN designed/VBN to/TO assess/VB the/DT natural/JJ progression/NN and/CC efficacy/NN of/IN treatment/NN of/IN Duchenne/NN muscular/JJ dystrophy/NN ./.
P06373787A07
In/IN extracts/NNS from/IN iliotibialis/NN and/CC posterior/JJ latissimus/NN dorsi/NN muscles/NNS of/IN adult/NN chickens/NNS ,/, we/PRP detected/VBD a/DT hitherto/RB unidentified/JJ protein/NN that/WDT was/VBD very/RB similar/JJ to/TO vimentin/NN in/IN molecular/JJ weight/NN but/CC did/VBD not/RB react/VBP with/IN our/PRP$ antivimentin/NN antibody/NN ./.
P06399229A02
In/IN 33/CD patients/NNS (/( 66/CD eyes/NNS )/) who/WP had/VBD avascular/JJ grafts/NNS ,/, there/EX was/VBD no/DT significant/JJ increase/NN in/IN the/DT incidence/NN of/IN allograft/NN rejection/NN reaction/NN after/IN corneal/JJ transplantation/NN in/IN the/DT second/JJ eye/NN ./.
P06405715A12
There/EX was/VBD also/RB a/DT high/JJ mortality/NN rate/NN with/IN reoperation/NN for/IN thrombosis/NN (/( 30/CD p./NN 100/CD )/) because/IN of/IN the/DT severe/JJ myocardial/JJ dysfunction/NN in/IN thrombosis/NN of/IN tricuspid/NN prostheses/NNS and/CC the/DT emergency/NN situation/NN associated/VBN with/IN mitral/JJ prosthetic/JJ valve/NN thrombosis/NN ./.
P06416857A05
However/WRB ,/, none/CD of/IN the/DT blood/NN cells/NNS tested/VBN served/VBD as/IN acceptor/NN for/IN lipolysis-generated/JJ free/JJ cholesterol/NN ,/, whereas/IN HDL/NN did/VBD ./.
P06427616A03
The/DT incidence/NN of/IN A./NN flavus/NN in/IN drought-stressed/JJ ,/, unshelled/JJ ,/, sound/JJ mature/JJ kernels/NNS (/( SMK/NN )/) decreased/VBD with/IN decreases/NNS in/IN the/DT mean/NN 5/CD cm/NN deep/JJ soil/NN temperature/NN ./.
P06438173A04
Clinical/JJ studies/NNS support/VBP these/DT findings/NNS ./.
P06458765A01
The/DT uncoupling/NN of/IN pituitary/NN stimulation/NN and/CC response/NN observed/VBN in/IN adults/NNS during/IN administration/NN of/IN the/DT luteinizing/JJ hormone-releasing/JJ hormone/NN analogue/NN ,/, D-Trp6-Pro9-NEt-LHRH/NN (/( LHRHa/NN )/) suggested/VBD that/IN this/DT drug/NN might/MD be/VBP useful/JJ in/IN treating/NN precocious/JJ puberty/NN ./.
P06465252A07
Maternal/JJ plasma/NN epinephrine/NN levels/NNS remained/VBD relatively/RB constant/JJ ,/, whereas/IN fetal/JJ epinephrine/NN levels/NNS increased/VBD fiftyfold/NN from/IN day/NN 17/CD to/TO day/NN 22/CD ./.
P06476888A03
Relatively/RB speaking/VBG ,/, more/DT men/NNS than/IN women/NNS died/VBD of/IN a/DT thin/JJ melanoma/NN :/: in/IN Group/NN 1/CD (/( deceased/VBN )/) there/EX were/VBD 32/CD men/NNS and/CC 28/CD women/NNS ,/, in/IN Group/NN 2/CD (/( alive/JJ )/) 58/CD men/NNS and/CC 242/CD women/NNS ./.
P06488185A02
A/DT microscopic/JJ cancer/NN was/VBD found/VBN by/IN 24/CD weeks/NNS ,/, and/CC macroscopic/JJ cancers/NNS were/VBD found/VBN after/IN 27/CD weeks/NNS ./.
P06499159A02
We/PRP studied/VBD the/DT influence/NN of/IN time/NN ,/, temperature/NN ,/, glucose/NN concentration/NN ,/, and/CC pH/NN on/IN results/NNS obtained/VBN by/IN three/CD commercially/RB available/JJ column/NN chromatographic/JJ procedures/NNS designed/VBN to/TO quantify/VB glycated/JJ hemoglobin/NN ./.
P06504800A04
With/IN early/JJ diagnosis/NN of/IN neck/NN infections/NNS ,/, serious/JJ complications/NNS such/JJ as/IN spread/NN to/TO vital/JJ structures/NNS ,/, toxicity/NN ,/, airway/NN compromise/NN ,/, and/CC sepsis/NN can/MD be/VBP prevented/VBN ./.
P06510887A14
They/PRP are/VBP the/DT most/RBS frequent/JJ cells/NNS after/IN 35/CD days/NNS of/IN age/NN ./.
P06517985A12
In/IN addition/NN ,/, the/DT eicosanoids/NNS released/VBN by/IN the/DT injured/JJ cell/NN are/VBP apparently/RB able/JJ to/TO participate/VB in/IN the/DT homeostatic/JJ response/NN of/IN the/DT cell/NN to/TO the/DT injury/NN ./.
P06530836A05
At/IN the/DT angle/NN recess/NN ,/, the/DT blood/NN cells/NNS accumulated/VBD in/IN the/DT perivascular/JJ connective/JJ tissue/NN of/IN the/DT major/JJ arterial/JJ circle/NN of/IN the/DT iris/NN ./.
P06538581A12
Physical/JJ activity/NN was/VBD maximal/JJ on/IN day/NN of/IN estrus/NN in/IN 73/CD %/SYM of/IN the/DT estrous/JJ periods/NNS ./.
P06572977A01
Murine/JJ erythroleukemia/NN cells/NNS (/( MELC/NN )/) are/VBP virus-transformed/JJ erythroid/NN precursors/NNS that/WDT appear/VBP to/TO be/VB blocked/VBN at/IN an/DT erythroid/NN precursor/NN stage/NN comparable/JJ to/TO the/DT erythroid/NN colony-forming/JJ unit/NN (/( CFU-e/NN )/) ./.
P06590912A03
Nulliparous/JJ women/NNS showed/VBD increased/JJ RR/NN (/( 3.9/CD )/) comparable/JJ to/TO the/DT RR/NN among/IN women/NNS who/WP first/RB bore/VBD a/DT child/NN at/IN age/NN 25/CD or/CC more/PRP ,/, regardless/RB of/IN the/DT number/NN of/IN births/NNS ./.
P06606416A04
With/IN semi-purified/JJ IL-2/NN preparations/NNS ,/, clones/NNS of/IN spontaneous/JJ cytotoxic/JJ cells/NNS are/VBP also/RB detectable/JJ in/IN nu/NN //SYM nu/NN spleen/NN cultures/NNS ./.
P06617177A01
Fourteen/CD patients/NNS presenting/VBG with/IN lumbar/JJ radiculopathy/NN had/VBD normal/JJ or/CC nondiagnostic/JJ plain/JJ radiographs/NNS ,/, myelograms/NNS and/CC polytomes/NNS of/IN lumbar/JJ spine/NN ./.
P06628556A02
The/DT effects/NNS of/IN the/DT coexistence/NN of/IN different/JJ species/NNS of/IN mitochondria/NNS on/IN cellular/JJ properties/NNS were/VBD examined/VBN in/IN these/DT clones/NNS ./.
P06646815A02
Skin/NN biopsy/NN identified/VBD the/DT causative/JJ organism/NN as/IN an/DT atypical/JJ mycobacterium/NN of/IN the/DT M./NN avium-intracellulare-scrofulaceum/NN (/( MAIS/NN )/) complex/NN ./.
P06673103A03
The/DT study/NN tested/VBD the/DT hypothesis/NN that/IN an/DT excess/NN of/IN lung/NN cancer/NN observed/VBN in/IN a/DT small/JJ town/NN of/IN the/DT Milano/NNP Province/NN in/IN Italy/NNP was/VBD attributable/JJ to/TO occupational/JJ exposures/NNS in/IN a/DT chemical/JJ plant/NN (/( SISAS/NN )/) producing/VBG mainly/RB acetylene/NN ,/, phthalic/JJ anhydride/NN ,/, and/CC their/PRP$ derivatives/NNS ./.
P06681578A04
The/DT 830/CD episodes/NNS involved/VBD 677/CD children/NNS aged/VBN 1/CD week/NN to/TO 17/CD years/NNS :/: 40/CD %/SYM were/VBD 24/CD months/NNS old/JJ or/CC younger/JJR ,/, and/CC 12/CD %/SYM were/VBD 60/CD months/NNS old/JJ or/CC older/JJR ./.
P06691283A07
During/IN control/NN state/NN ,/, SVT/NN could/MD be/VBP induced/VBN in/IN all/DT patients/NNS ;/: after/IN i.v./NN administration/NN of/IN the/DT drug/NN ,/, SVT/NN was/VBD presented/VBN in/IN 6/CD patients/NNS in/IN Group/NN I/CD and/CC in/IN 8/CD patients/NNS in/IN Group/NN II/CD ./.
P06701005A02
The/DT amino-acid/NN composition/NN of/IN the/DT collagen/NN did/VBD not/RB differ/VBP significantly/RB between/IN control/NN and/CC papain-treated/JJ groups/NNS ./.
P06711749A03
In/IN addition/NN ,/, 79/CD polyps/NNS in/IN 36/CD patients/NNS ,/, the/DT majority/NN of/IN which/WDT were/VBD also/RB undetected/VBN by/IN barium/NN enema/NN ,/, were/VBD found/VBN and/CC removed/VBN at/IN colonoscopy/NN ./.
P06727779A04
It/PRP appears/VBZ that/IN the/DT risk/NN for/IN developing/NN solid/NN tumors/NNS becomes/VBZ greatest/JJS when/WRB the/DT population/NN enters/VBZ the/DT age/NN group/NN at/IN which/WDT that/DT particular/JJ form/NN of/IN cancer/NN most/RBS commonly/RB occurs/VBZ ./.
P06744040A02
We/PRP now/RB report/VBP experiments/NNS in/IN which/WDT memory/NN states/NNS were/VBD established/VBN by/IN behavioral/JJ training/NN and/CC read/VBN out/IN by/IN a/DT test/NN procedure/NN applied/VBN to/TO the/DT isolated/JJ brains/NNS derived/VBN from/IN the/DT trained/JJ animals/NNS ./.
P06766341A04
One/CD pathway/NN projected/JJ through/IN the/DT alveus/NN and/CC stratum/NN oriens/NN ,/, with/IN results/NNS suggesting/VBG collateral/JJ input/NN to/TO the/DT basal/JJ dendritic/JJ pyramidal/JJ cell/NN region/NN ./.
P06778607A02
A/DT number/NN of/IN dose/NN schedules/NNS were/VBD used/VBN ,/, the/DT lowest/JJS dose/NN being/VBG 6/CD mg/NN //SYM kg/NN every/DT fourth/JJ day/NN and/CC the/DT highest/JJS dose/NN being/VBG 6.0/CD mg/NN //SYM kg/NN twice/RB daily/RB for/IN 9/CD days/NNS ;/: the/DT lowest/JJS and/CC highest/JJS doses/NNS produced/VBD treated/JJ versus/CC control/NN ratios/NNS of/IN 140/CD and/CC 220/CD %/SYM ,/, respectively/RB ./.
P06798562A01
The/DT kinetic/JJ parameters/NNS of/IN azoalbumin/NN hydrolysis/NN by/IN alkaline/JJ proteinase/NN from/IN Bacillus/NN subtilis/NN were/VBD determined/VBN to/TO be/VB Km/NN =/SYM 1.2/CD ./.
P06812287A05
Analysis/NN of/IN the/DT obtained/JJ classification/NN system/NN permits/VBZ sufficiently/RB grounded/JJ conclusions/NNS to/TO be/VB drawn/VBN with/IN regard/NN to/TO the/DT classification/NN position/NN of/IN certain/JJ viruses/NNS ,/, the/DT classification/NN of/IN which/WDT has/VBZ not/RB yet/RB been/VBN completed/VBN by/IN the/DT ICVT/NN ./.
P06836820A04
We/PRP believe/VBP that/IN segmental/JJ resection/NN is/VBZ indicated/VBN for/IN all/DT low-grade/NN and/CC low-stage/NN primary/JJ ureteral/JJ tumors/NNS regardless/RB of/IN their/PRP$ location/NN and/CC with/IN a/DT small/JJ change/NN for/IN recurrence/NN ./.
P06848491A08
Inhibition/NN of/IN O-alkyl/NN lipid/NN synthesis/NN by/IN means/NNS of/IN magnesium/NN or/CC NADPH/NN inhibited/VBD the/DT unusual/JJ cleavage/NN ./.
P06866035A01
Almost/RB all/DT states/NNS have/VBP enacted/VBN legislation/NN ,/, that/WDT allows/VBZ pharmacists/NNS to/TO substitute/VB drug/NN products/NNS when/WRB filling/VBG prescriptions/NNS ./.
P06872256A09
When/WRB the/DT assay/NN was/VBD applied/VBN to/TO serum/NN samples/NNS from/IN a/DT group/NN of/IN 39/CD Type/NN I/CD diabetic/JJ children/NNS more/RB than/IN 90/CD %/SYM of/IN the/DT children/NNS exceeded/VBD the/DT normal/JJ range/NN of/IN the/DT assay/NN ./.
P06889654A03
The/DT frequencies/NNS of/IN Y/NN //SYM F/NN indices/NNS for/IN these/DT groups/NNS were/VBD 0.0/CD ,/, 3.33/CD ,/, 56.67/CD ,/, 30.00/CD ,/, and/CC 10.00/CD %/SYM ,/, respectively/RB ./.
P06895843A02
Rats/NNS with/IN two/CD weeks/NNS of/IN PCS/NN underwent/VBD BDL/NN ,/, then/RB were/VBD killed/VBN after/IN 0/CD ,/, 5/CD or/CC 20/CD hours/NNS ,/, or/CC two/CD or/CC four/CD days/NNS ;/: rats/NNS undergoing/VBG sham/JJ PCS/NN were/VBD used/VBN as/IN controls/NNS ./.
P06927539A16
Thus/RB ,/, as/IN adults/NNS ,/, COPD/NN children/NNS had/VBD a/DT greater/JJR inspiratory/JJ neural/JJ drive/NN ./.
P06958056A01
There/EX are/VBP only/RB a/DT very/JJ small/JJ number/NN of/IN research/NN reports/NNS on/IN the/DT effect/NN of/IN regular/JJ physical/JJ activity/NN on/IN the/DT nervous/JJ system/NN ./.
P06981357A04
The/DT first/JJ site/NN of/IN recurrence/NN was/VBD the/DT central/JJ nervous/JJ system/NN in/IN three/CD (/( 42/CD %/SYM )/) cases/NNS ./.
P07010135A01
A/DT strain/NN of/IN Saccharomyces/NN cerevisiae/NN (/( MH41-7B/NN //SYM 011/CD )/) was/VBD resistant/JJ to/TO petite/JJ induction/NN by/IN ethidium/NN bromide/NN at/IN 30/CD degrees/NNS ,/, but/CC was/VBD sensitive/JJ to/TO induction/NN by/IN photolabeling/NN with/IN ethidium/NN monoazide/NN ./.
P07033388A03
Fresh/JJ adherent/JJ cells/NNS ,/, when/WRB added/VBN to/TO 24/CD h/NN incubated/JJ MNC/NN cultures/NNS before/IN ConA/NN stimulation/NN ,/, decreased/VBD LIF/NN production/NN ,/, in/IN contrast/NN to/TO in/FW vitro/FW irradiated/JJ or/CC overnight/RB cultured/JJ adherent/JJ cells/NNS ./.
P07055824A01
L-idaro-1/NN ,/, 4-lactone/NN was/VBD synthesized/VBN by/IN two/CD different/JJ ,/, published/JJ methods/NNS :/: (/( 1/CD )/) epimerization/NN of/IN monopotassium/NN D-glucarate/NN by/IN refluxing/NN in/IN aqueous/JJ barium/NN hydroxide/NN ,/, and/CC (/( 2/CD )/) oxidation/NN of/IN L-iditol/NN by/IN heating/NN in/IN dilute/JJ nitric/JJ acid/NN ./.
P07068280A04
No/DT growth/NN inhibition/NN of/IN other/JJ BALB/NN //SYM c/NN lymphomas/NNS induced/VBN by/IN Moloney/NN virus/NN (/( LSTRA/NN )/) ,/, X-rays/NNS (/( RL/NN male/NN I/CD )/) or/CC urethane/NN (/( UR-1/NN )/) was/VBD evident/JJ in/IN alloimmune/JJ mice/NNS ./.
P07080855A02
The/DT CT/NN results/NNS seem/VBP to/TO indicate/VB a/DT possibility/NN to/TO distinguish/VB between/IN superficially/RB and/CC deeply/RB invasive/JJ tumours/NNS ./.
P07094791A08
Thus/RB ,/, lipids/NNS are/VBP emptied/VBN more/RB slowly/RB than/IN any/DT other/JJ component/NN of/IN an/DT ordinary/JJ meal/NN ,/, and/CC this/PRP is/VBZ not/RB due/JJ only/RB to/TO layering/NN of/IN fat/NN above/IN water/NN ./.
P07116618A02
The/DT symptom/NN scores/NNS were/VBD related/VBN to/TO duration/NN of/IN breast-feeding/NN ./.
P07130636A02
This/DT paper/NN tests/VBZ the/DT hypothesis/NN for/IN black/NN and/CC white/NN differences/NNS by/IN age/NN in/IN cancer/NN incidence/NN rates/NNS ./.
P07146582A02
The/DT percentage/NN of/IN rats/NNS affected/VBN and/CC the/DT bilirubin/NN levels/NNS reached/VBN are/VBP higher/JJR between/IN the/DT 3rd/JJ and/CC 6th/JJ day/NN after/IN the/DT anoxic/JJ episode/NN ./.
P07171240A02
Preparation/NN of/IN a/DT full/JJ length/NN cDNA/NN and/CC its/PRP$ cloning/NN in/IN E./NN coli/NN have/VBP lead/VBN to/TO the/DT demonstration/NN that/IN the/DT polypeptides/NNS of/IN thyroglobulin/NN protomers/NNS were/VBD identical/JJ ./.
P07189159A06
Non-invasive/JJ examination/NN of/IN the/DT heart/NN is/VBZ advised/VBN before/IN beta-adrenergic/JJ drugs/NNS are/VBP given/VBN ./.
P07206839A04
Continuity/NN consistently/RB increased/VBD with/IN patient/NN age/NN ,/, but/CC appeared/VBD unrelated/VBN to/TO several/JJ other/JJ variables/NNS ./.
P07221512A05
A/DT ratio/NN of/IN specific/JJ cells/NNS to/TO connective/JJ tissue/NN below/IN 0.2/CD in/IN the/DT sinu-atrial/JJ node/NN is/VBZ highly/RB suggestive/JJ of/IN nodal/JJ dysfunction/NN ./.
P07235613A05
Both/CC red/JJ cell/NN rigidity/NN (/( 71/CD +/-/SYM 20/CD mmHg/NN )/) and/CC red/JJ cell/NN fragility/NN (/( 142/CD +/-/SYM 95/CD mg/NN //SYM l/NN )/) were/VBD significantly/RB higher/JJR (/( p/NN les/RB than/IN 0.0025/CD )/) than/IN in/IN the/DT control/NN group/NN (/( 54/CD +/-/SYM 10/CD mmHg/NN and/CC 63/CD +/-/SYM 29/CD mg/NN //SYM l/NN ,/, respectively/RB )/) ./.
P07249318A05
Calcification/NN was/VBD noted/VBN in/IN 11/CD of/IN 18/CD intracardiac/JJ porcine/JJ valves/NNS and/CC in/IN none/CD of/IN the/DT extracardiac/JJ valved/JJ conduits/NNS ./.
P07263709A05
On/IN the/DT other/JJ hand/NN ,/, the/DT absorption/NN spectra/NNS of/IN alpha/NN 2+/CD beta/NN 3+/CD )/) 2/CD and/CC (/( alpha/NN 3+/CD beta/NN 2+/CD )/) 2/CD changed/VBD with/IN excellent/JJ isosbestic/JJ points/NNS during/IN th/DT reductive/JJ reaction/NN by/IN ferredoxin-NADP/NN reductase/NN system/NN ,/, i.e./IN (/( alpha/NN 2+/CD beta/NN 3+/CD )/) 2/CD at/IN 526/CD and/CC 601/CD nm/NN and/CC (/( alpha/NN 3+/CD beta/NN 2+/CD )/) 2/CD at/IN 529/CD and/CC 599/CD nm/NN ./.
P07279044A05
This/DT inhibition/NN depended/VBD on/IN the/DT grating/JJ spatial/JJ frequencies/NNS ./.
P07302292A04
The/DT following/JJ organelles/NNS ,/, characterised/VBN by/IN their/PRP$ marker/NN enzymes/NNS were/VBD located/VBN in/IN the/DT density/NN gradients/NNS ;/: plasma/NN membrane/NN (/( 5'-nucleotidase/NN )/) brush/NN border/NN (/( alpha-glucosidase/NN ,/, pH/NN 6.0/CD )/) mitochondria/NNS (/( particulate/JJ malate/NN dehydrogenase/NN )/) ,/, peroxisomes/NNS (/( catalase/NN )/) ,/, lysosomes/NNS (/( N-acetyl-beta-glucosaminidase/NN )/) ,/, endoplasmic/JJ reticulum/NN (/( alpha-glucosidase/NN ,/, pH/NN 8.0/CD )/) ,/, cytosol/NN (/( lactate/NN dehydrogenase/NN )/) ./.
P07317612A04
The/DT peak/NN of/IN the/DT activity/NN curve/NN of/IN adrenergic/JJ fibers/NNS has/VBZ been/VBN fond/VBN to/TO coincide/VB with/IN the/DT activity/NN peak/NN at/IN 12/CD o'clock/NN ./.
P07333957A09
Amoeboid/JJ microglia/NNS with/IN large/JJ vacuoles/NNS were/VBD not/RB present/VBP in/IN the/DT prenatal/JJ spinal/JJ cord/NN ./.
P07358752A03
The/DT knees/NNS were/VBD extended/VBN from/IN 90/CD to/TO zero/CD degrees/NNS by/IN applying/NN tension/NN to/TO the/DT quadriceps/NN tendon/NN with/IN the/DT force/NN of/IN gravity/NN as/IN the/DT only/JJ resistance/NN ,/, and/CC separation/NN of/IN the/DT fracture/NN fragments/NNS was/VBD measured/VBN first/RB with/IN the/DT retinaculum/NN unrepaired/VBN and/CC then/RB again/RB with/IN the/DT retinaculum/NN repaired/VBN ./.
P07380851A05
The/DT greater/JJR average/NN improvement/NN (/( 36/CD points/NNS )/) in/IN this/DT group/NN was/VBD due/JJ primarily/RB to/TO the/DT absence/NN of/IN any/DT major/JJ complications/NNS ./.
P07396827A03
Labelling/JJ experiments/NNS with/IN [/( 35S/NN ]/) methionine/NN followed/VBN by/IN radioautography/NN or/CC gel/NN electrophoresis/NN and/CC fluorography/NN showed/VBD the/DT presence/NN of/IN label/NN only/RB in/IN epithelial/JJ proteins/NNS ./.
P07404165A06
Just/RB as/IN appendicitis/NN is/VBZ a/DT marker/NN of/IN westernization/NN in/IN young/JJ urban/JJ Blacks/NNS ,/, hiatus/NN hernia/NN may/MD be/VBP regarded/VBN as/IN a/DT marker/NN in/IN the/DT middle-aged/NN and/CC elderly/NN ./.
P07425225A01
The/DT technique/NN of/IN preservation/NN of/IN the/DT antral/JJ vagal/JJ nerve/NN supply/NN of/IN the/DT stomach/NN and/CC division/NN of/IN the/DT gastric/JJ branches/NNS of/IN the/DT nerves/NNS of/IN Latarjet/NN remains/VBZ unchanged/VBN ./.
P07437995A01
The/DT population/NN of/IN 42/CD adolescents/NNS admitted/VBN to/TO the/DT Sunnybrook/NNP Adolescent/NN Unit/NN in/IN 1977/CD is/VBZ described/VBN and/CC compared/VBN with/IN other/JJ populations/NNS of/IN general/JJ hospital/NN units/NNS previously/RB presented/VBN in/IN the/DT literature/NN ,/, in/IN order/NN to/TO derive/VB implications/NNS for/IN patient/NN selection/NN ,/, treatment/NN techniques/NNS and/CC outcome/NN ./.
P07457757A02
The/DT histopathology/NN in/IN two/CD additional/JJ cases/NNS ,/, in/IN which/WDT the/DT disease/NN process/NN was/VBD advanced/VBN and/CC uncontrolled/VBN ,/, is/VBZ presented/VBN to/TO illustrate/VB the/DT unique/JJ progression/NN of/IN temporal/JJ bone/NN osteomyelitis/NN due/JJ to/TO the/DT Pseudomonas/NN organism/NN ./.
P07464093A07
The/DT model/NN was/VBD found/VBN useful/JJ for/IN test/NN and/CC calibration/NN of/IN detecting/NN cells/NNS and/CC for/IN teaching/JJ purposes/NNS ./.
P07480533A01
Genetic/JJ differences/NNS in/IN ethanol/NN 's/POS ability/NN to/TO induce/VB conditioned/JJ place/NN preference/NN were/VBD studied/VBN in/IN 20/CD BXD/NN Recombinant/JJ Inbred/JJ (/( RI/NN )/) mouse/NN strains/NNS and/CC in/IN the/DT C57BL/NN //SYM 6J/NN and/CC DBA/NN //SYM 2J/NN progenitor/NN strains/NNS ./.
P07485344A02
STUDY/NN DESIGN/NN :/: Women/NNS with/IN intact/JJ membranes/NNS participating/VBG in/IN a/DT National/NN Institute/NN of/IN Child/NN Health/NN and/CC Human/NN Development/NN multicenter/NN randomized/JJ trial/NN of/IN adjunctive/JJ antibiotic/JJ therapy/NN for/IN preterm/NN labor/NN (/( 24/CD to/TO 34/CD weeks/NNS )/) were/VBD studied/VBN (/( n/NN =/SYM 275/CD )/) ./.
P07489792A05
Oxidation/NN of/IN GSH/NN to/TO glutathione/NN disulphide/NN (/( GSSG/NN )/) by/IN BA-cell/NN derived/JJ oxidants/NNS was/VBD detected/VBN as/IN a/DT decline/NN of/IN GSH/NN in/IN the/DT supernatants/NNS ./.
P07494154A03
A/DT generalized/JJ interface/NN condition/NN is/VBZ derived/VBN to/TO replace/VB the/DT usual/JJ condition/NN of/IN continuity/NN of/IN intensity/NN ./.
P07498682A15
Therefore/RB ,/, permanent/JJ biliary/JJ stenting/NN should/MD preferably/RB be/VBP restricted/VBN to/TO patients/NNS unfit/JJ for/IN elective/JJ treatment/NN at/IN a/DT later/JJR stage/NN and/CC with/IN a/DT short/JJ life/NN expectancy/NN ./.
P07507261A03
The/DT obstructive/JJ symptoms/NNS were/VBD relieved/VBN in/IN all/DT patients/NNS ;/: however/WRB ,/, 6/CD patients/NNS had/VBD lasting/JJ irritative/JJ symptoms/NNS ,/, 2/CD of/IN whom/WP were/VBD cured/VBN after/IN TURP/NN ./.
P07514976A04
Furthermore/RB ,/, cefepime/NN was/VBD as/RB effective/JJ as/IN ceftazidime/NN and/CC piperacillin/NN or/CC mezlocillin/NN in/IN combination/NN with/IN gentamicin/NN when/WRB administered/VBN as/IN empirical/JJ treatment/NN for/IN fever/NN in/IN patients/NNS with/IN neutropenia/NN ./.
P07519025A06
We/PRP propose/VBP that/IN p75LNTR/NN normally/RB acts/VBZ to/TO increase/VB binding/NN of/IN NGF/NN to/TO TrkA/NN ,/, possibly/RB by/IN increasing/NN the/DT local/JJ NGF/NN concentration/NN in/IN the/DT microenvironment/NN surrounding/VBG the/DT cell/NN surface/NN TrkA/NN receptor/NN ./.
P07522948A14
Maximum/NN mobilization/NN was/VBD recorded/VBN at/IN day/NN 11/CD of/IN the/DT first/JJ cycle/NN ./.
P07530803A04
Given/VBN the/DT low/JJ (/( micromolar/JJ )/) potency/NN of/IN SP/NN analogs/NNS at/IN displacing/NN [/( 3H/NN ]/) -DTG/NN binding/NN in/IN the/DT present/JJ series/NN of/IN experiments/NNS ,/, it/PRP is/VBZ unlikely/RB that/IN the/DT similar/JJ behavioral/JJ effects/NNS we/PRP have/VBP previously/RB observed/VBN elicited/VBN by/IN SP/NN (/( 1-7/CD )/) and/CC DTG/NN in/IN the/DT adult/JJ mouse/NN are/VBP a/DT result/NN of/IN a/DT direct/JJ action/NN of/IN SP/NN (/( 1-7/CD )/) at/IN the/DT sigma/NN binding/JJ site/NN ./.
P07534827A17
The/DT others/NNS either/CC showed/VBD regular/JJ spontaneous/JJ activity/NN ,/, or/CC their/PRP$ time-interval/NN histograms/NNS showed/VBD longer/JJR modes/NNS than/IN ascending/JJ fibers/NNS ./.
P07542701A04
However/WRB ,/, since/IN none/CD of/IN the/DT receptor/NN antagonists/NNS nor/CC transport/NN blockers/NNS tested/VBN could/MD inhibit/VBP dopamine/NN 's/POS action/NN ,/, the/DT mechanism/NN remains/VBZ obscure/JJ ./.
P07551121A03
Specifically/RB ,/, neuropsychological/JJ deficits/NNS regularly/RB occur/VBP on/IN measures/NNS of/IN recent/JJ memory/NN ,/, attention/NN ,/, information-processing/JJ speed/NN ,/, executive/JJ functions/NNS ,/, and/CC visuospatial/JJ perception/NN ./.
P07559742A02
For/IN the/DT preparation/NN of/IN a/DT GM-CSF/NN gene-modified/JJ tumor/NN vaccine/NN ,/, it/PRP is/VBZ important/JJ to/TO achieve/VB efficient/JJ genetic/JJ transduction/NN of/IN tumor/NN cells/NNS ,/, leading/VBG to/TO an/DT appropriate/JJ expression/NN of/IN the/DT induced/JJ gene/NN ./.
P07564268A09
Apoptotic/JJ cells/NNS were/VBD recognized/VBN by/IN their/PRP$ characteristic/JJ histologic/JJ and/CC ultrastructural/JJ features/NNS and/CC by/IN in/FW situ/FW detection/NN of/IN nuclear/JJ DNA/NN fragmentation/NN ./.
P07573781A03
The/DT amplitudes/NNS of/IN N1/NN ,/, P2/NN ,/, and/CC the/DT mismatch/JJ negativity/NN (/( MMN/NN )/) were/VBD significantly/RB diminished/VBN by/IN alcohol/NN ./.
P07578022A10
Values/NNS of/IN delta/NN GU/NN zero/CD obtained/VBN with/IN Gdn-HCl/NN and/CC urea/NN were/VBD in/IN good/JJ agreement/NN ,/, as/IN were/VBD values/NNS obtained/VBN from/IN linear/JJ extrapolation/NN and/CC nonlinear/JJ regression/NN fitting/NN to/TO a/DT two-state/NN equilibrium/NN ./.
P07582551A13
Acute/JJ antihypertensive/JJ calcium/NN blockade/NN with/IN a/DT single/JJ isradipine/NN dose/NN (/( 2.6/CD mg/NN kg-1/NN day-1/NN )/) caused/VBD a/DT similar/JJ shift/NN in/IN the/DT pressure-distensibility/NN curve/NN toward/IN the/DT WKY/NN curve/NN although/IN the/DT histomorphometric/JJ composition/NN of/IN the/DT arterial/JJ wall/NN differed/VBD significantly/RB from/IN that/PRP of/IN chronically/RB treated/JJ animals/NNS ./.
P07590877A08
The/DT oestrogen-mediated/JJ effects/NNS on/IN serum/NN IL-6/NN were/VBD consistent/JJ with/IN a/DT reduction/NN in/IN IL-6/NN mRNA/NN in/IN peritoneal/JJ macrophages/NNS from/IN oestrogen-treated/JJ mice/NNS ./.
P07599250A04
Copper/NN deficiency/NN decreased/VBD the/DT activity/NN level/NN of/IN ceruloplasmin/NN in/IN the/DT serum/NN of/IN young/JJ and/CC old/JJ rats/NNS by/IN 95/CD %/SYM ,/, and/CC the/DT copper/NN //SYM zinc/NN superoxide/NN dismutase/NN (/( CuZn-SOD/NN )/) activity/NN levels/NNS of/IN cerebrums/NNS ,/, lungs/NNS ,/, and/CC livers/NNS of/IN young/JJ rats/NNS by/IN 16/CD ,/, 36/CD ,/, and/CC 34/CD %/SYM ,/, respectively/RB ,/, but/CC did/VBD not/RB change/VBP the/DT CuZn-SOD/NN activity/NN levels/NNS of/IN tissues/NNS of/IN old/JJ rats/NNS ./.
P07608159A01
The/DT major/JJ apurinic/NN //SYM apyrimidinic/NN (/( AP/NN )/) endonuclease/NN of/IN human/NN cells/NNS ,/, the/DT Ape/NN protein/NN ,/, incises/VBZ DNA/NN adjacent/JJ to/TO abasic/JJ sites/NNS to/TO initiate/VB DNA/NN repair/NN and/CC counteract/VB the/DT cytotoxic/JJ and/CC mutagenic/JJ effects/NNS of/IN AP/NN sites/NNS ./.
P07612608A04
In/IN the/DT present/JJ study/NN ,/, chromogranin/NN B/NN was/VBD purified/VBN to/TO complete/VB homogeneity/NN in/IN its/PRP$ native/JJ state/NN from/IN the/DT secretory/JJ vesicle/NN lysates/NNS of/IN bovine/JJ adrenal/JJ chromaffin/NN cells/NNS using/VBG several/JJ chromatographic/JJ and/CC electrophoresis/NN steps/NNS ./.
P07617168A09
Oxytocin-induced/JJ Ca2+/NN transients/NNS (/( 0.32-1000/CD nM/NN )/) ,/, which/WDT were/VBD observed/VBN in/IN 32/CD %/SYM (/( 63/CD %/SYM )/) or/CC organum/NN vasculosum/NN laminae/NN terminalis/NN and/CC in/IN 54/CD %/SYM (/( 42/CD %/SYM )/) of/IN subfornical/JJ organ/NN neurons/NNS (/( astrocytes/NNS )/) ,/, were/VBD not/RB affected/VBN by/IN the/DT V1-specific/JJ antagonist/NN ./.
P07626088A03
However/WRB ,/, it/PRP is/VBZ still/RB unknown/VBN whether/IN G/NN beta/NN gamma/NN directly/RB interacts/VBZ with/IN GIRK1/NN ./.
P07635327A04
Depression/NN is/VBZ a/DT modifiable/JJ risk/NN factor/NN for/IN suicide/NN in/IN old/JJ age/NN ./.
P07639957A11
Systemic/JJ blood/NN pressure/NN and/CC benzylamine/NN oxidase/NN activity/NN were/VBD not/RB significantly/RB affected/VBN by/IN allylamine/NN or/CC by/IN ethanol/NN ./.
P07644388A13
At/IN any/DT dose/NN ,/, the/DT control/NN diet/NN group/NN maintained/VBD a/DT greater/JJR intake/NN on/IN Day/NN 1/CD than/IN the/DT other/JJ two/CD diet/NN groups/NNS ./.
P07654020A07
4MA/NN was/VBD administered/VBN to/TO male/NN Copenhagen/NN rats/NNS bearing/VBG R3327-H/NN androgen/NN dependent/JJ prostate/NN tumors/NNS and/CC levels/NNS of/IN different/JJ androgens/NNS in/IN serum/NN and/CC prostate/NN tumor/NN were/VBD measured/VBN using/VBG reversed/JJ phase/NN HPLC/NN and/CC radioimmunoassay/NN ./.
P07667811A02
We/PRP conducted/VBD a/DT cross-sectional/JJ survey/NN in/IN which/WDT 1072/CD French/JJ general/JJ practitioners/NNS (/( GPs/NNS )/) were/VBD evaluated/VBN for/IN their/PRP$ basic/JJ pharmacological/JJ knowledge/NN and/CC practice/NN of/IN NSAIDs/NNS prescription/NN ./.
P07672527A10
CONCLUSIONS/NNS --/: We/PRP demonstrated/VBD a/DT significative/JJ difference/NN of/IN therapeutic/JJ modalities/NNS between/IN these/DT different/JJ french/JJ geographic/JJ areas/NNS concerning/VBG adjuvant/NN radiotherapy/NN and/CC chemotherapy/NN ./.
P07681036A08
Finally/RB ,/, no/DT apparent/JJ direct/JJ correlation/NN was/VBD found/VBN between/IN the/DT ability/NN of/IN individual/JJ anti-CD23/NN mAb/NN to/TO alter/VB IgE/NN binding/NN to/TO cell-associated/JJ CD23/NN and/CC their/PRP$ ability/NN to/TO modulate/VB IgE/NN production/NN by/IN PBMNC/NN ./.
P07684800A11
This/DT methodology/NN can/MD be/VBP used/VBN to/TO purify/VB other/JJ cell/NN types/NNS ,/, including/VBG T/NN and/CC B/NN lymphocytes/NNS ./.
P07692657A12
One/CD hundred-sixty/CD patients/NNS underwent/VBD radical/JJ prostatectomy/NN and/CC pathologic/JJ staging/NN ./.
P07701466A02
This/PRP was/VBD an/DT unexpected/JJ finding/NN but/CC explained/VBD the/DT progressive/JJ airflow/NN limitation/NN which/WDT characterised/VBD the/DT patient/NN 's/POS clinical/JJ course/NN ./.
P07715104A01
To/TO examine/VB crosstalks/NNS (/( CRs/NNS )/) between/IN 99mTc-methoxyisobutyl/NN isonitrile/NN (/( MIBI/NN )/) and/CC beta-methyl-p-/NN (/( 123I/NN )/) iodophenyl-pentadecanoic/JJ acid/NN (/( BMIPP/NN )/) ,/, myocardial/JJ phantom/NN studies/NNS of/IN simultaneous/JJ acquisition/NN were/VBD performed/VBN with/IN three/CD window/NN widths/NNS and/CC four/CD energies/NNS where/WRB the/DT window/NN located/VBN ./.
P07724307A04
All/DT male/NN newborns/NNS born/VBN in/IN a/DT community/NN hospital/NN between/IN November/NN 1/CD ,/, 1989/CD and/CC August/NN 31/CD ,/, 1990/CD ,/, and/CC circumcised/VBN after/IN DPNB/NN were/VBD evaluated/VBN ./.
P07733788A02
Pregnant/JJ rats/NNS fed/VBN omega/NN 3/CD deficient/JJ diets/NNS were/VBD divided/VBN at/IN parturition/NN into/IN three/CD groups/NNS ./.
P07738246A07
Simultaneous/JJ isolation/NN of/IN other/JJ mastitis/NN pathogens/NNS was/VBD not/RB significantly/RB associated/VBN with/IN occurrence/NN of/IN Staph/NN ./.
P07742853A01
Urologic/JJ problems/NNS are/VBP a/DT major/JJ source/NN of/IN morbidity/NN for/IN patients/NNS with/IN multiple/JJ sclerosis/NN (/( MS/NN )/) ./.
P07747411A05
The/DT procedure/NN was/VBD repeated/VBN on/IN day/NN 28/CD ./.
P07751814A07
The/DT elongated/JJ and/CC desaturated/JJ metabolites/NNS of/IN oleate/NN were/VBD preferentially/RB esterified/VBN in/IN cellular/JJ triglyceride/NN when/WRB oleate/NN was/VBD delivered/VBN as/IN free/JJ oleate/NN ,/, but/CC they/PRP were/VBD preferentially/RB esterified/VBN in/IN phospholipids/NNS when/WRB oleate/NN was/VBD delivered/VBN as/IN triolein/NN in/IN LDL/NN ./.
P07765360A01
The/DT inhibition/NN of/IN wheat/NN Ca/NN (/( 2+/CD )/) -dependent/JJ protein/NN kinase/NN (/( CDPK/NN )/) by/IN substituted/JJ acridines/NNS and/CC substituted/JJ 5-/CD ,/, 6-/CD ,/, 7-/CD and/CC 8-azaacridines/NNS (/( 5-AA/NN ,/, 6-AA/NN ,/, 7-AA/NN and/CC 8-AA/NN )/) was/VBD examined/VBN ./.
P07774109A04
No/DT differences/NNS in/IN the/DT capillaroscopic/JJ pattern/NN were/VBD found/VBN between/IN rheumatoid/JJ factor/NN positive/JJ and/CC rheumatoid/JJ factor/NN negative/JJ patients/NNS ./.
P07783062A06
Concomitant/JJ administration/NN of/IN nonsteroidal/JJ antiinflammatories/NNS ,/, corticosteroids/NNS ,/, or/CC antimalarials/NNS was/VBD not/RB permitted/VBN ./.
P07787842A06
Rapamycin/NN inhibited/VBD PTTH-stimulated/JJ synthesis/NN of/IN p50/NN and/CC p70/NN ,/, suggesting/VBG that/IN specific/JJ protein/NN synthesis/NN is/VBZ also/RB required/VBN for/IN PTTH-stimulated/JJ ecdysteroidogenesis/NN ,/, confirming/VBG the/DT results/NNS of/IN Rybczynski/NNP and/CC Gilbert/NNP [/( (/( 1994/CD )/) Insect/NN Biochem./NN Molec./NN Biol./NN 24/CD ,/, 175-189/CD ]/) ,/, and/CC that/IN p34/NN phosphorylation/NN may/MD regulate/VBP the/DT downstream/JJ synthesis/NN of/IN p50/NN and/CC p70/NN ,/, possible/JJ key/JJ regulatory/JJ proteins/NNS leading/VBG to/TO ecdysteroidogenesis/NN ./.
P07797013A03
METHODS/NNS :/: HLA-B27/NN rats/NNS and/CC Fisher/NN 344/CD male/NN controls/NNS were/VBD used/VBN for/IN these/DT studies/NNS ./.
P07811113A02
Nine/CD years/NNS later/RB ,/, he/PRP presented/VBD with/IN an/DT intracerebral/JJ germ/NN cell/NN tumor/NN affecting/VBG both/CC the/DT suprasellar/JJ ventricles/NNS and/CC the/DT pineal/JJ area/NN ./.
P07815223A10
Clinical/JJ evidence/NN of/IN thrombosis/NN was/VBD found/VBN in/IN 69/CD %/SYM of/IN patients/NNS with/IN ,/, versus/CC 27/CD %/SYM of/IN patients/NNS without/IN ,/, ultrasound-proved/JJ thrombosis/NN (/( p/NN =/SYM 0.007/CD )/) ./.
P07824541A06
Increased/JJ standing/NN with/IN clonidine/NN and/CC the/DT medium/JJ dose/NN of/IN yohimbine/NN may/MD also/RB reflect/VBP sedation/NN ./.
P07833902A01
The/DT purpose/NN of/IN this/DT article/NN is/VBZ to/TO highlight/VB the/DT complex/JJ interrelationship/NN between/IN the/DT family/NN and/CC psychoactive/JJ substance/NN dependence/NN and/CC the/DT important/JJ role/NN of/IN the/DT family/NN in/IN the/DT prevention/NN ,/, treatment/NN ,/, rehabilitation/NN and/CC social/JJ reintegration/NN of/IN substance-dependent/JJ persons/NNS ./.
P07838631A18
123/CD (/( 57/CD %/SYM )/) saw/VBD their/PRP$ MAC/NN provider/NN within/IN one/CD week/NN of/IN the/DT denied/JJ PED/NN visit/NN ./.
P07843062A02
The/DT instrumentation/NN systems/NNS tested/VBN were/VBD the/DT Canal/NN Master/NN and/CC a/DT standard/JJ circumferential/JJ filing/JJ technique/NN in/IN which/WDT conventional/JJ K-files/NNS were/VBD used/VBN ./.
P07847520A15
Oral/JJ contraceptive/JJ pills/NNS should/MD not/RB be/VBP contraindicated/VBN in/IN normotensive/JJ women/NNS ./.
P07856748A09
In/IN senile/JJ plaques/NNS ,/, copper/NN ,/, zinc-superoxide/NN dismutase-positive/JJ globular/JJ structures/NNS were/VBD surrounded/VBN by/IN astrocytes/NNS highly/RB enriched/VBN in/IN manganese-superoxide/NN dismutase/NN ./.
P07865772A01
Antisense/NN oligodeoxynucleotide/NN complementary/JJ to/TO the/DT start/NN coding/JJ region/NN of/IN rat/NN corticotropin/NN releasing/JJ hormone/NN (/( CRH/NN )/) mRNA/NN was/VBD intracerebroventricularly/RB infused/VBN into/IN rats/NNS three/CD times/NNS at/IN 12-h/NN intervals/NNS ./.
P07870183A09
Removal/NN of/IN extracellular/JJ Ca2+/NN from/IN the/DT medium/NN reduced/VBD ATP-/NN and/CC electrically/RB induced/VBD overflow/NN by/IN about/RB 95/CD %/SYM ./.
P07879604A04
This/DT rare/JJ subtype/NN occurring/VBG in/IN very/JJ old/JJ (/( over/RB 80/CD years/NNS of/IN age/NN )/) subjects/NNS that/WDT does/VBZ not/RB fall/VBP within/IN the/DT currently/RB used/JJ neuropathological/JJ criteria/NNS for/IN diagnosis/NN of/IN AD/NN warrants/VBZ further/RB clinico-pathological/JJ documentation/NN ./.
P07888933A04
SUBJECTS/NNS --/: 2004/CD subjects/NNS aged/VBN 35-64/CD years/NNS were/VBD screened/VBN for/IN hypercholesterolaemia/NN ;/: 163/CD men/NNS and/CC 146/CD women/NNS with/IN a/DT repeat/NN total/JJ cholesterol/NN concentration/NN of/IN 6.0-8.5/CD mmol/NN //SYM l/NN entered/VBD the/DT trial/NN ./.
P07893188A06
The/DT epimerization/NN of/IN morphine/NN and/CC dihydromorphine/NN and/CC their/PRP$ N-substituted/JJ derivatives/NNS evoked/VBD only/RB slight/JJ changes/NNS in/IN opioid/NN activities/NNS in/FW vitro/FW ./.
P07901963A02
Plasma/NN atrial/JJ natriuretic/JJ factor/NN (/( ANF/NN )/) ,/, vasopressin/NN (/( Vas/NN )/) ,/, and/CC dynorphin/NN A/NN (/( Dyn/NN A/NN )/) were/VBD measured/VBN by/IN radioimmunoassay/NN ./.
P07911484A04
They/PRP all/PRP harboured/VBD C./NN difficile/NN in/IN their/PRP$ stools/NNS ./.
P07920572A02
Several/JJ works/NNS demonstrated/VBD that/IN acetylated/JJ carbohydrate/NN derivatives/NNS derived/VBN from/IN hemicellulose/NN played/VBD a/DT primary/JJ role/NN in/IN the/DT outbreak/NN and/CC that/IN uronic/JJ acid/NN residues/NNS were/VBD present/JJ in/IN the/DT carbohydrate/NN derivatives/NNS ./.
P07925018A05
A/DT maximal/JJ inhibition/NN of/IN 50/CD %/SYM was/VBD observed/VBN ./.
P07929195A06
Binding/NN of/IN LPS/NN to/TO Hb/NN also/RB was/VBD demonstrated/VBN wiht/IN a/DT radiolabeled/JJ LPS/NN photoaffinity/NN probe/NN ./.
P07933217A08
We/PRP recommend/VBP that/IN all/DT users/NNS of/IN such/DT lasers/NNS acquire/VBP a/DT laser/NN meter/NN to/TO allow/VB monitoring/NN of/IN the/DT energy/NN delivered/VBN by/IN the/DT fiber/NN tip/NN ./.
P07947529A02
To/TO investigate/VB the/DT efficacy/NN of/IN 800/CD micrograms/NNS misoprostol/NN (/( a/DT PGE1/NN analogue/NN )/) when/WRB administered/VBN to/TO women/NNS pretreated/VBN with/IN mifepristone/NN for/IN early/JJ pregnancy/NN termination/NN ./.
P07952114A01
An/DT improved/JJ method/NN for/IN the/DT simultaneous/JJ determination/NN of/IN cocaine/NN and/CC benzoylecgonine/NN by/IN means/NNS of/IN gas/NN chromatography/NN with/IN nitrogen-phosphorus/NN detection/NN is/VBZ described/VBN ./.
P07965042A02
We/PRP have/VBP made/VBN a/DT polyclonal/JJ antiserum/NN to/TO the/DT protein/NN product/NN of/IN the/DT Dlx-2/NN gene/NN ./.
P07969805A06
These/DT data/NNS suggest/VBP that/IN metabotropic/JJ glutamate/NN receptors/NNS are/VBP involved/VBN in/IN NTS/NN and/CC NRA/NN regulation/NN of/IN cardiorespiratory/JJ functions/NNS ./.
P07983470A01
When/WRB Ss/NNS are/VBP required/VBN to/TO recall/VB lists/NNS containing/VBG both/CC words/NNS and/CC digits/NNS ,/, memory/NN span/NN is/VBZ higher/JJR when/WRB the/DT digits/NNS precede/VBP the/DT words/NNS than/IN when/WRB the/DT words/NNS precede/VBP the/DT digits/NNS ./.
P07988197A08
Further/JJ studies/NNS seem/VBP justified/VBN to/TO investigate/VB the/DT role/NN of/IN the/DT surfactant/NN system/NN in/IN interstitial/JJ lung/NN diseases/NNS as/RB well/RB as/IN the/DT potential/JJ clinical/JJ usefulness/NN of/IN SP-A/NN measurements/NNS in/IN BAL/NN ./.
P07997241A05
Our/PRP$ data/NNS suggest/VBP that/IN p56lck/NN contains/VBZ both/CC positive/JJ and/CC negative/JJ regulatory/JJ sites/NNS which/WDT are/VBP constantly/RB dephosphorylated/VBN at/IN an/DT unexpectedly/RB high/JJ rate/NN by/IN cellular/JJ phosphotyrosine/NN phosphatases/NNS ./.
P08006339A04
Transsphenoidal/JJ resection/NN of/IN the/DT pituitary/NN adenomas/NNS were/VBD performed/VBN in/IN all/DT patients/NNS ./.
P08011632A06
Fluorescence/NN studies/NNS indicated/VBD that/IN GS-alpha-lactalbumin/NN showed/VBD a/DT [/( NaCl/NN ]/) -dependent/JJ partial/JJ shift/NN toward/IN a/DT more/RB nativelike/JJ state/NN ,/, which/WDT was/VBD enhanced/VBN by/IN the/DT presence/NN of/IN Ca2+/NN ions/NNS ./.
P08016025A12
These/DT results/NNS suggest/VBP that/IN increasing/JJ age/NN does/VBZ not/RB diminish/VBP the/DT relation/NN between/IN health/NN beliefs/NNS and/CC health/NN behaviors/NNS ./.
P08025020A06
3/CD )/) Sensitivity/NN to/TO anticancer/NN agents/NNS on/IN NUTLC-1/NN and/CC NUTLC-3/NN cells/NNS differed/VBD individually/RB according/VBG to/TO methylthiazol/NN tetrazorium/NN (/( bromide/NN )/) (/( MTT/NN )/) colorimetric/JJ assay/NN ./.
P08029499A09
A/DT key/JJ first/JJ step/NN is/VBZ the/DT determination/NN of/IN a/DT skin-to-air/NN or/CC skin-to-medium/NN partition/NN coefficient/NN to/TO estimate/VB a/DT potential/NN for/IN dermal/JJ absorption/NN ./.
P08043519A06
Although/IN the/DT detailed/JJ molecular/JJ mechanisms/NNS of/IN drug/NN action/NN are/VBP not/RB known/VBN ,/, protein/NN phosphorylations/NNS may/MD be/VBP involved/VBN ,/, since/IN drug-induced/JJ stimulation/NN could/MD be/VBP abrogated/VBN by/IN several/JJ protein/NN kinase/NN inhibitors/NNS ./.
P08056658A05
Significant/JJ differences/NNS were/VBD observed/VBN among/IN breeds/NNS in/IN all/DT measures/NNS of/IN gain/NN efficiency/NN ./.
P08061263A08
Compared/VBN to/TO hemodynamics/NNS at/IN induction/NN ,/, there/EX were/VBD no/DT clinically/RB significant/JJ changes/NNS following/VBG administration/NN of/IN pipecuronium/NN or/CC doxacurium/NN ./.
P08070317A10
p-Hydroxyamphetamine/NN was/VBD primarily/RB excreted/VBN into/IN urine/NN as/IN the/DT conjugated/JJ form/NN ./.
P08079104A10
RESULTS/NNS :/: Three/CD patients/NNS in/IN group/NN B/NN were/VBD lost/VBN to/TO follow-up/NN for/IN various/JJ reasons/NNS ,/, and/CC only/RB seven/CD remained/VBD eligible/JJ for/IN final/JJ analysis/NN ./.
P08083751A07
The/DT Ca2+/NN flux/NN through/IN neuronal/JJ nAChRs/NNS of/IN adrenal/JJ chromaffin/NN cells/NNS is/VBZ insensitive/JJ to/TO alpha-bungarotoxin/NN ./.
P08092929A01
Exposure/NN of/IN rat/NN pheochromocytoma/NN (/( PC12/NN )/) cells/NNS to/TO cyanide/NN produces/VBZ elevation/NN of/IN cytosolic/JJ calcium/NN ,/, impaired/JJ Na/NN (/( +/SYM )/) -H+/NN exchange/NN ,/, membrane/NN lipid/NN peroxidation/NN and/CC release/NN of/IN neurotransmitters/NNS ./.
P08103064A03
CD30/NN is/VBZ inducible/JJ on/IN approximately/RB 15/CD %/SYM of/IN normal/JJ PBMC/NN stimulated/VBN with/IN any/PRP of/IN a/DT variety/NN of/IN nonspecific/JJ T/NN cell/NN activators/NNS ,/, including/VBG PHA/NN ,/, Con/NN A/NN ,/, anti-T11/NN (/( 2/CD )/) +/SYM T11/NN (/( 3/CD )/) ,/, and/CC anti-CD3/NN ;/: ionomycin/NN alone/JJ induced/VBD lower/JJR percentages/NNS of/IN CD30+/NN T/NN cells/NNS (/( 3/CD +/-/SYM 2/CD %/SYM )/) compared/VBN to/TO other/JJ stimuli/NNS ./.
P08107567A06
Proteins/NNS of/IN Hsp70/NN and/CC Hsp90/NN families/NNS as/RB well/RB as/IN ubiquitin/NN belong/VBP to/TO the/DT same/JJ group/NN ./.
P08121683A01
We/PRP investigated/VBD the/DT postcaloric/JJ nystagmus/NN related/VBN to/TO positional/JJ change/NN ./.
P08130881A01
Methods/NNS for/IN the/DT synthesis/NN and/CC quantitation/NN of/IN the/DT novel/JJ choline/NN analogues/NNS ,/, telluronium/NN choline/NN and/CC acetyltelluronium/NN choline/NN ,/, are/VBP described/VBN ./.
P08140024A02
Symptoms/NNS and/CC signs/NNS usually/RB respond/VBP to/TO the/DT institution/NN of/IN a/DT gluten-free/JJ diet/NN ./.
P08149070A03
Eighteen/CD patients/NNS with/IN these/DT two/CD conditions/NNS from/IN an/DT area/NN with/IN 750,000/CD inhabitants/NNS in/IN Valencia/NNP (/( Spain/NNP )/) ,/, were/VBD studied/VBN for/IN 2/CD years/NNS ./.
P08158508A02
Clinical/JJ measurements/NNS included/VBD plaque/NN index/NN ,/, gingival/JJ index/NN ,/, bleeding/NN on/IN probing/NN ,/, suppuration/NN ,/, probing/JJ depth/NN ,/, clinical/JJ attachment/NN level/NN ,/, and/CC relative/JJ attachment/NN level/NN measured/VBN with/IN an/DT automated/JJ disk/NN probe/NN ./.
P08162969A07
These/DT results/NNS suggest/VBP that/IN TSMCs/NNS can/MD promote/VBP the/DT growth/NN of/IN TSMCs/NNS and/CC SMCs/NNS in/IN either/CC an/DT autocrine/JJ or/CC paracrine/JJ manner/NN and/CC that/IN they/PRP proliferate/VBP independently/RB of/IN the/DT collagen/NN matrices/NNS ./.
P08176674A01
We/PRP studied/VBD 20/CD normal/JJ subjects/NNS and/CC 20/CD suffering/VBG from/IN sacro-iliitis/NN ./.
P08181293A08
Overall/JJ daily/JJ losses/NNS of/IN catecholamines/NNS in/IN the/DT ultradiafiltrate/NN were/VBD small/JJ (/( dopamine/NN 404/CD micrograms/NNS ;/: epinephrine/NN 32/CD micrograms/NNS ;/: norepinephrine/NN 29/CD micrograms/NNS )/) ./.
P08185817A08
Additionally/RB ,/, we/PRP found/VBD that/IN C140/NN mRNA/NN was/VBD also/RB increased/VBN in/IN the/DT thyroid/NN tissue/NN of/IN a/DT patient/NN with/IN Graves/NN '/POS disease/NN ./.
P08190109A13
Ratios/NNS of/IN organ/NN to/TO blood/NN concentrations/NNS at/IN 2/CD hr/NN for/IN all/DT organs/NNS were/VBD 5/CD :/: 1/CD or/CC greater/JJR ./.
P08199276A01
The/DT production/NN of/IN the/DT allylic/JJ regulatory/JJ steroid/NN 3/CD alpha-hydroxy-4-pregnen-20-one/NN (/( 3/CD alpha/NN HP/NN )/) in/IN the/DT rat/NN ovary/NN was/VBD examined/VBN and/CC compared/VBN to/TO progesterone/NN levels/NNS through/IN use/NN of/IN specific/JJ RIAs/NNS that/WDT had/VBD been/VBN validated/VBN by/IN capillary/NN gas/NN chromatography-mass/NN spectrometry/NN (/( GC/NN //SYM MS/NN )/) ./.
P08203696A05
A/DT computerized/JJ personal/JJ interview/NN was/VBD administered/VBN to/TO 300/CD African-American/JJ 9-/CD to/TO 15-year-old/JJ children/NNS living/VBG in/IN six/CD public/JJ housing/JJ developments/NNS in/IN a/DT large/JJ US/NNP city/NN ./.
P08213081A01
Recently/RB tau/NN immunoreactivity/NN has/VBZ been/VBN observed/VBN in/IN astrocytes/NNS in/IN Alzheimer/NNP 's/POS disease/NN and/CC other/JJ neurological/JJ diseases/NNS ./.
P08222097A02
Antiplatelet/NN therapy/NN with/IN aspirin/NN and/CC antithrombotic/JJ therapy/NN with/IN heparin/NN both/CC prevent/VBP the/DT complications/NNS of/IN unstable/JJ angina/NN ;/: however/WRB ,/, no/DT definitive/JJ data/NNS exist/VBP on/IN the/DT relative/JJ clinical/JJ efficacy/NN of/IN the/DT two/CD drugs/NNS ./.
P08226432A05
Both/CC Cmax/NN and/CC AUC/NN were/VBD shown/VBN to/TO be/VB factors/NNS determining/VBG antibacterial/JJ activity/NN ;/: however/WRB Cmax/NN independently/RB represented/VBD some/DT 35/CD %/SYM of/IN total/JJ exposure/NN effect/NN ./.
P08235385A04
In/IN patients/NNS with/IN chronic/JJ pure/JJ red/JJ cell/NN aplasia/NN the/DT in/FW vitro/FW study/NN of/IN erythroid/NN precursors/NNS has/VBZ a/DT prognostic/JJ value/NN ./.
P08248763A03
The/DT subjects/NNS had/VBD moderately/RB reduced/JJ lung/NN function/NN of/IN restrictive/JJ type/NN ,/, and/CC none/CD of/IN the/DT subjects/NNS had/VBD forced/JJ expiratory/JJ volume/NN for/IN one/CD second/NN (/( FEV1/NN )/) below/IN 30/CD %/SYM of/IN predicted/JJ value/NN ,/, indicating/VBG that/IN hypoventilation/NN would/MD probably/RB not/RB occur/VBP ./.
P08257700A01
To/TO study/VB the/DT effects/NNS of/IN methylation/NN damage/NN on/IN DNA/NN replication/NN in/FW vitro/FW ,/, the/DT plasmid/NN pSVori/NN containing/VBG the/DT SV40/NN origin/NN of/IN replication/NN was/VBD reacted/VBN with/IN N-methyl-N-nitrosourea/NN and/CC used/VBN as/IN a/DT substrate/NN for/IN SV40/NN T/NN antigen/NN dependent/JJ replication/NN by/IN HeLa/NN cell/NN extracts/NNS ./.
P08262267A05
Evolutionary/JJ implications/NNS of/IN these/DT results/NNS are/VBP discussed/VBN ./.
P08280852A01
Patterns/NNS of/IN neural/JJ degeneration/NN were/VBD compared/VBN following/VBG continuous/JJ administration/NN of/IN four/CD drugs/NNS of/IN addiction/NN ,/, each/PRP of/IN which/WDT induces/VBZ model/NN psychoses/NNS in/IN chronic/JJ addicts/NNS ./.
P08285272A08
The/DT apparent/JJ volume/NN of/IN TTW/NN participating/VBG in/IN the/DT fluid/NN shift/NN averaged/VBD 65/CD +/-/SYM 1/CD ml/NN //SYM 100/CD g/NN (/( SE/NN )/) over/IN a/DT wide/JJ range/NN of/IN osmolality/NN increases/NNS ./.
P08294223A08
Both/DT patient/NN collectives/NNS had/VBD similar/JJ initial/JJ factors/NNS ./.
P08298814A08
Conversely/RB ,/, ionomycin/NN could/MD stimulate/VBP IPs/NNS accumulation/NN and/CC elevate/VBP [/( Ca2+/NN ]/) i/NN ./.
P08307958A05
The/DT data/NNS also/RB indicated/VBD that/IN Tus/NN existed/VBN as/IN a/DT monomeric/JJ protein/NN in/IN solution/NN and/CC when/WRB complexed/VBN with/IN its/PRP$ cognate/NN DNA/NN binding/JJ site/NN ./.
P08312437A11
ACTH/NN administration/NN (/( i.v./NN )/) induced/VBD a/DT similar/JJ cortisol/NN pulse/NN in/IN 4/CD of/IN 8/CD growth-restricted/JJ lambs/NNS and/CC in/IN 5/CD of/IN 6/CD ad/IN libitum-fed/JJ lambs/NNS ./.
P08326025A03
Losses/NNS of/IN alpha-tocopherol/NN occurred/VBD in/IN UHT/NN milk/NN after/IN 1/CD mo/NN of/IN storage/NN at/IN 30/CD degrees/NNS C/NN ;/: losses/NNS increased/VBD as/IN storage/NN time/NN increased/VBD ./.
P08330625A10
Therefore/RB ,/, when/WRB the/DT alpha/NN chain/NN is/VBZ part/NN of/IN high-affinity/NN receptors/NNS ,/, it/PRP is/VBZ endocytosed/VBN ,/, as/IN opposed/VBN to/TO when/WRB it/PRP is/VBZ part/NN of/IN low-affinity/NN receptors/NNS and/CC is/VBZ not/RB endocytosed/VBN ./.
P08339784A07
In/IN conclusion/NN ,/, these/DT data/NNS show/VBP a/DT distinct/JJ functional/JJ specificity/NN of/IN intrahippocampal/JJ LC/NN grafts/NNS in/IN the/DT kindling/JJ model/NN of/IN epilepsy/NN ./.
P08358223A01
The/DT importance/NN and/CC requirements/NNS for/IN catalytic/JJ activation/NN of/IN sialyl/NN donors/NNS are/VBP discussed/VBN ,/, leading/VBG to/TO the/DT acid/NN sensitive/JJ phosphite/NN and/CC phosphate/NN moiety/NN ,/, respectively/RB ,/, as/IN leaving/JJ group/NN and/CC nitriles/NNS as/IN solvent/NN ./.
P08362985A02
These/DT agents/NNS kill/VBP hepatocytes/NNS by/IN a/DT process/NN readily/RB distinguished/VBN from/IN two/CD well-known/JJ pathways/NNS that/WDT lead/VBP to/TO a/DT loss/NN of/IN viability/NN ,/, namely/RB ,/, oxidative/JJ stress/NN and/CC inhibition/NN of/IN mitochondrial/JJ electron/NN transport/NN ./.
P08367730A16
Eight/CD patients/NNS had/VBD neurological/JJ deficits/NNS ,/, some/PRP of/IN them/PRP minor/JJ ./.
P08376776A03
After/IN affinity/NN purification/NN ,/, this/DT antibody/NN ,/, anti-mMCP-2/NN (/( 56-71/CD )/) IgG/NN ,/, reacted/VBD in/IN SDS-PAGE/NN //SYM immunoblots/NNS against/IN a/DT 28-kDa/NN protein/NN in/IN BMMCW+IL-10/NN that/WDT had/VBD the/DT N-terminal/JJ amino/JJ acid/NN sequence/NN of/IN mMCP-2/NN ./.
P08381160A01
Using/VBG GC/NN //SYM MS/NN in/IN scanning/JJ mode/NN as/IN a/DT screening/JJ and/CC definitive/JJ identification/NN methodology/NN for/IN substance/NN abuse/NN testing/NN ,/, 4500/CD urine/NN samples/NNS have/VBP been/VBN analyzed/VBN ./.
P08385008A17
The/DT Ki/NN for/IN the/DT first/JJ product/NN off/RB (/( inositol/NN )/) was/VBD ,/, however/WRB ,/, unaltered/VBN by/IN Li+/NN ./.
P08392740A02
Sonography/NN can/MD also/RB establish/VBP the/DT diagnosis/NN of/IN nerve/NN sheath/NN tumors/NNS when/WRB the/DT normal/JJ nerve/NN is/VBZ visualized/VBN ./.
P08396637A07
Both/CC nocturnal/JJ administration/NN of/IN melatonin/NN for/IN 2/CD consecutive/JJ days/NNS (/( 9/CD mg/NN //SYM kg/NN //SYM day/NN ,/, s.c./NN )/) and/CC melatonin/NN incubation/NN (/( 100/CD pg/NN //SYM ml/NN ,/, 4/CD h/NN )/) of/IN the/DT vas/NN deferens/NN from/IN old/JJ rats/NNS sacrificed/VBN at/IN 15/CD :/: 00/CD h/NN significantly/RB potentiated/VBD the/DT ACh-induced/JJ contraction/NN ./.
P08405342A04
Abortion/NN attitudes/NNS vary/VBP little/JJ by/IN race/NN after/IN other/JJ social/JJ background/NN factors/NNS are/VBP controlled/VBN ./.
P08414171A03
The/DT subcutaneous/JJ injections/NNS were/VBD given/VBN during/IN either/CC the/DT diurnal/JJ or/CC nocturnal/JJ period/NN ./.
P08418920A11
However/WRB ,/, the/DT 4.0-mg/NN //SYM kg/NN BW/NN dose/NN of/IN progesterone/NN decreased/VBD ER/NN mRNA/NN levels/NNS ./.
P08428211A04
Tension/NN developed/VBD slowly/RB but/CC was/VBD sustained/VBN during/IN the/DT application/NN of/IN sarafotoxin/NN ./.
P08432738A05
Amongst/IN these/PRP ,/, endopeptidase/NN activity/NN produces/VBZ a/DT similar/JJ product/NN profile/NN from/IN the/DT nonapeptide/NN substrate/NN to/TO that/PRP of/IN human/NN leukocyte/NN elastase/NN ,/, an/DT enzyme/NN previously/RB shown/VBN to/TO be/VB capable/JJ of/IN releasing/NN a/DT bioactive/JJ ,/, mature/JJ form/NN of/IN TGF/NN alpha/NN from/IN its/PRP$ cell-bound/JJ precursor/NN ./.
P08437202A02
Thoracolumbar/JJ spine/NN films/NNS were/VBD obtained/VBN on/IN 106/CD patients/NNS ./.
P08442409A08
AIDS/NN patients/NNS with/IN progressive/JJ dementia/NN and/CC brains/NNS with/IN HIV-specific/JJ neuropathology/NN showed/VBD no/DT difference/NN in/IN neuronal/JJ densities/NNS as/IN compared/VBN to/TO those/PRP without/IN such/DT features/NNS ./.
P08451331A06
These/DT results/NNS provide/VBP compelling/JJ evidence/NN that/IN multisynaptic/JJ neural/JJ pathways/NNS linking/VBG the/DT chemosensory/JJ systems/NNS of/IN the/DT olfactory/NN bulbs/NNS with/IN the/DT rostral/JJ hypothalamus/NN are/VBP involved/VBN in/IN the/DT regulation/NN of/IN intermale/JJ aggression/NN in/IN mice/NNS ./.
P08460391A08
Advocates/NNS of/IN magnesium/NN criticize/VBP the/DT limited/JJ number/NN of/IN patients/NNS in/IN our/PRP$ study/NN as/RB well/RB as/IN the/DT administration/NN of/IN the/DT magnesium/NN substitute/NN ./.
P08474119A04
In/IN this/DT study/NN ,/, the/DT morphological/JJ and/CC cell-surface/NN characteristics/NNS of/IN the/DT avirulent/JJ parental/JJ strain/NN were/VBD compared/VBN with/IN those/PRP of/IN the/DT more/RB virulent/JJ variants/NNS to/TO determine/VB whether/IN pathogenicity/NN was/VBD associated/VBN with/IN one/CD or/CC more/DT cell-surface/NN constituents/NNS ./.
P08483260A05
Two/CD types/NNS of/IN scavenger/NN receptor/NN mRNA/NN were/VBD shown/VBN to/TO result/VB from/IN alternative/JJ splicing/NN of/IN exon/NN 9/CD for/IN type/NN II/CD or/CC 10/CD and/CC 11/CD for/IN type/NN I/CD to/TO the/DT common/JJ exon/NN 1-8/CD ./.
P08492479A05
Serum/NN 1/CD ,/, 25-dihydroxyvitamin-D/NN [/( 1/CD ,/, 25/CD (/( OH/NN )/) 2D/NN ]/) ,/, which/WDT is/VBZ produced/VBN in/IN the/DT proximal/JJ tubules/NNS through/IN 1/CD alpha-hydroxylation/NN from/IN 25-hydroxyvitamin-D/NN [/( 25OHD/NN ]/) ,/, was/VBD normal/JJ or/CC increased/VBN to/TO more/RB than/IN 60pg/NN //SYM ml/NN ./.
P08497432A09
Of/IN those/DT patients/NNS receiving/VBG thrombolysis/NN ,/, the/DT average/JJ time/NN delay/NN from/IN the/DT general/JJ practitioner/NN referring/NN the/DT patient/NN to/TO hospital/NN to/TO the/DT patient/NN being/NN treated/VBN was/VBD 107/CD minutes/NNS ./.
P08511438A03
Peripheral/JJ somatosensory/JJ input/NN seems/VBZ to/TO modulate/VB tremor/NN and/CC central/JJ nervous/JJ system/NN activity/NN related/VBN to/TO tremor/NN ./.
P08525333A03
Treatment/NN and/CC diagnostic/JJ guidelines/NNS in/IN different/JJ clinical/JJ entities/NNS have/VBP been/VBN based/VBN on/IN the/DT pillars/NNS of/IN medicine/NN -/: controlled/JJ studies/NNS and/or/CC a/DT common/JJ consensus/NN among/IN specialists/NNS and/CC practitioners/NNS ./.
P08529845A08
Damage/NN was/VBD inferred/VBN to/TO be/VB caused/VBN by/IN the/DT picolinate/NN ligand/NN because/IN picolinic/JJ acid/NN in/IN the/DT absence/NN of/IN chromium/NN was/VBD clastogenic/JJ ./.
P08539079A09
On/IN the/DT other/JJ hand/NN ,/, restrictions/NNS to/TO the/DT product/NN use/NN are/VBP a/DT less/RB constant/JJ activity/NN against/IN Neisseria/NN gonorrhoeae/NN and/CC a/DT lack/NN of/IN efficacy/NN on/IN Mycoplasma/NN hominis/NN ./.
P08548611A02
We/PRP present/VBP the/DT case/NN of/IN a/DT young/JJ patient/NN whose/WDT case/NN began/VBD ,/, four/CD years/NNS ago/RB ,/, with/IN depressive-type/NN manifestations/NNS ,/, with/IN diagnosis/NN only/RB being/NN made/VBN now/RB ./.
P08557486A06
For/IN example/NN ,/, the/DT lamins/NNS form/VBP nucleoplasmic/JJ foci/NNS ,/, distinct/JJ from/IN the/DT peripheral/JJ lamina/NN ,/, which/WDT vary/VBP in/IN their/PRP$ patterns/NNS of/IN distribution/NN as/RB well/RB as/IN their/PRP$ composition/NN in/IN a/DT cell/NN cycle-dependent/JJ manner/NN ./.
P08566217A03
AChE/NN was/VBD further/RB found/VBN to/TO be/VB expressed/VBN in/IN the/DT HMC-1/NN the/DT human/NN mast/JJ cell/NN precursor/NN line/NN ./.
P08579088A01
PURPOSE/NN :/: Chronic/JJ fatigue/NN syndrome/NN (/( CFS/NN )/) currently/RB is/VBZ defined/VBN by/IN a/DT working/JJ case/NN definition/NN developed/VBN under/IN the/DT leadership/NN of/IN the/DT United/JJ States/NNS Centers/NNS for/IN Disease/NN Control/NN and/CC Prevention/NN (/( CDC/NN )/) based/VBN on/IN a/DT consensus/NN among/IN experienced/JJ clinicians/NNS ./.
P08583242A05
Analysis/NN of/IN the/DT tumor/NN by/IN confocal/JJ laser/NN scanning/JJ microscopy/NN revealed/VBD that/IN labeled/JJ LCM/NN were/VBD inside/IN the/DT tumor/NN cells/NNS ./.
P08587485A10
These/DT results/NNS demonstrate/VBP that/IN changes/NNS in/IN myosin/NN heavy/JJ chain/NN expression/NN ,/, but/CC not/RB myosin/NN light/JJ chain/NN expression/NN accompany/VBP stretch-induced/JJ hypertrophy/NN in/IN the/DT quail/NN ALD/NN ./.
P08600841A06
This/DT report/NN presents/VBZ a/DT case/NN of/IN a/DT 2-year-old/JJ male/NN with/IN a/DT groin/NN superficial/JJ angiomyxoma/NN mimicking/VBG an/DT inguinal/JJ hernia/NN ./.
P08609917A01
Recording/JJ site/NN is/VBZ an/DT important/JJ cause/NN of/IN variability/NN of/IN compound/JJ muscle/NN action/NN potential/NN (/( CMAP/NN )/) and/CC conduction/NN parameters/NNS ,/, which/WDT can/MD be/VBP reduced/VBN by/IN using/NN large/JJ electrodes/NNS ./.
P08614556A07
In/IN contrast/NN to/TO weaver/NN (/( wv/NN //SYM +/SYM )/) mice/NNS ,/, the/DT number/NN of/IN apoptotic/JJ cells/NNS in/IN the/DT external/JJ granule/NN cell/NN layer/NN was/VBD not/RB increased/VBN ./.
P08623731A06
For/IN 99/CD %/SYM to/TO 100/CD %/SYM occlusions/NNS ,/, predictors/NNS were/VBD shorter/JJR duration/NN of/IN occlusion/NN and/CC more/RB jeopardized/JJ myocardium/NN ./.
P08632210A02
gamma-Tocotrienol/NN also/RB suppresses/VBZ tumor/NN growth/NN ./.
P08636514A05
Mercury/NN vapor/NN detection/NN ,/, sample/NN mass/NN changes/NNS and/CC x-ray/NN fluorescence/NN data/NNS were/VBD collected/VBN from/IN experimental/JJ steam/NN autoclave/NN sterilization/NN of/IN amalgam/NN samples/NNS sealed/VBN in/IN autoclave/NN bags/NNS ./.
P08640974A09
The/DT coefficient/NN of/IN variation/NN as/IN an/DT index/NN of/IN the/DT observed/JJ heterogeneity/NN of/IN myocardial/JJ blood/NN flow/NN averaged/VBD ,/, for/IN [/( 13N/NN ]/) ammonia/NN ,/, 9/CD +/-/SYM 4/CD %/SYM at/IN rest/NN and/CC 12/CD +/-/SYM 7/CD %/SYM during/IN stress/NN and/CC ,/, for/IN [/( 15O/NN ]/) water/NN ,/, 14/CD +/-/SYM 11/CD %/SYM at/IN rest/NN and/CC 16/CD +/-/SYM 9/CD %/SYM during/IN stress/NN ./.
P08645558A11
When/WRB the/DT first/JJ step/NN in/IN the/DT polyamine/NN biosynthetic/JJ pathway/NN is/VBZ blocked/VBN ,/, F9/NN teratocarcinoma/NN stem/NN cells/NNS accumulate/VBP large/JJ amounts/NNS of/IN decarboxylated/JJ AdoMet/NN ,/, the/DT aminopropyl/NN group/NN donor/NN in/IN polyamine/NN synthesis/NN ,/, and/CC go/VBP through/IN terminal/JJ differentiation/NN into/IN parietal/JJ endoderm/NN cells/NNS ./.
P08649990A09
The/DT enhancement/NN of/IN mutation/NN rate/NN was/VBD caused/VBN by/IN the/DT appearance/NN of/IN mutations/NNS at/IN three/CD new/JJ locations/NNS that/WDT correlated/VBD with/IN likely/JJ recombination/NN sites/NNS ./.
P08659938A01
An/DT unusual/JJ case/NN of/IN unilateral/JJ delayed/JJ and/CC progressive/JJ hearing/JJ loss/NN following/VBG a/DT microvascular/JJ decompression/NN operation/NN on/IN cranial/JJ nerves/NNS V/CD ,/, VII/CD ,/, and/CC VIII/CD on/IN the/DT left/JJ side/NN is/VBZ reported/VBN ./.
P08664513A03
From/IN this/DT group/NN of/IN patients/NNS we/PRP identified/VBD 7/CD patients/NNS with/IN primary/JJ gastrointestinal/JJ tract/NN (/( GIT/NN )/) CMV/NN disease/NN who/WP received/VBD treatment/NN with/IN GAN/NN ./.
P08669182A15
Discrepancies/NNS in/IN immunocytochemical/JJ staining/JJ results/NNS may/MD be/VBP caused/VBN partly/RB by/IN differences/NNS in/IN cell/NN preparation/NN ./.
P08678493A04
An/DT EO-RTC/NN questionnaire/NN system/NN was/VBD translated/VBN into/IN Japanese/NN and/CC its/PRP$ reproducibility/NN was/VBD assessed/VBN before/IN the/DT study/NN ./.
P08688228A05
Lung/NN lesions/NNS were/VBD demonstrated/VBN in/IN 214/CD patients/NNS ./.
P08692733A07
The/DT test/NN system/NN used/VBD a/DT CHO/NN cell/NN line/NN expressing/VBG the/DT enzyme/NN chloramphenicol/NN acetyl-transferase/NN (/( CAT/NN )/) under/IN the/DT control/NN of/IN an/DT inducible/JJ promoter/NN ./.
P08697750A05
The/DT aphasic/NN showed/VBD an/DT exactly/RB similar/JJ pattern/NN of/IN ERP/NN components/NNS as/IN the/DT controls/NNS did/VBD ,/, but/CC his/PRP$ performance/NN in/IN a/DT task/NN demanding/VBG explicit/NN differentiation/NN between/IN semantically/RB congruous/JJ and/CC incongruous/JJ sentences/NNS was/VBD at/IN the/DT chance/NN level/NN ./.
P08707007A06
METHODS/NNS :/: At/IN first/NN ,/, we/PRP studied/VBD 28/CD patients/NNS (/( pts/NNS )/) ,/, which/WDT we/PRP divided/VBD in/IN two/CD groups/NNS :/: Group/NN A/NN ,/, 18/CD pts/NNS 59.38/CD +/-/SYM 8.23/CD mean/NN age/NN ,/, 15/CD M./NN and/CC 3/CD F./NN ,/, with/IN anterior/JJ descending/JJ disease/NN ;/: Group/NN B/NN 10/CD pts/NNS ,/, 59.20/CD +/-/SYM 8.48/CD mean/NN age/NN ,/, 7/CD M./NN and/CC 3/CD F/NN ,/, without/IN significant/JJ stenosis/NN (/( >/SYM 75/CD %/SYM )/) ./.
P08718031A01
Over/IN the/DT past/JJ 10/CD years/NNS ,/, people/NNS with/IN learning/JJ disabilities/NNS have/VBP moved/VBN out/IN of/IN institutions/NNS and/CC into/IN the/DT community/NN ./.
P08726588A04
Improved/JJ antiemetics/NNS have/VBP led/VBN to/TO increased/JJ patient/NN tolerance/NN of/IN the/DT most/RBS acute/JJ symptoms/NNS of/IN aggressive/JJ chemotherapeutic/JJ dosing/NN ./.
P08730767A04
Of/IN the/DT 38/CD children/NNS not/RB identifying/VBG the/DT perpetrator/NN at/IN the/DT screening/JJ interview/NN ,/, 17/CD (/( 45/CD %/SYM )/) made/VBD disclosure/NN at/IN the/DT investigative/JJ interview/NN ./.
P08739132A02
From/IN an/DT experimental/JJ point/NN of/IN view/NN ,/, the/DT freezing/JJ water/NN was/VBD determined/VBN by/IN DSC/NN when/WRB the/DT total/JJ sorbed/JJ water/NN was/VBD obtained/VBN from/IN thermogravimetry/NN ./.
P08743195A09
The/DT increase/NN in/IN [/( Ca2+/NN ]/) i/NN may/MD act/VBP as/IN an/DT intracellular/JJ message/NN and/CC cause/VBP the/DT activation/NN of/IN the/DT GP/NN IIb-IIIa/NN complex/NN ./.
P08751720A02
Based/VBN on/IN its/PRP$ effects/NNS on/IN tumor/NN and/CC endothelial/JJ cell/NN behavior/NN ,/, this/DT member/NN of/IN the/DT thrombospondin/NN gene/NN family/NN has/VBZ attracted/VBN interest/NN as/IN a/DT potential/JJ regulator/NN of/IN tumor/NN growth/NN and/CC metastasis/NN ./.
P08756561A04
Their/PRP$ pubic/JJ symphysial/JJ tissues/NNS were/VBD then/RB removed/VBN and/CC analyzed/VBN for/IN collagen/NN content/NN and/CC solubility/NN ,/, whereas/IN collagen/NN composition/NN was/VBD determined/VBN by/IN SDS-PAGE/NN ./.
P08760820A08
Intraperitoneal/JJ administration/NN into/IN mice/NNS of/IN living/JJ S./NN pyogenes/NN bacteria/NN producing/VBG the/DT cysteine/NN proteinase/NN induced/VBD a/DT rapid/JJ breakdown/NN of/IN endogenous/JJ plasma/NN kininogens/NNS and/CC release/NN of/IN kinins/NNS ./.
P08765133A12
Both/CC BSA/NN and/CC lysozyme/NN were/VBD completely/RB partitioned/VBN to/TO the/DT water/NN phase/NN formed/VBN above/IN the/DT cloud/NN point/NN of/IN EO30/NN //SYM PO70/NN ./.
P08778553A02
Seven/CD sedentary/JJ subjects/NNS ,/, 10/CD endurance/NN runners/NNS ,/, and/CC seven/CD elite/JJ gymnasts/NNS of/IN similar/JJ height/NN and/CC weight/NN were/VBD investigated/VBN ./.
P08787405A02
Fifty-gram/NN oyster/NN samples/NNS were/VBD processed/VBN by/IN an/DT adsorption-elution/NN -precipitation/NN method/NN and/CC then/RB seeded/VBN with/IN 10/CD (/( 1/CD )/) to/TO 10/CD (/( 5/CD )/) PFU/NN of/IN poliovirus/NN type/NN 1/CD (/( PV1/NN )/) or/CC hepatitis/NN A/NN virus/NN (/( HAV/NN )/) ./.
P08792061A05
In/IN spite/NN of/IN the/DT limitations/NNS ,/, the/DT studies/NNS have/VBP been/VBN critical/JJ in/IN helping/NN determine/VB the/DT pathogenesis/NN of/IN sepsis/NN in/IN humans/NNS ./.
P08800818A06
In/IN palliative/JJ care/NN ,/, clinical/JJ and/CC academic/JJ approaches/NNS need/VBP greater/JJR integration/NN ./.
P08811029A05
Secondly/RB ,/, TAP/NN molecules/NNS fail/VBP to/TO associate/VB with/IN MHC/NN class/NN I/CD heavy/JJ chains/NNS indicating/VBG that/IN HCMV/NN early/JJ gene/NN expression/NN also/RB interferes/VBZ with/IN MHC/NN class/NN I/CD maturation/NN ./.
P08819791A08
The/DT biological/JJ implication/NN of/IN SCEs/NNS was/VBD discussed/VBN in/IN connection/NN with/IN the/DT generation/NN of/IN heteromorphism/NN ./.
P08828419A06
Major/JJ histocompatibility/NN complex/NN class/NN I/CD and/CC class/NN II/CD and/CC intercellular/JJ adhesion/NN molecule-1/NN cell/NN surface/NN antigens/NNS were/VBD determined/VBN by/IN fluorescence-activated/JJ cell/NN sorting/JJ analysis/NN ./.
P08836667A01
Recipients/NNS of/IN heart-lung/NN transplantation/NN (/( HLT/NN )/) show/VBP reduced/JJ exercise/NN capacity/NN due/JJ to/TO several/JJ pre-/JJ and/CC postsurgical/JJ factors/NNS ./.
P08844780A01
Although/IN physiological/JJ processes/NNS related/VBN to/TO vascular/JJ function/NN differ/VBP greatly/RB between/IN resistance/NN arteries/NNS and/CC conduit/NN arteries/NNS ,/, it/PRP is/VBZ not/RB known/VBN whether/IN the/DT effects/NNS of/IN calcitonin/NN gene-related/JJ peptide/NN (/( CGRP/NN )/) ,/, a/DT vasodilator/NN neuropeptide/NN ,/, on/IN these/DT arteries/NNS differ/VBP in/IN humans/NNS ./.
P08853414A02
This/DT 15.5-kDa/NN protein/NN binds/VBZ fatty/JJ acids/NNS in/FW vitro/FW and/CC has/VBZ identity/NN with/IN amino/JJ acids/NNS 10-117/CD of/IN alpha/NN 2/CD mu-globulin/NN (/( A2/NN fragment/NN )/) ,/, a/DT 19-kDa/NN protein/NN synthesized/VBN predominantly/RB in/IN the/DT male/NN liver/NN ./.
P08858021A07
The/DT other/JJ group/NN received/VBD vehicle/NN alone/JJ ./.
P08867358A04
Here/RB we/PRP report/VBP the/DT occurrence/NN of/IN HSE/NN in/IN a/DT 52/CD years/NNS old/JJ woman/NN two/CD months/NNS after/IN brain/NN irradiation/NN (/( 40/CD Gray/NN in/IN 20/CD fractions/NNS )/) and/CC dexamethasone/NN administration/NN for/IN a/DT metastatic/JJ brain/NN tumor/NN ./.
P08876014A07
Rotating/NN to/TO anterior-posterior/JJ commissure/NN points/NNS was/VBD the/DT best/NN of/IN the/DT tested/JJ two-point/NN registrations/NNS ,/, although/IN an/DT average/JJ angular/JJ rotation/NN was/VBD better/JJR ./.
P08884442A05
Radiographic/JJ loosening/NN of/IN one/CD or/CC both/DT components/NNS was/VBD evident/JJ in/IN 3/CD hips/NNS ./.
P08896813A03
Similarly/RB ,/, CGP/NN 39551/CD attenuated/VBD the/DT clonic/JJ and/CC tonic/JJ phases/NNS of/IN audiogenic/JJ seizures/NNS 120/CD min/NN after/IN acute/JJ treatment/NN with/IN ED50/NN values/NNS of/IN 17.2/CD and/CC 8.8/CD mumol/NN kg-1/NN ,/, respectively/RB ./.
P08901010A03
Intranigral/JJ application/NN of/IN the/DT non-competitive/JJ NMDA/NN receptor/NN antagonist/NN dizocilpine/NN (/( 150/CD nM/NN )/) ,/, or/CC the/DT competitive/JJ NMDA/NN receptor/NN antagonist/NN R-DL-/NN (/( E/NN )/) -2-amino-4-methyl-5-phosphono-3-pentanoate/NN (/( CGP/NN 40116/CD ,/, 10/CD microM/NN )/) ,/, via/IN the/DT dialysis/NN probe/NN ,/, did/VBD not/RB affect/VBP the/DT release/NN of/IN dopamine/NN or/CC its/PRP$ metabolites/NNS in/IN intact/JJ rats/NNS ,/, but/CC further/RB suppressed/VBD these/DT releases/NNS in/IN reserpine/NN plus/CC alpha-methyl-p-tyrosine-treated/JJ animals/NNS ./.
P08909990A05
5./CD The/DT longitudinal/JJ muscle/NN strips/NNS showed/VBD higher/JJR spontaneous/JJ and/CC evoked/JJ contractions/NNS ./.
P08918119A05
Sexual/JJ abuse/NN was/VBD most/RBS common/JJ (/( 55/CD %/SYM )/) ,/, followed/VBN by/IN physical/JJ abuse/NN (/( 48/CD %/SYM )/) ,/, and/CC rape/NN (/( 41/CD %/SYM )/) ./.
P08922531A11
Fibrillar/JJ and/CC basement/NN membrane/NN collagen/NN gene/NN expressions/NNS ,/, their/PRP$ protein/NN syntheses/NNS ,/, and/CC the/DT processing/NN of/IN these/DT procollagens/NNS seems/VBZ to/TO be/VB developmentally/RB regulated/VBN in/IN the/DT invasive/JJ cytotrophoblasts/NNS during/IN the/DT organization/NN of/IN feto-maternal/JJ placental/JJ tissue/NN ./.
P08935861A04
Two/CD studies/NNS were/VBD conducted/VBN ./.
P08940291A01
As/IN a/DT participant/NN of/IN the/DT endogenous/JJ arachidonic/JJ acid/NN metabolic/JJ cascade/NN ,/, microsomal/JJ cytochrome/NN P450/NN metabolizes/VBZ the/DT fatty/JJ acid/NN to/TO biologically/RB active/JJ hydroxyeicosatetraenoic/JJ and/CC epoxyeicosatrienoic/JJ acids/NNS ./.
P08944651A10
It/PRP is/VBZ concluded/VBN that/IN an/DT endogenous/JJ PKG/NN activates/VBZ BKCa/NN by/IN decreasing/NN the/DT Ca2+/NN and/CC voltage/NN activation/NN thresholds/NNS independently/RB of/IN sensitivities/NNS ./.
P08953633A08
Poor/JJ outcome/NN was/VBD not/RB predicted/VBN by/IN early/JJ gestation/NN at/IN diagnosis/NN ,/, the/DT hernial/JJ contents/NNS ,/, or/CC the/DT presence/NN of/IN polyhydramnios/NN ./.
P08967972A02
The/DT magnitude/NN of/IN these/DT depletions/NNS was/VBD similar/JJ to/TO those/PRP reported/VBN previously/RB in/IN Swiss/NN Webster/NN and/CC C57BL/NN //SYM 6/CD mice/NNS given/VBN 4/CD x/SYM 20/CD mg/NN //SYM kg/NN 2'-NH2-MPTP/NN ,/, and/CC in/IN keeping/NN with/IN these/DT prior/JJ studies/NNS ,/, striatal/JJ dopamine/NN levels/NNS were/VBD unchanged/VBN by/IN 2'-NH2-MPTP/NN treatment/NN in/IN CD-1/NN mice/NNS ./.
P08976926A06
CT/NN revealed/VBD subsegmental/JJ atelectasis/NN in/IN other/JJ lobes/NNS adjacent/JJ to/TO the/DT bullous/JJ lung/NN in/IN six/CD patients/NNS ./.
P08985690A03
Rats/NNS were/VBD subjected/VBN to/TO a/DT fluid/NN percussion/NN brain/NN injury/NN one/CD week/NN prior/RB to/TO experimentation/NN ,/, and/CC in/FW vitro/FW electrophysiological/JJ recording/JJ studies/NNS were/VBD conducted/VBN using/VBG combined/JJ hippocampal-entorhinal/JJ cortical/JJ slices/NNS (/( HEC/NN slices/NNS )/) ./.
P08989768A05
In/IN general/NN ,/, membrane/NN contours/NNS are/VBP smoother/JJR and/CC intracellular/JJ organelles/NNS more/RB regular/JJ in/IN shape/NN in/IN HPF/NN //SYM FS/NN samples/NNS as/IN compared/VBN with/IN the/DT chemically/RB fixed/JJ specimens/NNS ./.
P08999449A07
Signal/NN intensity/NN in/IN the/DT FLASH/NN sequence/NN decreased/VBD during/IN LITT/NN ,/, both/CC in/IN the/DT prostate/NN in/FW vivo/FW and/CC in/IN specimens/NNS of/IN bovine/JJ prostate/NN and/CC seminal/JJ vesicles/NNS in/FW vitro/FW ,/, with/IN signal/NN developments/NNS running/NN in/IN parallel/NN ./.
P09008386A01
The/DT promoters/NNS of/IN the/DT hemoglobin/NN genes/NNS from/IN the/DT nitrogen-fixing/JJ tree/NN Parasponia/NN andersonii/NN and/CC the/DT related/JJ nonnitrogen-fixing/JJ Trema/NN tomentosa/NN both/CC confer/VBP beta-glucuronidase/NN reporter/NN gene/NN expression/NN to/TO the/DT central/JJ zone/NN of/IN the/DT nodules/NNS of/IN a/DT transgenic/JJ legume/NN ,/, Lotus/NN corniculatus/NN ./.
P09012838A06
RF/NN B/NN cells/NNS exposed/VBN to/TO tolerogen/NN remain/VBP competent/JJ to/TO secrete/VB RF/NN in/FW vitro/FW if/IN provided/VBN with/IN an/DT appropriate/JJ antigenic/JJ stimulus/NN and/CC T/NN cell/NN help/NN ./.
P09022275A07
Our/PRP$ results/NNS show/VBP that/IN outer/JJ ear/NN temperature/NN measurement/NN is/VBZ the/DT method/NN which/WDT provides/VBZ the/DT best/JJS simplicity/NN //SYM quality/NN ratio/NN and/CC should/MD therefore/RB be/VBP proposed/VBN for/IN use/NN at/IN the/DT scene/NN when/WRB conditions/NNS are/VBP similar/JJ to/TO those/PRP of/IN our/PRP$ experiment/NN (/( within/IN buildings/NNS )/) ./.
P09037104A03
The/DT cysteine/NN motifs/NNS involved/VBN in/IN binding/NN two/CD iron-sulfur/NN clusters/NNS are/VBP conserved/VBN in/IN the/DT plant/NN protein/NN sequences/NNS ./.
P09046287A02
DESIGN/NN :/: An/DT electrophysiological/JJ evaluation/NN of/IN the/DT sensory/JJ nerve/NN to/TO the/DT lip/NN and/CC chin/NN was/VBD performed/VBN ./.
P09051095A06
In/IN 16/CD of/IN 30/CD seroconversion/NN samples/NNS ,/, both/DT immunoblot/NN assays/NNS produced/VBD HIV-1-positive/JJ results/NNS ./.
P09060661A07
However/WRB ,/, infected/JJ cells/NNS were/VBD not/RB detected/VBN in/IN SCID/NN mice/NNS (/( deficient/JJ in/IN mature/JJ T/NN and/CC B/NN cells/NNS )/) inoculated/VBN with/IN the/DT same/JJ virus/NN ,/, indicating/VBG that/IN precursor/NN B/NN cells/NNS are/VBP not/RB a/DT target/NN of/IN the/DT virus/NN in/IN the/DT absence/NN of/IN mature/JJ CD4+/NN T/NN cells/NNS ./.
P09070126A07
Relative/JJ risks/NNS ,/, derived/VBN from/IN Cox/NN 's/POS proportional/JJ hazards/NNS model/NN ,/, describing/VBG the/DT effect/NN on/IN survival/NN of/IN surgeons/NNS vs/CC gynaecologists/NNS as/IN baseline/NN ,/, high/JJ volume/NN vs/CC low/JJ volume/NN operators/NNS and/CC referral/NN vs/CC nonreferral/JJ to/TO an/DT oncologist/NN ./.
P09080555A04
Both/CC sensorineural/JJ threshold/NN elevation/NN and/CC tinnitus/NN (/( n/NN =/SYM 16/CD )/) diminished/VBD with/IN time/NN ./.
P09090743A02
Hispanics/NNS ,/, the/DT second/JJ largest/JJS of/IN these/DT groups/NNS ,/, face/VBP problems/NNS of/IN access/NN to/TO care/NN ,/, high/JJ rates/NNS of/IN substance/NN abuse/NN and/CC HIV/NN ,/, and/CC shortages/NNS of/IN Hispanic/JJ psychiatric/JJ professionals/NNS ./.
P09101131A04
This/PRP should/MD help/VBP improve/VB our/PRP$ patients/NNS '/POS quality/NN of/IN life/NN and/CC should/MD have/VBP a/DT positive/JJ economic/JJ impact/NN on/IN the/DT long-term/NN treatment/NN of/IN peptic/JJ ulcer/NN by/IN reducing/NN the/DT requirement/NN for/IN continuous/JJ medical/JJ treatment/NN ./.
P09110582A01
Edible/JJ mushrooms/NNS such/JJ as/IN shiitake/NN may/MD have/VBP important/JJ salutary/JJ effects/NNS on/IN health/NN or/CC even/RB in/IN treating/NN disease/NN ./.
P09119812A04
Histologically/RB ,/, the/DT valves/NNS showed/VBD thickening/NN and/CC hyalinization/NN of/IN the/DT collagen/NN fibers/NNS ,/, and/CC the/DT presence/NN of/IN foamy/JJ cells/NNS that/WDT contained/VBD a/DT large/JJ quantity/NN of/IN pure/JJ acid/NN mucopolysaccharide/NN ./.
P09129178A03
Retrogradely/RB labelled/JJ cells/NNS were/VBD quantitatively/RB recorded/VBN ./.
P09133667A06
The/DT immortalization/NN of/IN human/NN adipocytes/NNS will/MD permit/VBP pharmacological/JJ analysis/NN of/IN the/DT human/NN beta3-adrenoceptor/NN function/NN in/IN adipose/JJ cells/NNS and/CC will/MD allow/VBP detailed/JJ studies/NNS of/IN human/NN adipocyte/NN differentiation/NN ./.
P09142854A09
Trifluoperazine/NN ,/, which/WDT inhibits/VBZ MPT/NN ,/, did/VBD not/RB block/VBP the/DT initial/JJ oxidation/NN of/IN NAD/NN (/( P/NN )/) H/NN but/CC prevented/VBD the/DT second/JJ phase/NN of/IN oxidation/NN ,/, partially/RB blocked/VBD ROS/NN formation/NN ,/, and/CC preserved/VBD cell/NN viability/NN ./.
P09151518A03
Some/PRP of/IN these/DT diseases/NNS are/VBP of/IN known/JJ aetiology/NN ,/, whereas/IN others/NNS are/VBP not/RB ./.
P09160407A06
Undigested/JJ ,/, gastric/JJ digested/JJ and/CC combined/JJ gastric/JJ and/CC intestinal/JJ digested/JJ G115/NN significantly/RB dilated/VBD lungs/NNS (/( 44/CD %/SYM ,/, undigested/VBN ;/: 26/CD %/SYM ,/, gastric/JJ digested/VBN ;/: 45/CD %/SYM ,/, gastric/JJ and/CC intestinal/JJ digested/VBN )/) ./.
P09169305A03
A/DT series/NN of/IN studies/NNS has/VBZ shown/VBN that/IN interruption/NN of/IN serotonin/NN synthesis/NN compromises/VBZ the/DT efficacy/NN of/IN serotonin/NN but/CC not/RB noradrenaline/NN reuptake/NN inhibitors/NNS ,/, and/CC interruption/NN of/IN noradrenaline/NN synthesis/NN compromises/VBZ the/DT efficacy/NN of/IN noradrenaline/NN but/CC not/RB serotonin/NN reuptake/NN inhibitors/NNS (/( SSRIs/NNS )/) ./.
P09173958A10
Increased/JJ endurance/NN capacity/NN was/VBD not/RB directly/RB associated/VBN with/IN the/DT elevated/JJ levels/NNS of/IN muscle/NN glycogen/NN ,/, oxygen/NN transport/NN capacity/NN of/IN blood/NN ,/, or/CC VO2max/NN ./.
P09186818A03
As/IN control/NN ,/, 7/CD healthy/JJ adult/NN subjects/NNS (/( 3M/NN ,/, 4F/NN ;/: 26-50/CD yr/NN old/JJ )/) were/VBD studied/VBN in/IN basal/JJ condition/NN over/IN a/DT 24-h/NN span/NN ./.
P09191838A02
A/DT series/NN of/IN internal/JJ deletion/NN mutants/NNS of/IN DI/NN cDNA/NN was/VBD generated/VBN to/TO obtain/VB DI/NN genomic/JJ RNAs/NNS that/WDT differed/VBD from/IN one/CD another/PRP by/IN the/DT presence/NN of/IN different/JJ lengths/NNS of/IN 3'-terminal/JJ and/or/CC 5'-terminal/JJ sequences/NNS ./.
P09200771A01
A/DT simple/JJ and/CC rapid/JJ procedure/NN to/TO determine/VB felbamate/NN (/( 2-phenyl-1/NN ,/, 3-propanediol/NN dicarbamate/NN )/) concentrations/NNS in/IN human/NN plasma/NN //SYM serum/NN by/IN high-performance/NN liquid/NN chromatography/NN is/VBZ described/VBN ./.
P09204962A04
The/DT spatial/JJ expression/NN of/IN MMP-13/NN differed/VBN from/IN that/PRP of/IN collagenase-1/NN (/( MMP-1/NN )/) ,/, which/WDT was/VBD prominently/RB expressed/VBN by/IN migrating/JJ keratinocytes/NNS and/CC dermal/JJ cells/NNS located/VBN just/RB beneath/IN the/DT wound/NN surface/NN ./.
P09213427A04
Using/VBG this/DT panel/NN of/IN mAbs/NNS against/IN multiple/JJ epitopes/NNS ,/, only/RB alpha-calponin/NN was/VBD detected/VBN in/IN adult/JJ chicken/NN smooth/JJ muscles/NNS and/CC throughout/IN development/NN of/IN the/DT gizzard/NN ./.
P09218245A11
Similar/JJ systems/NNS are/VBP used/VBN to/TO scale/NN the/DT response/NN to/TO one/CD stimulus/NN feature/NN with/IN respect/NN to/TO a/DT second/JJ feature/NN ./.
P09222574A08
For/IN most/PRP of/IN the/DT cases/NNS ,/, participants/NNS believed/VBD that/IN they/PRP knew/VBD how/WRB to/TO deal/VB with/IN the/DT problem/NN ,/, that/IN the/DT clinical/JJ situation/NN was/VBD realistic/JJ ,/, that/IN the/DT simulated/JJ patient/NN was/VBD believable/JJ ,/, and/CC that/IN the/DT case/NN duration/NN was/VBD adequate/JJ ./.
P09235646A04
In/IN RA/NN patients/NNS the/DT above/JJ symptoms/NNS were/VBD absent/JJ ./.
P09240173A08
On/IN multivariate/JJ analysis/NN ,/, MDR-1/NN and/CC tumour/NN stage/NN were/VBD significant/JJ factors/NNS for/IN predicting/NN the/DT disease-free/JJ period/NN ,/, whereas/IN tumour/NN stage/NN and/CC malignancy/NN grade/NN were/VBD the/DT most/RBS relevant/JJ factors/NNS for/IN survival/NN time/NN ./.
P09253647A01
We/PRP have/VBP developed/VBN a/DT method/NN for/IN representing/NN biological/JJ pathways/NNS and/CC simulating/NN their/PRP$ behavior/NN based/VBN on/IN the/DT use/NN of/IN stochastic/JJ activity/NN networks/NNS (/( SANs/NNS )/) ./.
P09258295A04
This/DT paper/NN presents/VBZ some/PRP of/IN the/DT arguments/NNS for/IN and/CC against/IN two-tiered/JJ health/NN care/NN ./.
P09262254A19
The/DT suppression/NN occurred/VBD without/IN detectable/JJ amounts/NNS of/IN aspirin/NN or/CC salicylic/JJ acid/NN in/IN the/DT plasma/NN at/IN the/DT time/NN points/NNS studied/VBN ./.
P09276168A02
Some/DT pathologic/JJ conditions/NNS may/MD predispose/VBP to/TO sudden/JJ death/NN during/IN exercise/NN in/IN young/JJ athletes/NNS ./.
P09286099A03
Force/NN platform/NN and/CC kinematic/JJ measurements/NNS revealed/VBD that/IN two/CD species/NNS of/IN lizards/NNS ,/, Coleonyx/NN variegatus/NN and/CC Eumeces/NN skiltonianus/NN ,/, used/VBD two/CD basic/JJ gaits/NNS similar/JJ to/TO mammalian/JJ walking/JJ and/CC trotting/JJ gaits/NNS ./.
P09291163A07
An/DT important/JJ role/NN for/IN neurosteroids/NNS in/IN myelin/NN repair/NN has/VBZ been/VBN demonstrated/VBN in/IN the/DT rodent/NN sciatic/JJ nerve/NN ,/, where/WRB progesterone/NN and/CC its/PRP$ direct/JJ precursor/NN pregnenolone/NN are/VBP synthesized/VBN by/IN Schwann/NN cells/NNS ./.
P09305011A03
Home/NN health/NN agencies/NNS were/VBD less/RB likely/RB to/TO have/VB had/VBD programs/NNS in/IN the/DT past/NN and/CC more/RB likely/RB to/TO have/VB recently/RB established/VBN diabetes/NN education/NN programs/NNS ./.
P09314824A01
Needle/NN biopsy/NN of/IN the/DT prostate/NN plays/VBZ a/DT central/JJ role/NN in/IN the/DT diagnosis/NN of/IN prostate/NN cancer/NN and/CC the/DT prediction/NN of/IN outcome/NN ./.
P09327504A04
In/IN contrast/NN to/TO epilepsy/NN ,/, in/IN which/WDT a/DT proliferation/NN of/IN excitatory/JJ pathways/NNS or/CC inadequate/JJ inhibitory/JJ factors/NNS are/VBP paramount/JJ ,/, schizophrenia/NN may/MD represent/VBP a/DT genetically/RB and/CC age-determined/JJ elaboration/NN of/IN one/CD or/CC more/DT inhibitory/JJ networks/NNS in/IN response/NN to/TO specific/JJ physiological/JJ events/NNS (/( e.g./IN ,/, the/DT increased/JJ neuronal/JJ activity/NN in/IN limbic/JJ and/CC hypothalamic/JJ structures/NNS during/IN the/DT physiological/JJ events/NNS of/IN puberty/NN )/) or/CC to/TO brain/NN injury/NN or/CC defect/NN ./.
P09338094A06
Not/RB surprisingly/RB ,/, many/DT components/NNS of/IN the/DT cell/NN cycle/NN regulatory/JJ machinery/NN ,/, including/VBG CDKs/NNS ,/, CDK/NN inhibitors/NNS and/CC CDK/NN substrates/NNS ,/, are/VBP important/JJ targets/NNS of/IN mutations/NNS that/WDT lead/VBP to/TO human/NN malignancy/NN ./.
P09348251A09
CONCLUSION/NN :/: Using/VBG active/JJ expectant/JJ management/NN and/CC strict/JJ routines/NNS it/PRP seems/VBZ possible/JJ to/TO minimize/VB the/DT risk/NN for/IN perinatal/JJ asphyxia/NN and/CC mortality/NN ./.
P09361499A03
The/DT mean/NN failure/NN rate/NN was/VBD lowest/JJS in/IN Medicine/NN between/IN 1975/CD and/CC 1981/CD ,/, in/IN Obstetrics/NNS &/CC Gynaecology/NN between/IN 1982/CD and/CC 1989/CD and/CC in/IN Surgery/NN during/IN the/DT last/JJ 7/CD years/NNS ./.
P09370343A07
For/IN both/CC the/DT aqua-monoadduct/NN and/CC chloro-monoadduct/NN ,/, cis-/JJ [/( Pt/NN (/( NH3/NN )/) 2/CD (/( N7G/NN )/) (/( H2O/NN or/CC Cl/NN )/) ]/) ,/, the/DT 5'-G/NN monoadduct/NN is/VBZ much/RB longer/JJR lived/VBN (/( t1/NN //SYM 2/CD approximately/RB 4/CD h/NN at/IN 288/CD K/NN for/IN aqua/NN ,/, 80/CD h/NN at/IN 298/CD K/NN for/IN chloro/NN )/) than/IN the/DT 3'-G/NN monoadduct/NN (/( t1/NN //SYM 2/CD </SYM or/CC =/SYM 45/CD min/NN at/IN 288/CD K/NN for/IN aqua/NN ,/, 6/CD h/NN at/IN 298/CD K/NN for/IN chloro/NN )/) ./.
P09374561A12
Although/IN use/NN of/IN barrier/NN methods/NNS varies/VBZ ,/, all/DT sites/NNS cohort/VBP or/CC isolate/VBP RSV-positive/JJ patients/NNS in/IN single/JJ rooms/NNS ./.
P09383880A03
CDE/NN signals/NNS were/VBD recorded/VBN in/IN 20/CD singleton/NN pregnancies/NNS with/IN appropriate/JJ growth/NN and/CC imminent/JJ preterm/NN delivery/NN between/IN 26/CD and/CC 33/CD weeks/NNS of/IN gestation/NN ./.
P09393434A01
In/IN Saccharomyces/NN cerevisiae/NN ,/, entry/NN into/IN S/NN phase/NN requires/VBZ the/DT activation/NN of/IN the/DT protein/NN kinase/NN Cdc28p/NN through/IN binding/NN with/IN cyclin/NN Clb5p/NN or/CC Clb6p/NN ,/, as/RB well/RB as/IN the/DT destruction/NN of/IN the/DT cyclin-dependent/JJ kinase/NN inhibitor/NN Sic1p/NN ./.
P09397539A07
The/DT two/CD other/JJ subsets/NNS were/VBD subset/NN V/NN ,/, which/WDT contains/VBZ only/RB the/DT restriction/NN site/NN for/IN VspI/NN ,/, and/CC subset/NN N/NN ,/, which/WDT lacks/VBZ all/DT three/CD restriction/NN sites/NNS ./.
P09402084A10
It/PRP was/VBD observed/VBN that/IN luminal/JJ U37883A/NN (/( 100/CD microM/NN )/) significantly/RB attenuated/VBD TGF/NN ./.
P09410406A03
The/DT outcome/NN is/VBZ favorable/JJ under/IN corticotherapy/NN ./.
P09420353A04
Descriptions/NNS of/IN and/CC psychometric/JJ findings/NNS for/IN over/RB 2/CD dozen/NN measures/NNS are/VBP summarized/VBN ,/, including/VBG measures/NNS for/IN depression/NN ,/, anxiety/NN ,/, eating/JJ disorders/NNS ,/, pain/NN ,/, and/CC applications/NNS with/IN children/NNS and/CC adolescents/NNS ,/, and/CC conclusions/NNS and/CC future/JJ directions/NNS are/VBP suggested/VBN ./.
P09434208A01
The/DT responsiveness/NN of/IN the/DT parabrachial/JJ region/NN to/TO electrical/JJ stimulation/NN of/IN the/DT superior/JJ laryngeal/JJ nerve/NN was/VBD first/RB examined/VBN in/IN anesthetized/JJ rats/NNS ./.
P09438564A05
Of/IN the/DT medium-SES/NN 6-/CD and/CC 12-year-old/JJ children/NNS ,/, 79/CD and/CC 89/CD %/SYM were/VBD caries-free/JJ ,/, respectively/RB ;/: in/IN the/DT high-SES/NN children/NNS the/DT respective/JJ figures/NNS were/VBD 84/CD and/CC 86/CD %/SYM ./.
P09447740A01
The/DT concentration/NN of/IN fluoride/NN was/VBD determined/VBN in/IN water/NN ,/, forage/NN and/CC urine/NN and/CC serum/NN samples/NNS of/IN buffaloes/NNS from/IN the/DT Unnao/NNP district/NN of/IN India/NNP ./.
P09452452A09
Possible/JJ molecular/JJ mechanisms/NNS are/VBP discussed/VBN ./.
P09457262A14
After/IN a/DT mean/NN 6.5/CD year/NN follow-up/NN period/NN ,/, 13/CD patients/NNS (/( 45/CD %/SYM )/) are/VBP neurologically/RB intact/JJ ,/, 8/CD patients/NNS (/( 27.5/CD %/SYM )/) have/VBP a/DT moderate/JJ disability/NN ,/, without/IN evidence/NN of/IN tumor/NN recurrence/NN ./.
P09466264A07
Transformation/NN efficiencies/NNS of/IN recA+/NN (/( Ind-/NN )/) and/CC of/IN wild-type/NN cells/NNS were/VBD compared/VBN under/IN various/JJ conditions/NNS and/CC with/IN different/JJ donor/NN DNA/NN ./.
P09475172A02
A/DT cDNA/NN for/IN a/DT rat/NN liver/NN enzyme/NN hydrolyzing/VBG anandamide/NN as/RB well/RB as/IN oleamide/NN was/VBD overexpressed/VBN in/IN COS-7/NN cells/NNS ./.
P09484480A01
A/DT cDNA/NN encoding/VBG the/DT multifunctional/JJ cytochrome/NN P450/NN ,/, CYP71E1/NN ,/, involved/VBN in/IN the/DT biosynthesis/NN of/IN the/DT cyanogenic/JJ glucoside/NN dhurrin/NN from/IN Sorghum/NN bicolor/JJ (/( L./NN )/) Moench/NN was/VBD isolated/VBN ./.
P09488940A06
Left/JJ intraabdominal/JJ testis/NN was/VBD also/RB identified/VBN ./.
P09497501A07
Third/RB ,/, the/DT tissue/NN distribution/NN of/IN IF1/NN is/VBZ very/RB suggestive/JJ ./.
P09501857A09
Interestingly/RB ,/, SCFs/NNS produced/VBD and/CC secreted/VBD an/DT 18-kDa/NN extracellular/JJ isoform/NN of/IN FGF-2/NN ,/, the/DT synthesis/NN of/IN which/WDT is/VBZ further/RB stimulated/VBN by/IN TGF-beta/NN 1/CD and/CC TGF-beta/NN 3/CD ,/, respectively/RB ,/, whereas/IN the/DT neutralizing/JJ antibody/NN to/TO FGF-2/NN and/CC the/DT FGF-2-specific/JJ antisense/NN oligonucleotide/NN primers/NNS inhibited/VBD the/DT stimulatory/JJ activities/NNS of/IN TGF-beta/NN 1/CD in/IN SCFs/NNS ./.
P09506584A13
Also/RB ,/, anticentrosomal/JJ sera/NNS contained/VBD antibodies/NNS to/TO previously/RB undetected/JJ centrosomal/JJ components/NNS ./.
P09515719A06
The/DT expression/NN of/IN CD14/NN and/CC CD64/NN on/IN monocytes/NNS in/IN blood/NN was/VBD also/RB investigated/VBN ./.
P09524746A01
Infrastructure/NN of/IN 29/CD P./NN shigelloides/NN strains/NNS isolated/VBN as/IN the/DT only/RB positive/JJ finding/NN from/IN children/NNS with/IN diarrhea/NN (/( biochemical/JJ properties/NNS ,/, antigenic/JJ structure/NN ,/, antigenic/JJ relationship/NN to/TO shigellae/NN ,/, ATB/NN susceptibility/NN and/CC plasmids/NNS )/) were/VBD described/VBN ./.
P09529345A01
Family-based/JJ tests/NNS of/IN association/NN provide/VBP the/DT opportunity/NN to/TO test/VB for/IN an/DT association/NN between/IN a/DT disease/NN and/CC a/DT genetic/JJ marker/NN ./.
P09533829A15
Inhibition/NN of/IN phosphatase/NN by/IN calyculin/NN (/( 10/CD nm/NN )/) in/IN the/DT perforated-patch/NN configuration/NN did/VBD not/RB change/VBP membrane/NN conductance/NN ./.
P09543147A06
Our/PRP$ data/NNS demonstrate/VBP that/IN 1/CD )/) the/DT release/NN of/IN PI/NN provides/VBZ an/DT extracellular/JJ index/NN for/IN the/DT hormone/NN biosynthetic/JJ activity/NN of/IN human/NN beta-cells/NNS ;/: 2/CD )/) an/DT acute/JJ rise/NN in/IN glucose/NN exerts/VBZ a/DT stronger/JJR amplification/NN of/IN the/DT release/NN of/IN converted/JJ hormone/NN than/IN in/IN that/PRP of/IN nonconverted/JJ hormone/NN ;/: and/CC 3/CD )/) prolonged/JJ exposure/NN to/TO high/JJ glucose/NN levels/NNS results/VBZ in/IN an/DT elevated/JJ basal/JJ release/NN of/IN converted/JJ and/CC nonconverted/JJ PI/NN ;/: this/DT elevation/NN is/VBZ not/RB associated/VBN with/IN a/DT delay/NN in/IN PI/NN conversion/NN ,/, but/CC is/VBZ attributed/VBN to/TO the/DT hyperactivated/JJ state/NN of/IN the/DT human/NN beta-cell/NN population/NN ,/, which/WDT was/VBD recently/RB found/VBN to/TO be/VB responsible/JJ for/IN an/DT elevation/NN in/IN basal/JJ rates/NNS of/IN hormone/NN synthesis/NN ./.
P09551992A06
Photocinematography/NN confirmed/VBD that/IN macrophages/NNS first/RB phagocytosized/VBD and/CC then/RB lysed/VBD the/DT internalized/JJ mM-CSF/NN transfectant/NN cells/NNS ./.
P09557038A13
The/DT number/NN of/IN visits/NNS rose/VBD by/IN 10/CD %/SYM to/TO 7.8/CD (/( 3.7/CD )/) and/CC the/DT number/NN of/IN diagnostic/JJ laboratory/NN procedures/NNS by/IN 25/CD %/SYM to/TO 956/CD ./.
P09570690A01
To/TO study/VB peripheral/JJ nerves/NNS changes/NNS in/IN chronic/JJ alcoholism/NN and/CC in/IN malnutrition/NN ,/, we/PRP examined/VBD ultrastructurally/RB the/DT distal/JJ nerve/NN branches/NNS of/IN the/DT digits/NNS of/IN rats/NNS treated/VBN with/IN four/CD different/JJ dietary/JJ schemes/NNS ,/, as/IN follows/VBZ :/: controls/NNS (/( n/NN =/SYM 22/CD )/) ,/, fed/VBN standard/JJ rodent/NN diet/NN plus/CC water/NN ad/FW libitum/FW ;/: alcoholism/NN (/( n/NN =/SYM 12/CD )/) ,/, fed/VBN the/DT standard/JJ diet/NN and/CC 2-12/CD %/SYM ethanol/NN in/IN drinking/JJ water/NN ;/: malnutrition/NN (/( n/NN =/SYM 21/CD )/) ,/, fed/VBN with/IN corn/NN tortillas/NNS instead/RB of/IN standard/JJ diet/NN ;/: and/CC alcoholism/NN and/CC malnutrition/NN combined/VBN (/( n/NN =/SYM 22/CD )/) ./.
P09574886A06
In/IN distinguishing/NN between/IN children/NNS with/IN and/CC without/IN asthma/NN or/CC in/IN assessing/NN asthma/NN severity/NN ,/, serum/NN ECP/NN is/VBZ not/RB superior/JJ to/TO the/DT peripheral/JJ blood/NN eosinophil/NN count/NN ./.
P09583651A08
This/DT ratio/NN measure/NN was/VBD used/VBN to/TO estimate/VB the/DT projected/JJ unit/NN sales/NNS for/IN top-selling/JJ premium/NN brands/NNS in/IN 1993/CD and/CC was/VBD compared/VBN with/IN actual/JJ unit/NN sales/NNS for/IN the/DT same/JJ year/NN ./.
P09587995A06
An/DT algorithm/NN that/WDT uses/VBZ a/FW priori/FW knowledge/NN of/IN the/DT correlation/NN coefficient/NN function/NN was/VBD applied/VBN to/TO filter/VB the/DT obtained/JJ strain/NN data/NNS ./.
P09596808A05
Variable/JJ changes/NNS in/IN left/JJ ventricular/JJ dP/NN //SYM dt/NN max/NN occurred/VBD ,/, the/DT predominant/JJ response/NN being/VBG an/DT increase/NN ./.
P09601755A05
After/IN occupying/NN Bosnia/NNP and/CC Herzegovina/NNP ,/, Austro-Hungarian/JJ Monarchy/NN found/VBD only/RB "/`` Vakuf/NNP Hospital/NN "/'' and/CC Turkish/JJ Military/NN Hospital/NN ,/, in/IN 1866/CD ./.
P09606026A04
2-Amino-ethylphosphonic/JJ acid/NN (/( 2-AEPA/NN )/) increased/VBD the/DT overflow/NN of/IN [/( 3H/NN ]/) by/IN 46.8/CD +/-/SYM 10.9/CD %/SYM at/IN the/DT highest/JJS concentration/NN tested/VBN (/( 3/CD mmol/NN //SYM l/NN )/) ./.
P09610423A11
Two/CD women/NNS achieved/VBD a/DT second/JJ pregnancy/NN ./.
P09619422A03
To/TO test/VB this/DT hypothesis/NN ,/, adult/JJ females/NNS of/IN the/DT hymenopteran/NN ,/, Chrysis/NN ignita/NN were/VBD treated/VBN with/IN a/DT microtubule-assemble/NN inhibitor/NN ,/, colchicine/NN ./.
P09627921A02
The/DT author/NN spoke/VBD with/IN hospital/NN cleaners/NNS about/IN their/PRP$ jobs/NNS and/CC their/PRP$ health/NN ./.
P09637220A01
The/DT anthelmintic/JJ efficacy/NN of/IN benzimidazoles/NNS ,/, levamisole/NN ,/, rafoxanide/NN and/CC ivermectin/NN was/VBD evaluated/VBN on/IN an/DT institutional/JJ farm/NN in/IN Kenya/NNP using/VBG faecal/JJ egg/NN count/NN reduction/NN test/NN ,/, larval/JJ cultures/NNS and/CC a/DT controlled/JJ slaughter/NN trial/NN ./.
P09641359A11
In/IN conclusion/NN ,/, this/DT new/JJ fully/RB automated/JJ immunofluorimetric/JJ Lp/NN (/( a/RB )/) assay/NN enables/VBZ to/TO the/DT rapid/JJ ,/, accurate/JJ and/CC reliable/JJ determination/NN of/IN Lp/NN (/( a/NN )/) in/IN blood/NN samples/NNS ./.
P09650556A06
In/IN stratified/JJ analysis/NN ,/, significantly/RB higher/JJR risk/NN were/VBD found/VBN in/IN OC/NN use/NN before/IN 25/CD years/NNS old/JJ and/CC in/IN duration/NN of/IN use/NN less/RB than/IN one/CD year/NN among/IN post-menopausal/JJ subjects/NNS ./.
P09659302A07
These/DT results/NNS suggest/VBP that/IN healing/NN may/MD be/VBP an/DT effective/JJ adjunct/NN for/IN the/DT treatment/NN of/IN chronically/RB ill/JJ patients/NNS presenting/VBG in/IN general/JJ practice/NN ./.
P09663739A13
The/DT foreign/JJ body/NN reaction/NN could/MD be/VBP seen/VBN as/IN a/DT moderate/JJ accumulation/NN of/IN white/JJ blood/NN cells/NNS ./.
P09672958A09
Whether/IN this/DT change/NN is/VBZ sufficient/JJ to/TO increase/VB the/DT rates/NNS of/IN preventive/JJ services/NNS remains/VBZ to/TO be/VB documented/VBN ./.
P09681652A02
There/EX were/VBD significant/JJ alterations/NNS in/IN testicular/JJ sorbitol/NN dehydrogenase/NN ,/, lactic/JJ dehydrogenase/NN ,/, glucose-6-phosphate/NN dehydrogenase/NN ,/, gamma/NN glutamyl/NN transpeptidase/NN ;/: reduced/JJ quality/NN of/IN sperm/NN and/CC marked/JJ pathological/JJ changes/NNS in/IN the/DT testis/NN of/IN rats/NNS given/VBN aflatoxin/NN B1/NN alone/JJ ./.
P09685710A17
Our/PRP$ estimates/NNS for/IN the/DT rate/NN of/IN initiation/NN and/CC progression/NN mutation/NN rates/NNS show/VBP no/DT significant/JJ historical/JJ shifts/NNS and/CC are/VBP approximately/RB 1-2x10-7/CD events/NNS per/IN cell/NN division/NN ./.
P09698325A04
Several/JJ findings/NNS suggest/VBP that/IN this/DT decrease/NN in/IN AChR/NN clustering/NN is/VBZ likely/RB not/RB because/IN of/IN a/DT defect/NN in/IN agrin/NN signaling/NN through/IN the/DT MuSK/NN receptor/NN tyrosine/NN kinase/NN ./.
P09702434A10
CONCLUSIONS/NNS :/: The/DT results/NNS of/IN this/DT study/NN provide/VBP some/DT evidence/NN that/IN PCP/NN self-reported/JJ attitudes/NNS ,/, knowledge/NN ,/, and/CC practice/NN patterns/NNS in/IN delivering/NN diabetes/NN care/NN for/IN elderly/JJ patients/NNS in/IN the/DT office/NN setting/NN more/RB closely/RB reflect/VBP current/JJ recommended/JJ practice/NN than/IN reported/VBN in/IN previous/JJ physician/NN surveys/NNS ./.
P09711080A04
Human/NN peripheral/JJ blood/NN mononuclear/JJ cells/NNS (/( PBMC/NN )/) cultured/VBN in/IN medium/NN containing/VBG the/DT culture/NN supernatant/NN of/IN KB/NN //SYM IL-2/NN cells/NNS showed/VBD stronger/JJR cytotoxic/JJ activity/NN against/IN KB/NN cells/NNS than/IN the/DT control/NN ./.
P09719941A02
A/DT diagnosis/NN of/IN a/DT right/JJ renal/JJ tumor/NN was/VBD made/VBN after/IN several/JJ radiographic/JJ examinations/NNS and/CC right/JJ radical/JJ nephrectomy/NN was/VBD performed/VBN ./.
P09733110A01
Myoblasts/NNS and/CC myotubes/NNS are/VBP heterogeneous/JJ ,/, but/CC what/WP is/VBZ the/DT significance/NN of/IN this/DT heterogeneity/NN ?/.
P09737582A04
It/PRP has/VBZ also/RB been/VBN suggested/VBN that/IN variability/NN in/IN DC/NN expression/NN of/IN coreceptors/NNS for/IN M-tropic/JJ versus/CC T-tropic/JJ virus/NN could/MD explain/VBP the/DT restriction/NN in/IN the/DT transmitting/JJ virus/NN ./.
P09746482A03
The/DT mechanism/NN of/IN action/NN of/IN this/DT factor/NN does/VBZ not/RB involve/VBP inhibition/NN of/IN nitric/JJ oxide/NN (/( NO/NN )/) ,/, production/NN of/IN cyclooxygenase/NN metabolites/NNS ,/, 5-hydroxytryptamine/NN ,/, or/CC endothelin/NN ,/, or/CC the/DT activation/NN of/IN alpha-adrenoceptors/NNS but/CC is/VBZ a/DT Ca2+-dependent/JJ process/NN ,/, because/IN the/DT constriction/NN is/VBZ inhibited/VBN by/IN the/DT Ca2+-channel/NN blocker/NN amlodipine/NN ./.
P09755233A02
The/DT expression/NN of/IN TGF-alpha/NN ,/, EGFr/NN ,/, p53/NN nuclear/JJ protein/NN ,/, and/CC proliferation/NN rate/NN was/VBD correlated/VBN with/IN clinicopathological/JJ characteristics/NNS and/CC survival/NN after/IN partial/JJ liver/NN resection/NN ./.
P09759536A05
This/DT heterogeneity/NN in/IN the/DT chemoarchitecture/NN of/IN the/DT AOB/NN may/MD reflect/VBP a/DT fundamental/JJ organizational/JJ dichotomy/NN within/IN the/DT vomeronasal/JJ system/NN that/WDT corresponds/VBZ to/TO a/DT functional/JJ dichotomy/NN ./.
P09768675A02
Patients/NNS with/IN acromegaly/NN show/VBP an/DT exuberant/JJ GH/NN response/NN to/TO GHSs/NNS ,/, whereas/IN patients/NNS with/IN pituitary-dependent/JJ ACTH-secreting/JJ tumors/NNS show/VBP an/DT exaggerated/JJ rise/NN in/IN ACTH/NN and/CC cortisol/NN ./.
P09773286A02
Ninety-one/CD fewer/JJR positions/NNS were/VBD filled/VBN in/IN family/NN practice/NN residency/NN programs/NNS in/IN 1998/CD ,/, as/RB well/RB as/IN 21/CD fewer/JJR in/IN primary/JJ care/NN internal/JJ medicine/NN ,/, 12/CD fewer/JJR in/IN primary/JJ care/NN pediatrics/NNS ,/, and/CC 13/CD fewer/JJR in/IN internal/JJ medicine-pediatric/JJ programs/NNS ./.
P09782225A04
A/DT skin/NN patch/NN test/NN to/TO chromium/NN was/VBD negative/JJ ./.
P09791021A02
However/WRB ,/, recombinant/JJ G/NN protein/NN never/RB matches/VBZ intact/JJ viral/JJ particles/NNS for/IN immunogenicity/NN ./.
P09795353A07
The/DT magnitude/NN of/IN this/DT effect/NN increased/VBD with/IN increased/JJ dose/NN of/IN initial/JJ irradiation/NN ./.
P09804276A03
Two/CD weeks/NNS after/IN grafting/NN ,/, the/DT success/NN of/IN implantation/NN and/CC recovery/NN of/IN dopamine/NN function/NN were/VBD assessed/VBN by/IN tyrosine/NN hydroxylase/NN immunocytochemistry/NN (/( TH/NN )/) and/CC the/DT measurement/NN of/IN striatal/JJ dopamine/NN content/NN ./.
P09808591A09
Interleukin/NN (/( IL/NN )/) -10/CD but/CC not/RB IL-2/NN messenger/NN RNA/NN was/VBD expressed/VBN in/IN NBB/NN cells/NNS as/IN opposed/VBN to/TO BM/NN cells/NNS ./.
P09817083A08
This/DT metabolic/JJ reaction/NN was/VBD ,/, however/WRB ,/, insensitive/JJ to/TO a/DT specific/JJ anti-CYP2B1/NN sera/NNS that/WDT had/VBD been/VBN shown/VBN to/TO inhibit/VB enzyme/NN activities/NNS attributed/VBN only/RB to/TO CYP2BI/NN suggesting/VBG that/IN the/DT CYP2B2/NN pathway/NN is/VBZ predominant/JJ in/IN NP/NN metabolism/NN ./.
P09825423A09
The/DT associations/NNS with/IN occupational/JJ status/NN and/CC educational/JJ level/NN were/VBD steeper/JJR than/IN those/PRP with/IN neighbourhood/NN income/NN ./.
P09829643A10
However/WRB ,/, mechanisms/NNS other/JJ than/IN viral/JJ persistence/NN may/MD be/VBP more/RB important/JJ in/IN the/DT progression/NN of/IN IDCM/NN to/TO end-stage/NN heart/NN failure/NN in/IN this/DT age/NN group/NN ./.
P09844067A02
MATERIALS/NNS AND/CC METHODS/NNS :/: Helicobacter/NN heilmannii/NN infected/JJ and/CC uninfected/JJ mice/NNS were/VBD treated/VBN with/IN 150/CD microg/NN //SYM ml/NN N-methyl-N'-nitro-N-nitrosoguanidine/NN in/IN drinking/JJ water/NN for/IN either/CC 20/CD or/CC 38/CD weeks/NNS ./.
P09848430A05
OBJECTIVES/NNS :/: We/PRP aimed/VBD to/TO ascertain/VB the/DT views/NNS of/IN GPs/NNS on/IN service/NN provision/NN for/IN people/NNS with/IN epilepsy/NN in/IN primary/JJ care/NN and/CC on/IN specific/JJ initiatives/NNS to/TO improve/VB care/NN ./.
P09852884A04
Patients/NNS had/VBD a/DT left/JJ ventricular/JJ ejection/NN fraction/NN (/( LVEF/NN )/) of/IN >/SYM 25/CD %/SYM and/CC were/VBD not/RB amenable/JJ to/TO CABG/NN or/CC PTCA/NN ./.
P09857236A03
No/DT differences/NNS in/IN the/DT four/CD angiogenic/JJ factor/NN levels/NNS were/VBD found/VBN between/IN the/DT follicular/JJ and/CC luteal/JJ phases/NNS of/IN normal/JJ menstruation/NN ./.
P09862128A07
The/DT hydroxyl/NN hydrogens/NNS of/IN Tyr33/NN and/CC Ser78/NN are/VBP clearly/RB observed/VBN indicating/VBG that/IN these/DT residues/NNS are/VBP buried/VBN and/CC hydrogen/NN bonded/VBN ./.
P09871450A05
A/DT model/NN is/VBZ proposed/VBN suggesting/VBG that/IN NO/NN protects/VBZ SFO-neurons/NNS from/IN overexcitability/NN by/IN excitatory/JJ neurotransmitters/NNS ./.
P09884330A01
The/DT adapter/NN protein/NN SLP-76/NN is/VBZ expressed/VBN in/IN T/NN lymphocytes/NNS and/CC hematopoietic/JJ cells/NNS of/IN the/DT myeloid/NN lineage/NN ,/, and/CC is/VBZ known/VBN to/TO be/VB a/DT substrate/NN of/IN the/DT protein/NN tyrosine/NN kinases/NNS that/WDT are/VBP activated/VBN after/IN ligation/NN of/IN the/DT T-cell/NN antigen/NN receptor/NN ./.
P09888596A07
The/DT complete/JJ potential/NN of/IN the/DT system/NN will/MD become/VBP apparent/JJ as/IN new/JJ uses/NNS of/IN the/DT technique/NN are/VBP devised/VBN ,/, particularly/RB with/IN respect/NN to/TO human/NN adrenocortical/JJ cells/NNS and/CC to/TO genetically/RB modified/JJ cells/NNS ./.
P09920526A01
The/DT local/JJ distribution/NN of/IN laser/NN Doppler/NN flux/NN (/( mainly/RB thermoregulatory/JJ perfusion/NN )/) and/CC capillary/NN density/NN (/( nutritive/JJ circulation/NN )/) within/IN 25/CD ischemic/JJ leg/NN ulcers/NNS and/CC their/PRP$ adjacent/JJ skin/NN were/VBD investigated/VBN ./.
P09925216A03
Hemangiosarcomas/NNS were/VBD the/DT most/RBS frequent/JJ primary/JJ neoplasms/NNS ,/, followed/VBN by/IN chemodectomas/NNS ./.
P09933960A05
This/DT QSAR/NN represented/VBD the/DT amine/NN narcosis/NN mechanism/NN of/IN toxic/JJ action/NN ./.
P09988057A03
Valproate/NN is/VBZ also/RB being/VBG increasingly/RB used/VBN in/IN disorders/NNS with/IN aggressive/JJ or/CC agitated/JJ features/NNS ,/, such/JJ as/IN the/DT behavioral/JJ disorders/NNS of/IN dementia/NN ;/: yet/RB ,/, few/JJ studies/NNS have/VBP documented/VBN the/DT utility/NN of/IN valproate/NN in/IN geriatric/JJ patients/NNS ./.
P10022932A07
The/DT percentage/NN of/IN surface/NN area/NN operated/VBN upon/RP rather/RB than/IN the/DT amount/NN of/IN fat/NN removed/VBN was/VBD the/DT most/RBS important/JJ relevant/JJ factor/NN ./.
P10037316A05
RESULTS/NNS :/: The/DT average/JJ mean/NN teaching/JJ evaluation/NN score/NN was/VBD associated/VBN with/IN the/DT scores/NNS on/IN the/DT NBME/NN surgery/NN subject/NN examination/NN (/( P/NN =/SYM 0.0005/CD )/) ./.
P10065864A05
The/DT expression/NN of/IN both/CC mRNA/NN and/CC protein/NN appear/VBP to/TO be/VB decreased/VBN in/IN hyperplastic/JJ Leydig/NN cells/NNS ,/, whereas/IN in/IN the/DT Leydig/NN cell/NN adenomas/NNS studied/VBN ,/, large/JJ central/JJ areas/NNS of/IN the/DT adenoma/NN were/VBD devoid/JJ of/IN RLF/NN mRNA/NN and/CC protein/NN ./.
P10074558A03
These/DT results/NNS revealed/VBD that/IN the/DT HGV/NN genome/NN can/MD be/VBP classified/VBN into/IN at/IN least/JJS four/CD major/JJ genotypes/NNS ./.
P10084062A08
The/DT increase/NN in/IN low-frequency/NN power/NN was/VBD more/RB evident/JJ in/IN Group/NN C/NN patients/NNS than/IN in/IN the/DT other/JJ two/CD groups/NNS (/( p/NN </SYM 0.005/CD )/) ./.
P10097868A02
Manual/JJ dissection/NN can/MD compromise/VBP the/DT heart/NN and/CC reduce/VBP blood/NN pressure/NN ./.
P10101885A11
CONCLUSIONS/NNS :/: The/DT locoregional/JJ tumor/NN control/NN and/CC disease-free/JJ survival/NN rates/NNS for/IN this/DT group/NN of/IN 23/CD patients/NNS who/WP received/VBD combined/JJ therapy/NN with/IN external/JJ irradiation/NN and/CC radioactive/JJ gold/NN grain/NN implantation/NN (/( Au198/NN )/) were/VBD slightly/RB lower/JJR than/IN those/PRP obtained/VBN in/IN another/DT group/NN of/IN 104/CD patients/NNS treated/VBN at/IN our/PRP$ Service/NN of/IN Radiotherapeutic/JJ Oncology/NN with/IN radical/JJ external/JJ radiation/NN therapy/NN and/CC can/MD be/VBP ascribed/VBN mainly/RB to/TO poor/JJ patient/NN selection/NN and/CC inadequate/JJ radiation/NN dose/NN ./.
P10132072A05
MAIN/JJ MEASURES/NNS --/: Treatment/NN of/IN oesophagectomy/NN ,/, mortality/NN within/IN 30/CD days/NNS of/IN oesophagectomy/NN ,/, and/CC duration/NN of/IN survival/NN from/IN date/NN of/IN diagnosis/NN to/TO death/NN ,/, according/VBG to/TO patient/NN and/CC tumour/NN characteristics/NNS ./.
P10143699A07
The/DT patient-focused/JJ evaluation/NN of/IN large/JJ scale/NN systems/NNS and/CC the/DT hospital-focused/JJ evaluation/NN of/IN all/DT PACS/NN systems/NNS could/MD feasibly/RB be/VBP conducted/VBN as/IN contemporaneous/JJ experimental/JJ comparisons/NNS between/IN hospitals/NNS but/CC the/DT large/JJ research/NN costs/NNS implied/VBN by/IN such/PDT a/DT design/NN almost/RB certainly/RB mean/VBP that/IN non-contemporaneous/JJ ,/, non-experimental/JJ comparisons/NNS within/IN hospitals/NNS are/VBP more/RB realistic/JJ ./.
P10179363A02
While/IN the/DT frequency/NN of/IN hospital/NN mergers/NNS is/VBZ growing/VBG at/IN tremendous/JJ rates/NNS ,/, the/DT actual/JJ consolidation/NN of/IN services/NNS following/VBG mergers/NNS is/VBZ slow/JJ ./.
P10192456A04
However/WRB ,/, it/PRP is/VBZ not/RB clear/VBP if/IN all/DT haematological/JJ cells/NNS expressing/VBG the/DT mutant/JJ WASP/NN allele/NN are/VBP eliminated/VBN in/IN WAS/NN carriers/NNS ./.
P10201301A02
Additionally/RB ,/, we/PRP sought/VBD to/TO determine/VB which/DT findings/NNS had/VBD predictive/JJ value/NN for/IN surgical/JJ outcome/NN ./.
P10205776A02
METHODS/NNS :/: This/DT study/NN comprised/VBD 52/CD normal/JJ pregnant/JJ women/NNS ,/, including/VBG 11/CD in/IN the/DT first/JJ ,/, 19/CD in/IN the/DT second/JJ ,/, and/CC 22/CD in/IN the/DT third/JJ trimester/NN ,/, in/IN addition/NN to/TO 30/CD healthy/JJ ,/, fertile/JJ nonpregnant/JJ women/NNS of/IN comparable/JJ age/NN and/CC with/IN normal/JJ body/NN mass/NN index/NN (/( BMI/NN )/) ./.
P10210179A09
Despite/IN presenting/NN little/JJ or/CC no/DT sequence/NN similarity/NN ,/, an/DT analysis/NN of/IN the/DT beta-prism/NN reveals/VBZ a/DT canonical/JJ feature/NN repeatedly/RB present/JJ in/IN all/PDT such/DT structures/NNS ,/, which/WDT is/VBZ based/VBN on/IN six/CD largely/RB hydrophobic/JJ residues/NNS within/IN a/DT beta-hairpin/NN containing/VBG two/CD classic-type/NN beta-bulges/NNS ./.
P10218998A09
These/DT data/NNS indicate/VBP that/IN relaxin-induced/JJ uterine/JJ edema/NN and/CC growth/NN is/VBZ mediated/VBN by/IN ERs/NNS ./.
P10223220A14
Absolute/JJ eosinophilia/NN is/VBZ a/DT putative/JJ cause/NN of/IN EMF/NN ,/, a/DT finding/NN not/RB explained/VBN by/IN parasitism/NN ./.
P10231718A04
It/PRP appears/VBZ that/IN inclusion/NN of/IN HOTic/NN in/IN place/NN of/IN Tyr/NN to/TO introduce/VB conformational/JJ constrain/NN to/TO peptide/NN analogs/NNS can/MD cause/VBP or/CC augment/VBP a/DT tendency/NN towards/IN conformations/NNS with/IN increasing/JJ occlusion/NN of/IN N-terminal/JJ amino/JJ groups/NNS and/CC result/VBP in/IN the/DT need/NN for/IN altered/JJ coupling/JJ strategies/NNS for/IN completion/NN of/IN analog/NN synthesis/NN ./.
P10287713A02
The/DT authors/NNS discuss/VBP case-management/NN services/NNS as/IN they/PRP apply/VBP to/TO persons/NNS with/IN AIDS/NN and/CC AIDS-related/JJ complex/NN ./.
P10319780A05
Continuous/JJ model-simulated/JJ cardiac/JJ output/NN (/( MCO/NN )/) was/VBD computed/VBN from/IN radial/JJ or/CC femoral/JJ artery/NN pressure/NN ./.
P10325418A06
V81x/NN RSS/NN mediated/VBD recombination/NN at/IN rates/NNS significantly/RB higher/JJR than/IN another/DT VHRSS/NN ./.
P10334500A04
The/DT results/NNS showed/VBD that/IN the/DT regions/NNS with/IN metabolic/JJ change/NN are/VBP somewhat/RB different/JJ from/IN those/DT results/NNS studied/VBN with/IN microdialysis/NN and/CC the/DT Fos/NN immunohistochemistry/NN ./.
P10349838A01
We/PRP investigated/VBD the/DT effects/NNS of/IN nerve/NN growth/NN factor/NN (/( NGF/NN )/) and/CC NGF/NN withdrawal/NN on/IN expression/NN of/IN members/NNS of/IN the/DT bcl-2/NN family/NN of/IN genes/NNS and/CC caspase-3/NN in/IN PC12/NN cells/NNS ./.
P10354845A05
An/DT oncological/JJ resection/NN was/VBD performed/VBN in/IN 55/CD patients/NNS ./.
P10359345A03
One/CD day/NN later/RB the/DT epithelium/NN was/VBD removed/VBN from/IN the/DT central/JJ cornea/NN and/CC a/DT standardized/JJ inoculum/NN of/IN Candida/NN albicans/NN blastoconidia/NN was/VBD placed/VBN on/IN the/DT corneal/JJ surface/NN and/CC covered/VBN with/IN a/DT contact/NN lens/NN ./.
P10363585A04
The/DT IC50/NN of/IN SW480/NN //SYM dThdPase/NN was/VBD lower/JJR than/IN that/PRP of/IN SW480/NN or/CC SW480/NN //SYM V1/NN ,/, although/IN the/DT differences/NNS were/VBD not/RB statistically/RB significant/JJ ./.
P10367847A09
The/DT ultrafiltrate/NN contained/VBD 100/CD %/SYM fPSA/NN in/IN high-flux/NN membranes/NNS and/CC no/DT fPSA/NN in/IN low-flux/NN membranes/NNS ./.
P10372401A09
The/DT human/NN h-APJ/NN receptor/NN is/VBZ a/DT co-receptor/NN for/IN entry/NN of/IN the/DT HIV/NN into/IN T/NN cells/NNS ,/, a/DT property/NN associated/VBD only/RB with/IN CXC/NN chemokine/NN receptors/NNS in/IN the/DT lymphocyte/NN population/NN ./.
P10380904A03
Anti-inflammatory/JJ cytokines/NNS ,/, IL-10/NN ,/, and/CC transforming/JJ growth/NN factor/NN (/( TGF/NN )/) -beta/NN sequentially/RB inhibited/VBD LPS-/NN and/CC cytokine-induced/JJ microglial/JJ cell/NN NF-kappaB/NN activation/NN ,/, RANTES/NN mRNA/NN expression/NN ,/, and/CC protein/NN release/NN ./.
P10389993A03
All/PDT the/DT 158/CD women/NNS (/( 159/CD tumours/NNS )/) were/VBD treated/VBN with/IN breast/NN conserving/JJ surgery/NN and/CC postoperative/JJ radiotherapy/NN ./.
P10394292A05
It/PRP is/VBZ necessary/JJ to/TO make/VB a/DT strict/JJ government/NN surveillance/NN over/IN the/DT design/NN ,/, testing/NN of/IN these/DT agents/NNS ./.
P10407139A05
These/PRP include/VBP its/PRP$ role/NN in/IN membrane/NN fusion/NN ,/, microtubule/NN bundling/NN ,/, phosphotransferase/NN activity/NN ,/, nuclear/JJ RNA/NN export/NN ,/, DNA/NN replication/NN and/CC DNA/NN repair/NN ./.
P10411582A08
The/DT selective/JJ inhibitor/NN of/IN MAPK/NN ,/, PD98059/NN ,/, diminished/JJ PAH/NN uptake/NN at/IN 5/CD x/SYM 10/CD (/( -5/CD )/) M/NN by/IN 23.2/CD +/-/SYM 6.8/CD %/SYM and/CC at/IN 10/CD (/( -4/CD )/) M/NN by/IN 18.3/CD +/-/SYM 5.2/CD %/SYM ./.
P10420138A06
Atopic/JJ skin/NN had/VBD significantly/RB reduced/JJ trypsin/NN activity/NN ,/, increased/JJ acid/NN phosphatase/NN and/CC no/DT change/NN in/IN the/DT activities/NNS of/IN three/CD other/JJ studied/JJ enzymes/NNS ./.
P10428948A01
The/DT integrin/NN alpha6beta4/NN is/VBZ an/DT essential/JJ component/NN of/IN hemidesmosomes/NNS but/CC it/PRP also/RB plays/VBZ a/DT dynamic/JJ role/NN in/IN invasive/JJ carcinoma/NN cells/NNS ./.
P10433418A10
With/IN regard/NN to/TO the/DT force/NN magnitudes/NNS and/CC their/PRP$ directions/NNS ,/, sheep/NN seem/VBP to/TO be/VB a/DT good/JJ model/NN for/IN testing/NN human/NN implant/NN at/IN the/DT proximal/JJ femur/NN ./.
P10442113A04
Thermophilic/JJ campylobacters/NNS were/VBD identified/VBN and/CC characterised/VBN using/VBG standard/JJ physical/JJ and/CC biochemical/JJ tests/NNS ./.
P10446389A07
We/PRP hypothesise/VBP that/IN in/IN the/DT presence/NN of/IN an/DT electron/NN carrier/NN the/DT electron/NN donors/NNS active/JJ in/IN the/DT reduction/NN of/IN CTC/NN are/VBP located/VBN in/IN the/DT intracellular/JJ compartment/NN ,/, as/RB well/RB as/IN in/IN plasma/NN membranes/NNS ./.
P10455107A01
Malonyl-CoA/NN decarboxylase/NN (/( MCD/NN )/) catalyzes/VBZ the/DT proton-consuming/JJ conversion/NN of/IN malonyl-CoA/NN to/TO acetyl-CoA/NN and/CC CO/NN (/( 2/CD )/) ./.
P10459558A06
Body/NN fat/NN distribution/NN was/VBD evaluated/VBN by/IN the/DT waist/NN circumference/NN and/CC the/DT waist/NN to/TO hip/NN ratio/NN (/( WHR/NN )/) ./.
P10463853A07
The/DT meningeal/JJ markers/NNS cystatin-C/NN and/CC beta-trace/NN protein/NN as/RB well/RB as/IN total/JJ protein/NN did/VBD not/RB differ/VBP in/IN TLE/NN and/CC TN/NN ./.
P10472638A06
However/WRB ,/, things/NNS are/VBP moving/VBG ,/, and/CC the/DT general/JJ tendency/NN now/RB is/VBZ to/TO reduce/VB the/DT total/JJ number/NN of/IN beds/NNS in/IN the/DT Swiss/JJ hospitals/NNS ,/, and/CC to/TO open/VB some/DT specialised/JJ wards/NNS under/IN the/DT direct/JJ supervision/NN of/IN specialists/NNS ,/, including/VBG pneumologists/NNS ./.
P10481442A02
Magnetic/JJ resonance/NN imaging/NN revealed/VBD dilated/JJ perimedullary/JJ veins/NNS around/IN the/DT spinal/JJ cord/NN at/IN C-1/NN and/CC C-2/NN levels/NNS ,/, as/RB well/RB as/IN high/JJ intensity/NN signals/NNS in/IN the/DT spinal/JJ cord/NN on/IN T2-weighted/JJ images/NNS ./.
P10489996A09
However/WRB ,/, these/DT data/NNS do/VBP not/RB suggest/VBP an/DT independent/JJ effect/NN of/IN weight/NN cycling/NN on/IN risk/NN of/IN hypertension/NN ./.
P10498804A06
On/IN the/DT other/JJ hand/NN ,/, it/PRP stimulates/VBZ the/DT metabolism/NN of/IN phosphatidylinositol/NN ,/, thus/RB causing/VBG accumulation/NN of/IN diacylglycerol/NN and/CC inositol-1/NN ,/, 4/CD ,/, 5-triphosphate/NN ,/, which/WDT in/IN turn/NN activate/VBP protein/NN kinase/NN C/NN ./.
P10508084A05
Plants/NNS in/IN this/DT family/NN are/VBP considered/VBN to/TO be/VB promiscuous/JJ hosts/NNS because/IN several/JJ species/NNS are/VBP effectively/RB nodulated/VBN by/IN most/DT isolated/JJ strains/NNS of/IN Frankia/NN in/IN the/DT greenhouse/NN ./.
P10512254A10
Stress/NN testing/NN alone/JJ was/VBD associated/VBN with/IN reduced/JJ long-term/NN mortality/NN in/IN patients/NNS undergoing/VBG infrainguinal/JJ revascularization/NN ./.
P10521060A02
Its/PRP$ cardiotoxic/JJ potential/NN is/VBZ known/VBN ,/, but/CC considered/JJ uncommon/JJ and/CC usually/RB not/RB life/NN threatening/NN ,/, although/IN some/DT cases/NNS of/IN severe/JJ cardiotoxicity/NN related/VBN to/TO 5-FU/NN have/VBP been/VBN reported/VBN ./.
P10525492A09
The/DT strong/JJ parallelism/NN to/TO the/DT experimental/JJ data/NNS obtained/VBN in/IN the/DT stroke-prone/JJ animal/NN model/NN provides/VBZ assurance/NN for/IN the/DT relevance/NN of/IN our/PRP$ observation/NN ./.
P10534322A02
Radiolabeled/JJ tirofiban/NN was/VBD synthesized/VBN with/IN either/CC (/( 3/CD )/) H-label/NN incorporated/VBN into/IN the/DT phenyl/NN ring/NN of/IN the/DT tyrosinyl/NN residue/NN or/CC (/( 14/CD )/) C-label/NN in/IN the/DT butane/NN sulfonyl/NN moiety/NN ./.
P10540061A01
A/DT survey/NN of/IN 35/CD hospitals/NNS in/IN the/DT United/JJ Kingdom/NN has/VBZ uncovered/VBN a/DT wide/JJ variety/NN of/IN syringe/NN drug/NN labels/NNS ./.
P10544963A10
The/DT remaining/JJ 81/CD %/SYM of/IN DNA-protein/NN crosslinks/NNS appear/VBP to/TO be/VB oxidatively/RB crosslinked/VBN out/IN of/IN which/WDT about/RB 45/CD %/SYM appear/VBP to/TO be/VB through/IN sulfhydryl/NN groups/NNS and/CC another/DT 36/CD %/SYM appear/VBP to/TO be/VB through/IN non-sulfhydryl/NN groups/NNS ./.
P10558291A03
The/DT prediction/NN for/IN physician/NN executives/NNS ?/.
P10562976A10
The/DT increased/JJ risk/NN attributable/JJ to/TO advanced/JJ donor/NN age/NN was/VBD also/RB supported/VBN by/IN the/DT UNOS/NN data/NNS ./.
P10571753A07
Many/JJ questions/NNS about/IN partial/JJ liquid/NN ventilation/NN remain/VBP unanswered/VBN particularly/RB with/IN regard/NN to/TO the/DT dose/NN of/IN PFC/NN required/VBN ,/, its/PRP$ ideal/JJ method/NN of/IN administration/NN and/CC the/DT long-term/NN effects/NNS ./.
P10585420A03
Amino/JJ acid/NN sequencing/NN allowed/VBD the/DT cloning/NN of/IN a/DT full-length/NN cDNA/NN encoding/VBG the/DT glucosyltransferase/NN ./.
P10589804A08
Our/PRP$ results/NNS show/VBP that/IN this/DT single/JJ primer/NN pair/NN AA1416/NN can/MD be/VBP used/VBN in/IN PCR/NN to/TO identify/VB A./NN actinomycetemcomitans/NN isolates/NNS and/CC differentiate/VBP them/PRP from/IN other/JJ periodontal/JJ bacteria/NN ./.
P10598863A02
We/PRP have/VBP developed/VBN an/DT electroporation/NN technique/NN that/IN efficiently/RB transfers/VBZ RNA/NN ,/, DNA/NN and/CC other/JJ large/JJ membrane-impermeant/JJ molecules/NNS into/IN adherent/JJ hippocampal/JJ neurons/NNS ./.
P10602912A07
When/WRB viewed/VBN through/IN the/DT necessarily/RB coarse/JJ filter/NN of/IN ecological/JJ data/NNS acquisition/NN ,/, and/CC regardless/RB of/IN their/PRP$ detailed/JJ topology/NN ,/, these/DT attractors/NNS are/VBP often/RB indistinguishable/JJ from/IN multi-annual/JJ cycles/NNS ./.
P10607457A08
The/DT precipitated/JJ CaF/NN (/( 2/CD )/) may/MD act/VBP as/IN a/DT reservoir/NN for/IN the/DT subsequent/JJ fluoridation/NN of/IN the/DT mineral/NN and/CC may/MD inhibit/VBP bacterial/JJ action/NN in/IN the/DT mouth/NN ./.
P10622204A02
The/DT number/NN of/IN eligible/JJ subjects/NNS was/VBD 1673/CD ./.
P10626851A07
Part/NN 2/CD :/: Twenty-two/CD SD/NN and/CC 17/CD TS/NN rats/NNS (/( day/NN 0/CD )/) were/VBD injected/VBN with/IN either/CC capsaicin/NN or/CC vehicle/NN ./.
P10631090A05
In/IN addition/NN ,/, DEPC/NN treatment/NN abolished/VBD the/DT ability/NN of/IN PDK/NN to/TO trans-phosphorylate/VB and/CC inactivate/VB PDC/NN ./.
P10644761A02
BCP/NN showed/VBD a/DT thioredoxin-dependent/JJ thiol/NN peroxidase/NN activity/NN ./.
P10653619A02
The/DT EEG/NN activity/NN was/VBD recorded/VBN simultaneously/RB from/IN intracranial/JJ electrodes/NNS inserted/VBN through/IN the/DT foramen/NN ovale/NN (/( FO/NN )/) and/CC scalp/NN electrodes/NNS ./.
P10662748A03
The/DT present/JJ study/NN examined/VBD arrhythmic/JJ risk/NN in/IN patients/NNS with/IN overt/JJ and/CC concealed/JJ forms/NNS of/IN the/DT disease/NN and/CC the/DT effectiveness/NN of/IN sodium/NN channel/NN blockers/NNS to/TO unmask/VB the/DT syndrome/NN and/CC ,/, thus/RB ,/, identify/VB patients/NNS at/IN risk/NN ./.
P10667500A09
In/IN addition/NN ,/, the/DT personnel/NN were/VBD instructed/VBN to/TO be/VB more/RB vigilant/JJ and/CC specific/JJ measures/NNS aimed/VBN at/IN reducing/NN the/DT accidental/JJ removal/NN were/VBD introduced/VBN ./.
P10671843A06
No/DT in-line/NN temperatures/NNS reached/VBD 40/CD degrees/NNS C/CD ./.
P10680483A07
RESULT/NN :/: Totally/RB 151/CD cases/NNS of/IN unilateral/JJ and/CC bilateral/JJ cleft/NN palate/NN have/VBP been/VBN repaired/VBN with/IN this/DT method/NN ./.
P10689116A02
These/DT algorithms/NNS consist/VBP of/IN blocks/NNS of/IN 8/CD amino/JJ acids/NNS containing/VBG an/DT amino/JJ acid/NN anchor/NN (/( Tyr/NN ,/, Phe/NN ,/, Trp/NN ,/, Leu/NN ,/, Ile/NN ,/, or/CC Val/NN )/) at/IN position/NN i/NN and/CC different/JJ amino/JJ acid/NN combinations/NNS at/IN positions/NNS i+2/NN to/TO i+7/NN depending/VBG on/IN the/DT class/NN II/CD molecule/NN ./.
P10693940A07
Together/RB ,/, these/DT results/NNS indicate/VBP that/IN pooled/JJ samples/NNS of/IN amperometric/JJ spike/NN characteristics/NNS can/MD give/VBP results/NNS that/WDT may/MD confound/VBP the/DT interpretation/NN of/IN amperometric/JJ data/NNS ./.
P10702737A04
The/DT animals/NNS were/VBD divided/VBN into/IN three/CD groups/NNS of/IN 20/CD rats/NNS each/PRP and/CC received/VBD either/CC normal/JJ saline/NN ,/, heparin/NN 100/CD U/NN //SYM kg/NN body/NN weight/NN ,/, or/CC rt-PA/NN 3.5/CD mg/NN //SYM kg/NN body/NN weight/NN intravenously/RB ./.
P10706876A11
Finally/RB ,/, our/PRP$ results/NNS suggest/VBP that/IN a/DT cellular/JJ model/NN with/IN doxycycline-inducible/JJ IkappaBalpha/NN (/( 32/CD //SYM 36A/NN )/) may/MD be/VBP useful/JJ in/IN the/DT identification/NN of/IN genuine/JJ NF-kappaB/NN target/NN genes/NNS in/IN EBV-infected/JJ B/NN cells/NNS ./.
P10715614A03
This/DT discussion/NN features/VBZ several/JJ examples/NNS of/IN regulations/NNS and/CC judicial/JJ decisions/NNS that/WDT have/VBP begun/VBN to/TO recognize/VB hormetic/JJ effects/NNS ./.
P10724325A01
The/DT authors/NNS of/IN this/DT article/NN ,/, who/WP were/VBD the/DT members/NNS and/CC staff/NN of/IN a/DT research/NN panel/NN formed/VBN by/IN the/DT AAMC/NN as/IN part/NN of/IN its/PRP$ mission-based/JJ management/NN initiative/NN ,/, reflect/VBP on/IN the/DT growing/JJ interest/NN in/IN quantitative/JJ information/NN in/IN the/DT management/NN of/IN the/DT research/NN mission/NN of/IN medical/JJ schools/NNS ./.
P10732943A04
Full-scan/NN mass/NN spectra/NNS of/IN drugs/NNS examined/VBN by/IN means/NNS of/IN APCI/NN with/IN collision-induced/JJ dissociation/NN showed/VBD protonated/JJ molecular/JJ ions/NNS and/CC fragments/NNS typical/JJ for/IN particular/JJ drugs/NNS ./.
P10737485A08
Median/JJ time/NN from/IN the/DT diagnosis/NN to/TO orchiectomy/NN was/VBD 23/CD months/NNS ./.
P10746726A05
We/PRP interrupted/VBD motion/NN viewing/NN with/IN electrical/JJ microstimulation/NN of/IN the/DT frontal/JJ eye/NN field/NN and/CC analysed/VBD the/DT resulting/JJ ,/, evoked/JJ eye/NN movements/NNS for/IN evidence/NN of/IN ongoing/JJ activity/NN associated/VBN with/IN the/DT oculomotor/NN response/NN ./.
P10755366A02
Therefore/RB ,/, searching/NN for/IN sensitive/JJ indicators/NNS of/IN nephrotoxic/JJ action/NN is/VBZ well/RB worth/IN the/DT effort/NN ./.
P10764021A01
Gastro-oesophageal/JJ reflux/NN disease/NN (/( GORD/NN )/) occurs/VBZ more/RB frequently/RB in/IN Europe/NNP and/CC North/NN America/NNP than/IN in/IN Asia/NNP but/CC its/PRP$ prevalence/NN is/VBZ now/RB increasing/VBG in/IN many/DT Asian/JJ countries/NNS ./.
P10772578A04
The/DT recombinant/JJ protein/NN expressed/VBN from/IN the/DT plasmid/NN has/VBZ been/VBN used/VBN to/TO develop/VB an/DT indirect/JJ ELISA/NN for/IN IgM/NN antibody/NN detection/NN ./.
P10776948A08
Four/CD (/( 27/CD %/SYM )/) of/IN 15/CD patients/NNS with/IN chronic/JJ HCV/NN ,/, receiving/VBG treatment/NN with/IN interferon/NN ,/, were/VBD coinfected/VBN by/IN HGV/NN and/CC became/VBD HGV-RNA/NN negative/JJ during/IN therapy/NN ./.
P10781656A04
RESULTS/NNS :/: 14/CD of/IN the/DT 26/CD patients/NNS (/( 54/CD %/SYM )/) showed/VBD a/DT significant/JJ vasodilation/NN (/( i.e./IN a/DT decrease/NN of/IN R/NN (/( fa/NN )/) of/IN more/RB than/IN 10/CD %/SYM )/) ./.
P10786642A01
Dopamine/NN (/( DA/NN )/) release/NN (/( r/NN )/) from/IN the/DT carotid/JJ body/NN (/( CB/NN )/) is/VBZ thought/VBN to/TO be/VB modulated/VBN by/IN feedback/NN inhibition/NN mediated/VBN by/IN DA/NN D2/NN autoreceptors/NNS ./.
P10796081A15
The/DT length/NN of/IN time/NN taken/VBN for/IN the/DT synthetic/JJ material/NN to/TO be/VB absorbed/VBN is/VBZ of/IN concern/NN ./.
P10805219A06
The/DT health/NN control/NN patients/NNS had/VBD levels/NNS of/IN 25/CD pg/NN //SYM ml/NN (/( 95/CD percent/NN confidence/NN interval/NN ,/, 10-35/CD )/) ./.
P10809682A10
Analysis/NN of/IN a/DT codY/NN mutant/NN bearing/VBG a/DT hag-lacZ/NN reporter/NN revealed/VBD that/IN flagellin/NN expression/NN is/VBZ released/VBN from/IN nutritional/JJ repression/NN in/IN this/DT strain/NN ,/, whereas/IN mutations/NNS in/IN the/DT transition/NN state/NN preventor/NN genes/NNS abrB/NN ,/, hpr/NN ,/, and/CC sinR/NN failed/VBD to/TO elicit/VB a/DT similar/JJ effect/NN during/IN growth/NN in/IN complex/JJ medium/NN ./.
P10818427A08
No/DT treatment/NN to/TO restore/VB fertility/NN in/IN patients/NNS with/IN premature/JJ ovarian/JJ failure/NN has/VBZ proved/VBN to/TO be/VB safe/JJ and/CC effective/JJ in/IN prospective/JJ controlled/JJ studies/NNS ./.
P10827197A08
Mutations/NNS at/IN residues/NNS K68A/NN and/CC K309A/NN reduced/VBD the/DT potency/NN of/IN ATP/NN by/IN >/SYM 1400-fold/NN and/CC prolonged/VBD the/DT time/NN course/NN of/IN the/DT P2X/NN (/( 1/CD )/) receptor/NN current/NN but/CC had/VBD no/DT effect/NN on/IN suramin/NN antagonism/NN ./.
P10840302A04
METHODS/NNS :/: We/PRP removed/VBD 56/CD sessile/JJ colorectal/JJ polyps/NNS 2/CD cm/NN or/CC greater/JJR in/IN diameter/NN in/IN 56/CD patients/NNS by/IN using/NN an/DT endoscopic/JJ submucosal/JJ saline/NN injection/NN technique/NN ./.
P10844817A07
Kappa/NN showed/VBD values/NNS of/IN 0.85/CD and/CC 0.78/CD ,/, which/WDT can/MD be/VBP described/VBN as/IN excellent/JJ ./.
P10853977A04
RESULTS/NNS :/: Seventy-three/CD subjects/NNS (/( 54/CD %/SYM )/) achieved/VBD suppression/NN of/IN plasma/NN HIV-1/NN RNA/NN to/TO levels/NNS below/IN 400/CD copies/NNS //SYM ml/NN during/IN the/DT observation/NN period/NN ,/, 31/CD individuals/NNS (/( 23/CD %/SYM )/) had/VBD detectable/JJ plasma/NN HIV-1/NN RNA/NN below/IN 10,000/CD copies/NNS //SYM ml/NN and/CC 31/CD subjects/NNS (/( 23/CD %/SYM )/) had/VBD virological/JJ failures/NNS with/IN viral/JJ loads/NNS above/IN 10,000/CD copies/NNS //SYM mL/NN ./.
P10858386A06
We/PRP found/VBD two/CD significant/JJ predictive/JJ factors/NNS of/IN N2/NN disease/NN on/IN the/DT basis/NN of/IN multivariable/JJ analysis/NN :/: maximum/NN tumor/NN dimension/NN and/CC serum/NN carcinoembryonic/JJ antigen/NN (/( CEA/NN )/) concentrations/NNS ./.
P10867250A05
On/IN the/DT basis/NN of/IN the/DT calculated/JJ binding/JJ capacity/NN ,/, the/DT complex/NN was/VBD prepared/VBN ,/, dried/VBN and/CC milled/VBN ./.
P10875558A05
Patients/NNS with/IN suspected/JJ sleep/NN disorders/NNS underwent/VBD physical/JJ and/CC psychiatric/JJ assessment/NN as/RB well/RB as/IN sleep/NN studies/NNS ./.
P10880117A04
Ethylene/NN oxide/NN and/CC Sterrad/NN (/( R/NN )/) sterilization/NN techniques/NNS did/VBD not/RB modify/VBP the/DT corrosion/NN resistance/NN of/IN electropolished/JJ NiTi/NN ,/, whereas/IN a/DT steam/NN autoclave/NN and/CC ,/, to/TO a/DT lesser/JJR extent/NN ,/, peracetic/JJ acid/NN sterilization/NN produced/VBD scattered/JJ breakdown/NN potential/NN ./.
P10884478A10
Brain/NN mRNA/NN levels/NNS of/IN the/DT other/JJ proinflammatory/JJ cytokines/NNS ,/, including/VBG tumor/NN necrosis/NN factor-alpha/NN ,/, IL-1beta/NN ,/, and/CC IL-1/NN receptor/NN antagonist/NN ,/, were/VBD 50/CD %/SYM lower/JJR in/IN IL-6-deficient/JJ ischemic/JJ animals/NNS than/IN in/IN normal/JJ animals/NNS ./.
P10888979A10
Most/PRP of/IN these/DT events/NNS occurred/VBD after/IN initiation/NN of/IN PI/NN therapy/NN ./.
P10898533A03
Both/DT inhibitors/NNS reduced/VBD and/CC then/RB abolished/VBD uterine/JJ force/NN ,/, irrespective/RB of/IN how/WRB it/PRP was/VBD produced/VBN ;/: this/PRP was/VBD the/DT case/NN for/IN both/CC human/NN and/CC rat/NN myometrium/NN ,/, and/CC pregnant/JJ and/CC non-pregnant/JJ tissue/NN ./.
P10902715A11
Thus/RB ,/, it/PRP was/VBD concluded/VBN that/IN Ncc-tmp1A/NN is/VBZ not/RB required/VBN for/IN compatibility/NN with/IN its/PRP$ own/JJ cytoplasm/NN ./.
P10907554A13
In/IN yeast/NN ,/, this/PRP is/VBZ catalysed/VBN by/IN an/DT NADPH-linked/JJ transmembrane/JJ reductase/NN ,/, which/WDT has/VBZ homology/NN with/IN the/DT NADPH/NN oxidase/NN of/IN neutrophils/NNS ./.
P10912630A04
The/DT determination/NN of/IN the/DT levels/NNS of/IN adenosine/NN deaminase/NN (/( ADA/NN )/) in/IN pleural/JJ fluid/NN offers/VBZ high/JJ performance/NN in/IN its/PRP$ discriminating/JJ capacity/NN to/TO identify/VB TP/NN (/( sensitivity/NN 87/CD to/TO 100/CD %/SYM ,/, specificity/NN 81/CD to/TO 97/CD %/SYM )/) ./.
P10921701A03
METHODS/NNS :/: One/CD hundred/CD forty/CD patients/NNS were/VBD randomly/RB divided/VBN into/IN two/CD groups/NNS :/: an/DT amiodarone/NN group/NN (/( n/NN =/SYM 74/CD )/) receiving/VBG intravenous/JJ amiadarone/NN in/IN a/DT loading/JJ dose/NN of/IN 150/CD mg/NN and/CC maintenance/NN dose/NN of/IN 0.4/CD mg/NN x/SYM kg/NN (/( -1/CD )/) x/SYM h/NN (/( -1/CD )/) for/IN 3/CD days/NNS before/IN and/CC 5/CD days/NNS after/IN operation/NN and/CC a/DT control/NN group/NN (/( n/NN =/SYM 76/CD )/) receiving/VBG matching/JJ infusions/NNS of/IN 5/CD %/SYM glucose/NN solution/NN ./.
P10926291A07
Iron/NN staining/NN and/CC CytOx/NN activity/NN of/IN 20/CD brain/NN structures/NNS were/VBD mapped/VBN histochemically/RB in/IN 25/CD rats/NNS from/IN each/DT group/NN ./.
P10930832A10
Although/IN the/DT contributions/NNS to/TO bond/NN valency/NN or/CC bonding/JJ energy/NN of/IN such/DT interactions/NNS may/MD not/RB be/VBP great/JJ ,/, their/PRP$ effect/NN on/IN geometry/NN can/MD be/VBP considerable/JJ ;/: they/PRP can/MD ,/, for/IN example/NN ,/, cause/VBP much/RB larger/JJR distortions/NNS of/IN tetrahedral/JJ Zn/NN complexes/NNS than/IN indicated/VBN above/RB ./.
P10939481A11
Cerales-D/NN proves/VBZ to/TO be/VB an/DT efficient/JJ tool/NN for/IN CT-guided/JJ PLDD/NN on/IN non-sequestered/JJ herniated/JJ lumbar/JJ discs/NNS ./.
P10953053A04
The/DT effect/NN of/IN retigabine/NN was/VBD associated/VBN with/IN a/DT slowing/NN of/IN M-like/JJ tail/NN current/NN deactivation/NN in/IN these/DT cells/NNS ./.
P10958337A08
LKATP/NN was/VBD sensitive/JJ to/TO intracellular/JJ Ca2+/NN but/CC insensitive/JJ to/TO iberiotoxin/NN ./.
P10966810A03
The/DT membrane/NN fragments/NNS were/VBD obtained/VBN by/IN a/DT short/JJ treatment/NN of/IN thylakoid/NN membranes/NNS with/IN the/DT mild/JJ detergent/NN n-dodecyl-alpha/NN ,/, d-maltoside/NN and/CC are/VBP thought/VBN to/TO reflect/VB the/DT grana/NN membranes/NNS in/IN a/DT native/JJ state/NN ./.
P10971038A08
IIX/NN fibers/NNS were/VBD not/RB identified/VBN until/IN P40/NN in/IN the/DT TA/NN ./.
P10980289A07
These/DT results/NNS demonstrate/VBP a/DT shelf-life/NN of/IN 5/CD months/NNS for/IN S./NN carpocapsae/NN at/IN 25/CD degrees/NNS C/CD and/CC 9/CD months/NNS at/IN 5/CD degrees/NNS C/CD in/IN WG/NN with/IN over/RB 90/CD %/SYM IJ/NN survival/NN ./.
P10993945A02
These/DT viruses/NNS lack/VBP about/RB 25/CD kbp/NN of/IN sequence/NN information/NN and/CC are/VBP no/RB longer/RB infectious/JJ for/IN insects/NNS ./.
P10998311A04
It/PRP is/VBZ shown/VBN that/IN D/NN (/( e/NN )/) increases/VBZ (/( up/IN to/TO the/DT relative/JJ adsorption/NN equal/JJ to/TO approximately/RB 0.6/CD )/) with/IN rise/NN in/IN the/DT magnitude/NN of/IN the/DT enthalpy/NN of/IN immersion/NN of/IN carbons/NNS in/IN water/NN ./.
P11012475A01
BACKGROUND/NN :/: Intestinal/JJ type/NN metaplasia/NN plays/VBZ a/DT role/NN in/IN intestinal/JJ type/NN gastric/JJ carcinoma/NN development/NN ./.
P11016868A03
Using/VBG [/( 3H/NN ]/) -inulin/NN we/PRP measured/VBD the/DT Glomerular/JJ Inulin/NN Space/NN (/( GIS/NN )/) ,/, (/( that/WDT reflects/VBZ mainly/RB glomerular/JJ intracapillary/JJ volume/NN )/) ,/, in/IN the/DT presence/NN of/IN ATP/NN and/CC its/PRP$ analogues/NNS e.g./IN 2-methylthio-ATP/NN (/( P2Y-receptor/NN agonist/NN )/) and/CC beta/NN ,/, gamma-methylene-ATP/NN (/( P2X-receptor/NN agonist/NN )/) ./.
P11020986A10
The/DT respiratory/JJ failure/NN was/VBD dramatically/RB improved/VBN ,/, resulting/VBG in/IN disappearance/NN of/IN the/DT abnormal/JJ lymphoid/JJ cells/NNS from/IN the/DT bone/NN marrow/NN ./.
P11030627A04
The/DT mechanism/NN linking/VBG the/DT action/NN of/IN SYT/NN //SYM p300/NN complexes/NNS to/TO adhesion/NN function/NN is/VBZ ,/, at/IN least/JJS in/IN part/NN ,/, transcription/NN activation-independent/JJ and/CC results/VBZ in/IN proper/JJ activation/NN of/IN beta1/NN integrin/NN ,/, a/DT major/JJ adhesion/NN receptor/NN ./.
P11039598A05
These/DT immunoglobulin/NN isotypes/NNS and/CC subisotypes/NNS were/VBD found/VBN in/IN lymphocytes/NNS and/CC plasma/NN cells/NNS ./.
P11054633A02
The/DT drug/NN is/VBZ widely/RB used/VBN to/TO improve/VB symptoms/NNS of/IN benign/JJ prostatic/JJ hyperplasia/NN in/IN man/NN ./.
P11059298A07
This/DT question/NN is/VBZ currently/RB under/IN investigation/NN in/IN two/CD global/JJ phase/NN III/CD trials/NNS ,/, namely/RB the/DT SILCAAT/NN and/CC the/DT ESPRIT/NN studies/NNS ./.
P11074216A01
In/IN a/DT prospective/JJ study/NN of/IN 98/CD persons/NNS >/SYM or/CC =/SYM 65/CD years/NNS of/IN age/NN with/IN chronic/JJ renal/JJ insufficiency/NN (/( serum/NN creatinine/NN >/SYM 3.0/CD mg/NN //SYM dl/NN )/) for/IN >/SYM 1/CD year/NN and/CC 98/CD age-/NN and/CC sex-matched/JJ persons/NNS with/IN normal/JJ renal/JJ function/NN (/( serum/NN creatinine/NN </SYM or/CC =/SYM 1.2/CD mg/NN //SYM dl/NN )/) ,/, new/JJ coronary/JJ events/NNS developed/VBN at/IN 23-month/NN follow-up/NN in/IN 69/CD persons/NNS (/( 70/CD %/SYM )/) with/IN chronic/JJ renal/JJ insufficiency/NN and/CC at/IN 48-month/NN follow-up/NN in/IN 24/CD persons/NNS (/( 24/CD %/SYM )/) with/IN normal/JJ renal/JJ function/NN (/( p/NN </SYM 0.0001/CD )/) ./.
P11078840A13
Decreased/JJ air/NN pressure/NN reduced/VBD the/DT occurrence/NN of/IN visual/JJ field/NN defects/NNS significantly/RB (/( 24/CD %/SYM in/IN group/NN A/NN versus/CC 4/CD %/SYM in/IN group/NN C/NN ,/, P/NN =/SYM .011/CD )/) ./.
P11083045A11
The/DT additional/JJ decrease/NN in/IN hazard/NN observed/VBN for/IN the/DT 1990/CD cohort/NN may/MD be/VBP attributed/VBN to/TO the/DT effect/NN of/IN the/DT Specified/JJ Bovine/JJ Offal/NN ban/NN instituted/VBN in/IN September/NN 1990/CD ./.
P11091492A09
Although/IN all/PDT the/DT transplanted/JJ fetal/JJ sheep/NN showed/VBD the/DT presence/NN of/IN human/NN cells/NNS in/IN their/PRP$ bone/NN marrow/NN (/( BM/NN )/) ,/, the/DT highest/JJS levels/NNS of/IN long-term/NN engraftment/NN in/IN primary/JJ recipients/NNS were/VBD obtained/VBN with/IN the/DT fraction/NN of/IN cells/NNS cultured/VBN for/IN 3/CD days/NNS followed/VBN by/IN 7/CD days/NNS in/IN the/DT absence/NN of/IN serum/NN ./.
P11095653A13
The/DT developmental/JJ expression/NN of/IN beta-galactosidase/NN in/IN transgenic/JJ embryos/NNS was/VBD also/RB analyzed/VBN ./.
P11104765A08
Coimmunoprecipitation/NN experiments/NNS from/IN yeast/NN cell/NN lysates/NNS resulted/VBD in/IN the/DT isolation/NN of/IN a/DT Mex67p-Nup116p/NN complex/NN ./.
P11113534A02
However/WRB ,/, behavioral/JJ evidence/NN for/IN altered/JJ mnemonic/JJ function/NN due/JJ to/TO altered/JJ PAC1/NN activity/NN is/VBZ missing/VBG ./.
P11118176A10
Private/JJ maternity/NN patients/NNS are/VBP a/DT lucrative/JJ source/NN of/IN income/NN ./.
P11127268A03
In/IN this/DT study/NN ,/, 91/CD sera/NNS were/VBD used/VBN to/TO assess/VB the/DT reliability/NN of/IN the/DT Widal/NN agglutination/NN assay/NN based/VBN on/IN antibodies/NNS to/TO the/DT Vi/NN antigens/NNS ./.
P11131512A06
However/WRB ,/, this/PRP was/VBD observed/VBN only/RB for/IN a/DT few/JJ individual/JJ cases/NNS and/CC its/PRP$ amplitude/NN was/VBD small/JJ ./.
P11140087A01
This/DT study/NN was/VBD carried/VBN out/RP to/TO know/VB the/DT prevalence/NN and/CC determinants/NNS of/IN tuberculin/NN reactors/NNS and/CC the/DT size/NN of/IN booster/NN phenomenon/NN in/IN 211/CD Japanese/JJ residents/NNS of/IN a/DT provincial/JJ nursing/JJ home/NN for/IN elderly/NN ./.
P11144920A08
They/PRP suggest/VBP that/IN the/DT extraordinary/JJ therapeutic/JJ effects/NNS of/IN antibiotics/NNS ,/, coupled/VBN with/IN the/DT problems/NNS that/WDT may/MD arise/VBP when/WRB they/PRP are/VBP inappropriately/RB used/VBN and/CC with/IN the/DT extraordinary/JJ amount/NN of/IN resources/NNS spent/VBN on/IN antibiotics/NNS worldwide/RB justify/VBP a/DT global/JJ effort/NN to/TO reduce/VB their/PRP$ inappropriate/JJ use/NN and/CC promote/VBP their/PRP$ adequate/JJ administration/NN ./.
P11153569A09
Induced/JJ sputum/NN and/CC exhaled/JJ gases/NNS are/VBP important/JJ markers/NNS of/IN inflammation/NN in/IN childhood/NN asthma/NN ./.
P11161972A05
Receptor/NN modulation/NN was/VBD observed/VBN at/IN the/DT two/CD highest/JJS doses/NNS ,/, but/CC no/DT depletion/NN of/IN T/NN cells/NNS at/IN any/DT dose/NN ./.
P11170035A03
In/IN accordance/NN with/IN previously/RB reported/JJ data/NNS in/IN the/DT bis/JJ (/( SATE/NN )/) prodrug/NN series/NN ,/, the/DT present/JJ results/NNS demonstrate/VBP that/IN the/DT studied/JJ bis/JJ (/( hydroxytBuSATE/NN )/) phosphotriester/NN exerts/VBZ its/PRP$ biological/JJ effects/NNS via/IN intracellular/JJ delivery/NN of/IN the/DT 5'-monophosphate/NN of/IN AZT/NN ./.
P11174003A01
There/EX is/VBZ evidence/NN that/IN crescentic/JJ glomerulonephritis/NN initiated/VBN in/IN rodents/NNS by/IN heterologous/JJ antibodies/NNS against/IN the/DT glomerular/JJ basement/NN membrane/NN (/( anti-GBM/NN glomerulonephritis/NN )/) depends/VBZ on/IN a/DT Th1-type/NN immune/JJ reaction/NN ./.
P11178779A15
This/PRP might/MD result/VBP from/IN inhibition/NN of/IN the/DT local/JJ release/NN of/IN PAF/NN ./.
P11195272A03
This/DT document/NN represents/VBZ the/DT consensus/NN achieved/VBN at/IN that/DT meeting/NN as/IN agreed/VBN upon/RP by/IN the/DT participants/NNS at/IN the/DT final/JJ "/`` consensus/NN achieving/JJ "/'' session/NN ./.
P11199721A02
Pure/JJ cultures/NNS of/IN P./NN endodontalis/NN were/VBD grown/VBN in/IN TYP/NN medium/NN ,/, in/IN an/DT anaerobic/JJ chamber/NN ./.
P11204621A06
Broken/JJ ,/, oblique/JJ ,/, and/CC loss/NN of/IN stereocilia/NNS ,/, denuded/JJ epithelial/JJ cells/NNS ,/, and/CC flattening/NN of/IN the/DT tubule/NN were/VBD observed/VBN ./.
P11218585A18
Their/PRP$ treatment/NN is/VBZ surgical/JJ and/CC should/MD be/VBP undertaken/VBN before/IN the/DT appearance/NN of/IN complications/NNS ./.
P11227586A08
Persistent/JJ damage/NN of/IN the/DT already/RB implanted/JJ pacing/JJ system/NN was/VBD not/RB observed/VBN ./.
P11237093A04
The/DT half-life/NN for/IN decomposition/NN (/( tau/NN (/( 1/CD //SYM 2/CD )/) )/) of/IN the/DT unsymmetrical/JJ initiators/NNS at/IN 37/CD degrees/NNS C/CD in/IN methanol/NN covered/VBD a/DT range/NN of/IN 121/CD hours/NNS for/IN SA-1/NN ,/, 77/CD hours/NNS for/IN SA-2/NN ,/, and/CC approximately/RB 25/CD hours/NNS for/IN the/DT series/NNS C-16/NN ,/, C-12/NN ,/, and/CC C-8/NN ./.
P11245760A04
SETTING/NN :/: Community/NN in/IN northern/JJ California/NNP after/IN inpatient/NN rehabilitation/NN ./.
P11254728A01
We/PRP recently/RB showed/VBD that/IN a/DT class/NN of/IN novel/JJ carboxylated/JJ N/NN :/: -glycans/NNS was/VBD constitutively/RB expressed/VBN on/IN endothelial/JJ cells/NNS ./.
P11259340A05
These/DT genes/NNS have/VBP been/VBN cloned/VBN and/CC their/PRP$ functions/NNS elucidated/VBN ./.
P11263824A07
A/DT meat/NN sample/NN was/VBD taken/VBN from/IN the/DT longissimus/NN thoracis/NN muscle/NN for/IN physical/JJ ,/, chemical/JJ ,/, and/CC sensory/JJ analysis/NN ./.
P11269488A03
METHODS/NNS :/: The/DT analysis/NN is/VBZ designed/VBN to/TO determine/VB the/DT cost-effectiveness/NN of/IN LVRS/NN versus/CC medical/JJ therapy/NN for/IN those/PRP who/WP are/VBP eligible/JJ for/IN the/DT procedure/NN ./.
P11274020A16
Because/IN it/PRP is/VBZ convenient/JJ to/TO use/VB and/CC has/VBZ high/JJ throughput/NN ,/, this/DT serum/NN bone/NN resorption/NN marker/NN may/MD be/VBP useful/JJ for/IN the/DT investigation/NN of/IN patients/NNS with/IN osteoporosis/NN ./.
P11282493A07
These/DT changes/NNS were/VBD prevented/VBN by/IN treatment/NN with/IN UDCA/NN ./.
P11291392A01
In/IN 1998/CD the/DT Faculty/NN of/IN Pharmacy/NN and/CC Pharmaceutical/JJ Sciences/NNS at/IN the/DT University/NN of/IN Alberta/NNP ,/, Canada/NNP ,/, introduced/VBD a/DT new/JJ elective/JJ semester/NN course/NN entitled/VBN "/`` The/DT Pain/NN Module/NN "/'' for/IN pharmacy/NN students/NNS in/IN their/PRP$ final/JJ year/NN of/IN undergraduate/NN training/NN ./.
P11295616A02
Recent/JJ advances/NNS in/IN the/DT fields/NNS of/IN genomics/NNS and/CC biotechnology/NN have/VBP dramatically/RB increased/VBN the/DT quantity/NN and/CC accessibility/NN of/IN molecular/JJ information/NN that/WDT is/VBZ relevant/JJ to/TO the/DT study/NN of/IN prostate/NN carcinogenesis/NN ./.
P11304547A07
The/DT behavior/NN of/IN the/DT double/JJ mutant/NN is/VBZ dominated/VBN by/IN the/DT G83A/NN mutation/NN ./.
P11313077A10
The/DT SF-36/NN values/NNS of/IN the/DT ARDS/NN survivors/NNS indicated/VBD impaired/JJ health/NN status/NN on/IN seven/CD out/IN of/IN eight/CD domains/NNS when/WRB compared/VBN to/TO normative/JJ population/NN data/NNS ./.
P11321732A02
We/PRP describe/VBP a/DT case/NN of/IN pulmonary/JJ spindle-cell/NN tumor/NN with/IN features/NNS of/IN infantile/JJ fibrosarcoma/NN and/CC discuss/VBP the/DT differential/JJ diagnosis/NN of/IN spindle-cell/NN lesions/NNS in/IN this/DT location/NN ./.
P11334903A04
PATIENT/NN (/( S/NNS )/) :/: 1388/CD patients/NNS undergoing/VBG long/JJ protocol/NN in/FW vitro/FW fertilization/NN //SYM embryo/NN transfer/NN (/( IVF-ET/NN )/) using/VBG buserelin/NN acetate/NN from/IN day/NN 2/CD of/IN the/DT cycle/NN and/CC either/CC rFSH/NN (/( follitropin/NN beta/NN )/) (/( n/NN =/SYM 694/CD )/) or/CC uFSH/NN (/( n/NN =/SYM 694/CD )/) with/IN equal/JJ number/NN of/IN ampules/NNS started/VBN (/( rFSH/NN :/: 50/CD IU/NN ,/, uFSH/NN :/: 75/CD IU/NN )/) ./.
P11339688A06
The/DT concept/NN of/IN salt-sensitivity/NN is/VBZ a/DT novel/JJ biological/JJ component/NN that/WDT might/MD contribute/VBP to/TO reactivity/NN research/NN in/IN subjects/NNS at/IN high/JJ risk/NN for/IN essential/JJ hypertension/NN ./.
P11348819A12
Induration/NN results/NNS were/VBD 0/CD mm/NN ,/, 216/CD tests/NNS ;/: 1-9/CD mm/NN ,/, 9/CD tests/NNS ;/: >/SYM or/CC =10/CD mm/NN ,/, 2/CD tests/NNS ./.
P11367678A02
The/DT results/NNS are/VBP as/IN follows/VBZ :/: (/( 1/CD )/) Tau/NN acted/VBD on/IN strychnine-sensitive/JJ glycine/NN (/( Gly/NN )/) receptors/NNS and/CC elicited/VBD inward/JJ currents/NNS at/IN a/DT holding/JJ potential/NN (/( VH/NN )/) of/IN -40/CD mV/NN in/IN SDCN/NN neurons/NNS ;/: (/( 2/CD )/) in/IN a/DT range/NN of/IN 0.01/CD to/TO 100/CD mumol/NN //SYM L/NN ,/, 5-HT/NN enhanced/VBD ITau/NN in/IN a/DT concentration-dependent/JJ manner/NN ;/: (/( 3/CD )/) both/CC the/DT reversal/NN potential/NN of/IN Tau/NN and/CC the/DT binding/JJ affinity/NN of/IN Tau/NN to/TO Gly/NN receptor/NN were/VBD not/RB affected/VBN by/IN 5-HT/NN ;/: (/( 4/CD )/) when/WRB the/DT neurons/NNS were/VBD loaded/VBN with/IN 3/CD mumol/NN //SYM L/NN chelerythrine/NN ,/, application/NN of/IN 1/CD mumol/NN //SYM L/NN 5-HT/NN failed/VBD to/TO enhance/VB ITau/NN ./.
P11376516A02
Then/RB ,/, it/PRP was/VBD used/VBN during/IN acute/JJ respiratory/JJ failure/NN to/TO improve/VB gas/NN exchange/NN ./.
P11381130A01
Type/NN IV/CD pili/NNS are/VBP thin/JJ filaments/NNS that/WDT extend/VBP from/IN the/DT poles/NNS of/IN a/DT diverse/JJ group/NN of/IN bacteria/NN ,/, enabling/VBG them/PRP to/TO move/VB at/IN speeds/NNS of/IN a/DT few/JJ tenths/NNS of/IN a/DT micrometer/NN per/IN second/NN ./.
P11390215A02
In/IN the/DT microphysiometer/NN ,/, different/JJ sensitive/JJ membranes/NNS are/VBP illuminated/VBN in/IN parallel/NN with/IN n/NN light/NN sources/NNS at/IN different/JJ frequencies/NNS ,/, the/DT response/NN amplitudes/NNS of/IN each/DT frequency/NN component/NN can/MD be/VBP measured/VBN on-line/NN by/IN parallel/JJ processing/JJ algorithm/NN ./.
P11399116A02
A/DT low/JJ serum/NN phosphate/NN (/( S-P/NN )/) level/NN may/MD be/VBP a/DT limiting/JJ factor/NN for/IN glucose/NN metabolism/NN and/CC may/MD account/VBP for/IN hyperglycaemia/NN ,/, with/IN an/DT increased/JJ risk/NN of/IN NIDDM/NN and/CC hypertension/NN and/CC consequent/JJ increased/JJ risk/NN of/IN stroke/NN ./.
P11407815A02
Its/PRP$ structure/NN was/VBD elucidated/VBN by/IN spectroscopic/JJ methods/NNS ./.
P11416509A07
The/DT only/JJ in-hospital/NN complications/NNS was/VBD the/DT death/NN of/IN 1/CD patient/NN (/( 3.8/CD %/SYM )/) after/IN an/DT abrupt/JJ closure/NN ,/, and/CC a/DT dissection/NN of/IN 1/CD lesion/NN of/IN another/DT patient/NN ,/, with/IN a/DT favorable/JJ subsequent/JJ outcome/NN ./.
P11421369A06
Both/PRP affected/VBD children/NNS more/RB than/IN adults/NNS ,/, but/CC Cryptosporidium/NN affected/VBD children/NNS at/IN a/DT younger/JJR age/NN than/IN Cyclospora/NN (/( median/NN age/NN 2/CD years/NNS versus/CC 5/CD years/NNS ;/: P/NN </SYM 0.001/CD )/) ./.
P11430088A02
Nucleophilic/JJ attack/NN leads/VBZ to/TO at/IN least/JJS two/CD reaction/NN channels/NNS ,/, one/CD of/IN which/WDT has/VBZ been/VBN previously/RB detected/VBN (/( pathway/NN a/NN )/) and/CC leads/VBZ to/TO novel/JJ aminals/NNS 19/CD ./.
P11439290A02
However/WRB ,/, these/DT investigations/NNS used/VBD supraphysiological/JJ doses/NNS ./.
P11443913A02
It/PRP is/VBZ assumed/VBN that/IN the/DT success/NN in/IN plant/NN genomics/NNS will/MD result/VBP in/IN revolutionary/JJ changes/NNS in/IN biotechnology/NN and/CC plant/NN breeding/NN ./.
P11452990A01
An/DT ion/NN chromatography/NN method/NN was/VBD developed/VBN to/TO determine/VB trace/JJ anionic/JJ contamination/NN in/IN matrices/NNS that/WDT have/VBP a/DT high/JJ concentration/NN of/IN nitrate/NN ion/NN ./.
P11457220A06
Incorporation/NN of/IN this/DT analogue/NN into/IN peptides/NNS or/CC proteins/NNS should/MD allow/VBP for/IN even/RB more/RB specific/JJ interactions/NNS between/IN the/DT photoactivatable/JJ isoprenoid/NN and/CC any/DT number/NN of/IN isoprenoid/NN binding/JJ proteins/NNS ./.
P11471071A04
Chimeric/JJ receptors/NNS were/VBD expressed/VBN in/IN 3T3-L1/NN pre-adipocytes/NNS ,/, which/WDT do/VBP not/RB show/VBP insulin-specific/JJ responses/NNS upon/IN EGF/NN stimulation/NN ./.
P11484586A02
The/DT sample/NN consisted/VBD of/IN panoramic/JJ radiographs/NNS from/IN 70/CD subjects/NNS ./.
P11488890A10
The/DT histopathologic/JJ extent/NN of/IN the/DT reaction/NN to/TO either/DT type/NN of/IN electrodes/NNS could/MD not/RB be/VBP precisely/RB defined/VBN because/IN of/IN the/DT retrospective/JJ nature/NN of/IN this/DT study/NN ./.
P11494592A12
2./CD The/DT most/RBS popular/JJ method/NN of/IN infant/NN nutrition/NN was/VBD breast-feeding/NN ,/, utilized/VBN by/IN 60.1/CD %/SYM ./.
P11499048A03
However/WRB ,/, in/IN the/DT absence/NN of/IN clear/JJ guidelines/NNS ,/, continuous/JJ monitoring/NN and/CC an/DT adequate/JJ supply/NN of/IN financial/JJ and/CC human/NN resources/NNS ,/, decentralization/NN processes/NNS are/VBP more/RB likely/RB to/TO have/VB a/DT low/JJ impact/NN on/IN the/DT process/NN of/IN health/NN care/NN reform/NN and/CC can/MD ,/, to/TO a/DT certain/JJ extent/NN ,/, provoke/VBP inequalities/NNS between/IN regions/NNS in/IN the/DT same/JJ country/NN ./.
P11512310A04
Graft/NN survival/NN was/VBD significantly/RB improved/VBN using/VBG Tacrolimus/NN immunosuppression/NN ./.
P11520780A08
No/DT serious/JJ adverse/JJ events/NNS were/VBD reported/VBN ;/: nor/CC were/VBD there/EX events/NNS that/WDT met/VBD the/DT criteria/NNS for/IN dose-limiting/JJ toxicity/NN ./.
P11530183A06
This/DT system/NN is/VBZ based/VBN on/IN the/DT self/PRP replication/NN of/IN engineered/JJ HCV/NN minigenomes/NNS (/( replicons/NNS )/) in/IN a/DT transfected/JJ human/NN hepatoma/NN cell/NN line/NN ./.
P11547838A05
The/DT femur/NN and/CC tibia/NN were/VBD then/RB excised/VBN ,/, cleaned/VBN ,/, and/CC scanned/VBN in/IN triplicate/NN ,/, with/IN repositioning/NN ./.
P11556744A02
Collagen/NN sponges/NNS of/IN different/JJ biodegradabilities/NNS were/VBD prepared/VBN through/IN chemical/JJ cross-linking/NN of/IN Type/NN I/CD collagen/NN with/IN glutaraldehyde/NN (/( GA/NN )/) at/IN concentrations/NNS of/IN 0.2/CD ,/, 1.0/CD ,/, and/CC 2.0/CD wt/NN %/SYM ./.
P11561143A02
This/PRP is/VBZ mediated/VBN by/IN an/DT effect/NN on/IN the/DT endothelium/NN analogous/JJ to/TO other/JJ endothelial/JJ responses/NNS ,/, and/CC insulin/NN resistance/NN is/VBZ reflected/VBN in/IN ,/, and/CC in/IN part/NN due/JJ to/TO ,/, impaired/JJ vasodilatory/JJ actions/NNS of/IN insulin/NN ./.
P11569866A05
On/IN dilution/NN Rh/NN (/( III/CD )/) tends/VBZ to/TO be/VB readily/RB hydrolyzed/VBN ,/, giving/VBG rise/NN to/TO a/DT wider/JJR variety/NN (/( and/CC a/DT varied/JJ distribution/NN )/) of/IN complexed/JJ forms/NNS ./.
P11579072A05
After/IN confounding/JJ factors/NNS had/VBD been/VBN controlled/VBN for/IN ,/, the/DT exercise/NN group/NN did/VBD not/RB make/VBP significant/JJ gains/NNS compared/VBN with/IN their/PRP$ control/NN counterparts/NNS ,/, although/IN there/EX were/VBD consistent/JJ trends/NNS toward/IN greater/JJR improvement/NN in/IN all/DT three/CD primary/JJ outcome/NN measures/NNS ./.
P11584254A11
The/DT group/NN that/WDT receives/VBZ education/NN about/IN universal/JJ precautions/NNS has/VBZ a/DT higher/JJR level/NN of/IN knowledge/NN and/CC performance/NN of/IN the/DT universal/JJ precautions/NNS than/IN that/DT group/NN that/WDT receives/VBZ no/PDT such/DT education/NN ./.
P11593455A06
Tree/NN shrews/NNS can/MD be/VBP regarded/VBN as/IN a/DT suitable/JJ animal/NN model/NN to/TO investigate/VB the/DT neurobiological/JJ basis/NN of/IN affective/JJ disorders/NNS since/IN (/( 1/CD )/) behavioral/JJ and/CC endocrine/JJ symptoms/NNS of/IN subordinates/NNS resemble/VBP those/PRP of/IN depressive/JJ patients/NNS ,/, (/( 2/CD )/) antidepressant/NN treatments/NNS lead/VBP to/TO an/DT improvement/NN of/IN symptoms/NNS ,/, and/CC (/( 3/CD )/) also/RB in/IN humans/NNS chronic/JJ stress/NN can/MD lead/VBP to/TO depression/NN ./.
P11598036A11
An/DT important/JJ component/NN of/IN our/PRP$ study/NN was/VBD the/DT use/NN of/IN heparin/NN to/TO prevent/VB reinfection/NN of/IN cells/NNS and/CC thus/RB enable/VB the/DT infection/NN to/TO be/VB followed/VBN from/IN a/DT discrete/JJ time/NN point/NN ./.
P11606558A03
General/JJ diploid/NN selection/NN is/VBZ allowed/VBN ,/, but/CC the/DT approach/NN is/VBZ currently/RB restricted/VBN to/TO models/NNS ,/, such/JJ as/IN the/DT infinite/JJ alleles/NNS model/NN and/CC certain/JJ K-models/NNS ,/, in/IN which/WDT the/DT type/NN of/IN a/DT mutant/JJ allele/NN does/VBZ not/RB depend/VBP on/IN the/DT type/NN of/IN its/PRP$ progenitor/NN allele/NN ./.
P11669999A02
The/DT halide/NN Re/NN (/( 3/CD )/) (/( &mgr;/NN -Cl/NN )/) (/( 3/CD )/) Cl/NN (/( 6/CD )/) (/( THF/NN )/) (/( 3/CD )/) reacts/VBZ at/IN room/NN temperature/NN in/IN THF/NN with/IN 9/CD equiv/NN of/IN NaOCH/NN (/( 2/CD )/) CMe/NN (/( 3/CD )/) to/TO give/VB Re/NN (/( 3/CD )/) (/( &mgr;/NN -OCH/NN (/( 2/CD )/) CMe/NN (/( 3/CD )/) )/) (/( 3/CD )/) (/( OCH/NN (/( 2/CD )/) CMe/NN (/( 3/CD )/) )/) (/( 6/CD )/) ./.
P11674532A05
Optimization/NN of/IN binding/NN was/VBD achieved/VBN by/IN changing/NN polymerization/NN conditions/NNS (/( thermal/JJ versus/CC photochemical/JJ polymerization/NN ,/, monomer/NN :/: template/NN ratio/NN )/) for/IN t-BOC-phenylalanine/NN imprinted/JJ polymers/NNS employing/VBG the/DT N-/NN (/( 2-aminopyridine/NN )/) methacrylamide/NN monomer/NN ./.
P11683809A06
An/DT asymmetric/JJ index/NN (/( AI/NN )/) was/VBD designed/VBN ./.
P11688318A08
The/DT mortality/NN rate/NN varies/VBZ according/VBG to/TO the/DT causes/NNS and/CC the/DT age/NN ./.
P11693764A06
The/DT presence/NN of/IN SCIs/NNS was/VBD associated/VBN with/IN older/JJR age/NN ,/, higher/JJR levels/NNS of/IN 24-h/NN systolic/JJ blood/NN pressure/NN ,/, 2-h/NN insulin/NN ,/, thrombin-generation/NN markers/NNS (/( prothrombin/NN fragment/NN 1+2/CD and/CC thrombin-antithrombin/NN complexes/NNS )/) ,/, plasminogen/NN activator/NN inhibitor-1/NN (/( PAI-1/NN )/) ,/, D-dimer/NN and/CC von/IN Willebrand/NN factor/NN (/( vWF/NN )/) ,/, but/CC not/RB with/IN plasmin-alpha2-plasmin/NN complex/NN (/( PIC/NN )/) levels/NNS ./.
P11707065A02
Using/VBG stereotactic/JJ techniques/NNS ,/, it/PRP is/VBZ possible/JJ to/TO characterize/VB neuroanatomical/JJ relationships/NNS through/IN the/DT delivery/NN of/IN neurotropic/JJ viral/JJ vectors/NNS to/TO specific/JJ brain/NN regions/NNS ./.
P11716155A05
Non-classic/JJ CAH-21/NN OHD/NN may/MD be/VBP detected/VBN in/IN up/IN to/TO 1-3/CD %/SYM of/IN certain/JJ populations/NNS ,/, and/CC is/VBZ often/RB mistaken/VBN for/IN idiopathic/JJ precocious/JJ pubarche/NN in/IN children/NNS or/CC polycystic/JJ ovary/NN syndrome/NN in/IN young/JJ women/NNS ./.
P11724819A05
Raver1/NN colocalizes/VBZ with/IN polypyrimidine/NN tract/NN binding/JJ protein/NN (/( PTB/NN )/) //SYM hnRNPI/NN ,/, a/DT protein/NN involved/VBN in/IN RNA/NN splicing/NN of/IN microfilament/NN proteins/NNS ,/, in/IN the/DT perinucleolar/JJ compartment/NN and/CC forms/VBZ complexes/NNS with/IN PTB/NN //SYM hnRNPI/NN ./.
P11729241A11
Further/JJ experiments/NNS are/VBP required/VBN to/TO establish/VB whether/IN these/DT events/NNS are/VBP functionally/RB related/VBN ./.
P11742329A01
BACKGROUND/NN :/: Different/JJ minimally/RB invasive/JJ techniques/NNS of/IN parathyroidectomy/NN have/VBP been/VBN described/VBN ./.
P11746443A02
Sciatic/JJ nerve/NN crush/NN was/VBD performed/VBN in/IN 2-day-old/JJ rats/NNS ,/, and/CC reinnervation/NN of/IN the/DT extensor/NN digitorum/NN longus/NN muscle/NN was/VBD monitored/VBN ./.
P11755384A02
The/DT present/JJ study/NN aims/VBZ to/TO demonstrate/VB a/DT quantitative/JJ use/NN of/IN these/DT devices/NNS in/IN pharmacological/JJ bioassays/NNS ./.
P11759993A03
ANIMALS/NNS :/: 17/CD neutered/JJ cats/NNS >/SYM 1/CD year/NN old/NN with/IN objectionable/JJ urine/NN spraying/JJ behavior/NN ./.
P11764572A04
All/DT stages/NNS of/IN performance/NN of/IN the/DT access/NN ,/, including/VBG trepanation/NN of/IN the/DT internal/JJ acoustic/JJ meatus/NN ,/, are/VBP considered/VBN in/IN detail/NN ./.
P11769320A11
The/DT amount/NN of/IN ions/NNS (/( P/NN ,/, K/NN ,/, Mg/NN and/CC Ca/NN )/) often/RB showed/VBD negative/JJ correlations/NNS with/IN the/DT developmental/JJ rate/NN ,/, particularly/RB of/IN earlier/JJR phenophases/NNS of/IN both/CC native/JJ and/CC cultivated/JJ plants/NNS (/( except/IN for/IN the/DT apple/NN '/`` Gravenstein/NN '/'' and/CC pear/NN '/`` Moltke/NN '/'' )/) ,/, possibly/RB ,/, indicating/VBG that/IN a/DT high/JJ nutrient/NN level/NN delayed/VBD plant/NN development/NN ./.
P11778117A03
Loco-regional/JJ techniques/NNS together/RB with/IN an/DT effective/JJ pain/NN management/NN should/MD accelerate/VBP rehabilitation/NN ,/, decrease/VBP risk/NN of/IN postoperative/JJ complications/NNS and/CC speed/VBP return/NN to/TO normal/JJ activities/NNS ./.
P11782348A06
These/DT tissues/NNS showed/VBD a/DT significant/JJ increase/NN in/IN apoptosis/NN as/IN determined/VBN by/IN in/FW situ/FW end-labeling/NN for/IN both/DT ITC-NAC-treated/JJ groups/NNS ./.
P11786823A06
Also/RB ,/, the/DT global/JJ rating/JJ score/NN for/IN appearance/NN and/CC quality/NN of/IN the/DT final/JJ surgical/JJ product/NN significantly/RB improved/VBD from/IN 2.7/CD to/TO 3.3/CD after/IN the/DT practice/NN session/NN (/( p/NN </SYM 0.01/CD )/) ./.
P11795867A06
Pleiotrophin/NN is/VBZ the/DT first/JJ ligand/NN of/IN any/PRP of/IN the/DT known/JJ transmembrane/JJ tyrosine/NN phosphatases/NNS ./.
P11800366A09
In/IN 8/CD cases/NNS ,/, one/CD or/CC both/PRP of/IN the/DT vocal/JJ cords/NNS became/VBD mobile/JJ 3/CD to/TO 4/CD months/NNS after/IN the/DT operation/NN ./.
P11813784A01
Domestic/JJ abuse/NN is/VBZ the/DT leading/JJ cause/NN of/IN injuries/NNS and/CC death/NN among/IN women/NNS of/IN childbearing/JJ age/NN in/IN the/DT United/JJ States/NNS ./.
P11818410A09
We/PRP conclude/VBP that/IN the/DT circadian/JJ clock/NN generates/VBZ a/DT rhythm/NN of/IN luminal/JJ acidification/NN by/IN regulating/NN the/DT levels/NNS and/CC subcellular/JJ distribution/NN of/IN V-ATPase/NN in/IN the/DT UVD/NN epithelium/NN ./.
P11827397A03
When/WRB the/DT arsenosugar/NN in/IN the/DT oyster/NN was/VBD quantified/VBN using/VBG the/DT two/CD detection/NN methods/NNS and/CC external/JJ calibration/NN with/IN standard/JJ arsenosugar/NN ,/, there/EX was/VBD a/DT large/JJ discrepancy/NN between/IN the/DT two/CD sets/NNS of/IN results/NNS ./.
P11832091A09
The/DT median/JJ survival/NN was/VBD 26.5/CD months/NNS in/IN Group/NN 1/CD and/CC 57.0/CD months/NNS in/IN Group/NN 2/CD (/( P/NN </SYM 0.01/CD )/) ./.
P11836425A02
All/DT sequenced/JJ gammaherpesviruses/NNS encode/VBP a/DT BCL-2/NN homologue/NN that/IN potently/RB inhibits/VBZ apoptosis/NN and/CC apparently/RB escapes/VBZ some/PRP of/IN the/DT regulatory/JJ mechanisms/NNS that/WDT govern/VBP the/DT functions/NNS of/IN their/PRP$ cellular/JJ counterparts/NNS ./.
P11850165A11
The/DT majority/NN (/( 98/CD %/SYM )/) of/IN M./NN catarrhalis/NN isolates/NNS was/VBD found/VBN to/TO be/VB beta-lactamase-positive/JJ and/CC resistant/JJ to/TO penicillins/NNS ,/, however/WRB ,/, resistance/NN to/TO erythromycin/NN and/CC tetracycline/NN was/VBD also/RB low/JJ at/IN 1.8/CD %/SYM ./.
P11854657A13
Fetal/JJ blood/NN gases/NNS and/CC pH/NN were/VBD unchanged/VBN with/IN time/NN in/IN all/DT 3/CD groups/NNS ./.
P11863688A05
The/DT same/JJ property/NN holds/VBZ for/IN the/DT approximate/JJ wave/NN functions/NNS ./.
P11872968A05
The/DT isolated/JJ systolic/JJ hypertension/NN and/CC large/JJ pulse/NN pressure/NN that/WDT predominate/VBP in/IN the/DT elderly/NN is/VBZ now/RB recognized/VBN as/IN a/DT coronary/JJ disease/NN hazard/NN ./.
P11877563A01
Microalbuminuria/NN (/( MA/NN )/) is/VBZ associated/VBN with/IN adverse/JJ health/NN outcomes/NNS in/IN diabetic/JJ and/CC hypertensive/JJ adults/NNS ./.
P11882196A02
The/DT research/NN question/NN arose/VBD when/WRB professional/JJ preunderstandings/NNS about/IN schizophrenia/NN as/IN a/DT biological/JJ disturbance/NN were/VBD bracketed/VBN as/IN a/DT Husserlian/NN form/NN of/IN phenomenology/NN was/VBD adopted/VBN ./.
P11886711A05
Sixty/CD percent/NN of/IN our/PRP$ patients/NNS had/VBD chronic/JJ myelocytic/JJ leukemia/NN (/( CML/NN )/) ./.
P11891134A05
Both/DT deduced/JJ amino/JJ acid/NN sequences/NNS show/VBP substantial/JJ similarity/NN to/TO human/NN IRP1/NN and/CC Drosophila/NN IRP1A/NN and/CC IRP1B/NN ,/, and/CC all/PRP of/IN the/DT residues/NNS thought/VBN to/TO be/VB involved/VBN in/IN aconitase/NN activity/NN and/CC iron-sulfur/NN cluster/NN formation/NN are/VBP conserved/VBN ./.
P11900689A01
OBJECTIVES/NNS :/: To/TO analyze/VB the/DT influence/NN of/IN routine/JJ imaging/NN of/IN the/DT upper/JJ abdomen/NN by/IN conventional/JJ computed/JJ tomography/NN (/( CT/NN )/) to/TO stage/VB bronchopulmonary/JJ carcinoma/NN and/CC to/TO detect/VB liver/NN or/CC adrenal/JJ metastasis/NN ./.
P11905619A05
The/DT need/NN for/IN dedicated/JJ services/NNS for/IN these/DT patients/NNS has/VBZ been/VBN accepted/VBN ,/, but/CC the/DT resources/NNS to/TO meet/VB this/DT need/NN have/VBP rarely/RB been/VBN identified/VBN ./.
P11920197A01
INTRODUCTION/NN :/: Reduced/JJ glutathione/NN is/VBZ an/DT important/JJ antioxidant/NN in/IN red/JJ cells/NNS whose/WDT depletion/NN may/MD contribute/VBP to/TO the/DT pathophysiology/NN of/IN sickle/JJ cell/NN disease/NN ./.
P11924694A04
Results/NNS indicate/VBP that/IN moving/NN in/IN the/DT past/JJ 12/CD months/NNS is/VBZ positively/RB associated/VBN with/IN a/DT nearly/RB lethal/JJ suicide/NN attempt/NN (/( adjusted/JJ odds/NNS ratio/NN of/IN 2.1/CD ,/, with/IN 95/CD %/SYM confidence/NN interval/NN of/IN 1.4-3.3/CD )/) ,/, as/IN are/VBP specific/JJ characteristics/NNS of/IN the/DT move/NN (/( e.g./IN ,/, frequency/NN ,/, recency/NN ,/, distance/NN ,/, and/CC difficulty/NN staying/NN in/IN touch/NN )/) ./.
P11929207A04
Unrecognized/JJ saphenous/JJ neuritis/NN can/MD confuse/VBP the/DT patient/NN 's/POS clinical/JJ picture/NN ,/, complicate/VBP treatment/NN ,/, and/CC compromise/VBP results/NNS ./.
P11933551A17
Surgical/JJ acts/NNS which/WDT do/VBP not/RB impose/VBP major/JJ constraints/NNS on/IN the/DT cardiocirculatory/JJ apparatus/NN (/( ophthalmic/JJ surgery/NN for/IN example/NN )/) do/VBP not/RB require/VBP supplementary/JJ examinations/NNS ./.
P11943839A04
We/PRP therefore/RB developed/VBD a/DT mathematical/JJ model/NN to/TO estimate/VB life/NN expectancy/NN in/IN patients/NNS with/IN a/DT body/NN mass/NN index/NN (/( BMI/NN )/) >/SYM or/CC =40/CD kg/NN //SYM m/NN (/( 2/CD )/) undergoing/VBG bariatric/JJ surgery/NN ./.
P11951099A07
With/IN arteriography/NN as/IN the/DT "/`` gold/JJ standard/NN ,/, "/'' B-mode/NN image/NN (/( BMI/NN )/) measurement/NN of/IN the/DT maximal/JJ ICA/NN luminal/JJ narrowing/NN relative/JJ to/TO the/DT carotid/JJ bulb/NN (/( n=162/NN )/) as/RB well/RB as/IN the/DT peak/JJ systolic/JJ velocity/NN in/IN the/DT internal/JJ carotid/JJ artery/NN (/( PSVICA/NN )/) (/( n=330/NN )/) ,/, end-diastolic/JJ velocity/NN in/IN the/DT internal/JJ carotid/JJ artery/NN (/( EDV/NN (/( ICA/NN )/) )/) (/( n=198/NN )/) ,/, and/CC the/DT ratio/NN of/IN the/DT PSVs/NNS in/IN both/CC the/DT ICA/NN and/CC the/DT CCA/NN (/( PSVICA/NN //SYM CCA/NN )/) ratio/NN (/( n=319/NN )/) were/VBD subjected/VBN to/TO receiver/NN operator/NN characteristics/NNS (/( ROC/NN )/) curves/NNS for/IN 3/CD clinically/RB relevant/JJ stenoses/NNS thresholds/NNS :/: 50-99/CD %/SYM ,/, 60-99/CD %/SYM ,/, and/CC 70-99/CD %/SYM ./.
P11956156A07
Consistent/JJ with/IN the/DT reduction/NN in/IN expression/NN of/IN acetyl/NN CoA/NN carboxylase/NN 2/CD ,/, liver/NN triglyceride/NN levels/NNS were/VBD reduced/VBN ./.
P11967096A03
No/DT other/JJ nitrilase/NN genes/NNS respond/VBP to/TO sulphur/NN supply/NN //SYM deficiency/NN ./.
P11977166A03
The/DT dearth/NN of/IN archaeological/JJ cases/NNS may/MD be/VBP due/JJ to/TO lack/NN of/IN definite/JJ skeletal/JJ changes/NNS or/CC as/IN a/DT result/NN of/IN the/DT remains/NNS being/NN denied/VBN burial/NN within/IN consecrated/JJ ground/NN ./.
P11987685A05
Patients/NNS were/VBD classified/VBN as/IN planned/JJ (/( PL-D/NN )/) or/CC unplanned/JJ dialysis/NN (/( UNPL-D/NN )/) ,/, depending/VBG on/IN whether/IN or/CC not/RB the/DT patient/NN had/VBD a/DT vascular/JJ or/CC peritoneal/JJ access/NN ready/JJ to/TO use/VB for/IN initiating/NN RRT/NN ./.
P11992638A06
In/IN CFSC-2G/NN cultures/NNS ,/, MeAIB/NN selectively/RB inhibited/VBD the/DT incorporation/NN of/IN proline/NN into/IN cellular/JJ macromolecules/NNS by/IN 43/CD +/-/SYM 4/CD %/SYM ,/, while/IN the/DT synthesis/NN of/IN proteins/NNS containing/VBG leucine/NN was/VBD not/RB affected/VBN ./.
P12002346A03
We/PRP used/VBD a/DT model/NN that/WDT considers/VBZ variations/NNS in/IN skull/NN thicknesses/NNS to/TO determine/VB the/DT conductivity/NN of/IN the/DT tri-layer/NN skull/NN and/CC its/PRP$ individual/JJ anatomical/JJ structures/NNS ./.
P12011480A05
The/DT doses/NNS of/IN the/DT mixture/NN that/WDT were/VBD administered/VBN were/VBD related/VBN to/TO minimum/NN risk/NN levels/NNS or/CC tolerable/JJ daily/JJ intakes/NNS of/IN these/DT substances/NNS ,/, as/IN derived/VBN by/IN risk/NN assessment/NN with/IN the/DT 1x/NN ,/, 10x/NN ,/, 100x/NN ,/, and/CC 1000x/NN groups/NNS receiving/VBG mixture/NN components/NNS at/IN doses/NNS equivalent/JJ to/TO 1x/NN ,/, 10x/NN ,/, 100x/NN ,/, or/CC 1000x/NN the/DT minimum/NN risk/NN level/NN (/( or/CC tolerable/JJ daily/JJ intake/NN ,/, reference/NN dose/NN )/) ,/, respectively/RB ./.
P12016505A08
However/WRB ,/, the/DT long-term/NN effect/NN of/IN postoperative/JJ bandaging/NN remains/VBZ unknown/VBN ./.
P12026051A04
Four/CD histologic/JJ sections/NNS of/IN 12/CD specimens/NNS from/IN each/DT age/NN group/NN were/VBD stained/VBN with/IN toluidine/NN blue/JJ to/TO identify/VB the/DT MCs/NNS ,/, which/WDT were/VBD counted/VBN using/VBG a/DT computer-assisted/JJ image/NN analysis/NN system/NN ./.
P12035538A03
These/DT antibodies/NNS have/VBP recognized/VBN glycine/NN conjugated/VBN with/IN proteins/NNS by/IN glutaraldehyde/NN and/CC glycine/NN conjugated/VBN with/IN glycogen/NN by/IN bis-oxyran/NN ,/, however/WRB they/PRP have/VBP failed/VBN to/TO recognized/VB others/NNS amino/JJ acids/NNS in/IN the/DT analogical/JJ conjugates/NNS ./.
P12045762A01
This/DT prospective/JJ clinical/JJ study/NN assessed/VBD the/DT effect/NN of/IN the/DT Frankel/NN Functional/JJ Regulator-II/NN (/( FR-II/NN )/) treatment/NN on/IN the/DT position/NN and/CC shape/NN of/IN the/DT articular/JJ disc/NN of/IN the/DT temporomandibular/JJ joint/NN ./.
P12050378A04
Following/VBG gene/NN gun/NN bombardments/NNS of/IN DNA/NN ,/, both/PRP were/VBD biased/VBN towards/IN type/NN 2/CD immune/JJ responses/NNS and/CC the/DT production/NN of/IN interleukin-4/NN ./.
P12059479A01
Compressional/JJ pulses/NNS were/VBD launched/VBN in/IN a/DT two-dimensional/JJ Yukawa/NN lattice/NN ,/, a/DT hexagonal/JJ monolayer/NN of/IN polymer/NN microspheres/NNS suspended/VBN in/IN a/DT plasma/NN ./.
P12068149A04
Hence/RB ,/, this/DT association/NN should/MD be/VBP considered/VBN in/IN cases/NNS with/IN brain/NN abscesses/NNS of/IN undetermined/JJ etiologic/JJ factors/NNS ./.
P12077276A07
Although/IN the/DT arthritic/JJ score/NN of/IN the/DT C3/NN (/( -/-/SYM )/) mice/NNS was/VBD low/JJ ,/, the/DT arthritis/NN in/IN FB/NN (/( -/-/SYM )/) mice/NNS ranked/VBD intermediate/JJ with/IN regard/NN to/TO C3/NN (/( -/-/SYM )/) and/CC control/NN mice/NNS ./.
P12086533A06
A/DT pattern/NN of/IN water/NN molecules/NNS at/IN locations/NNS beyond/IN the/DT surface/NN of/IN the/DT solute/NN molecules/NNS is/VBZ detected/VBN ,/, evidence/NN of/IN an/DT emergent/JJ property/NN in/IN this/DT solvent-solute/NN system/NN ./.
P12100511A04
On/IN day/NN 15/CD post-transplant/NN ,/, because/IN flow/NN velocity/NN was/VBD remarkably/RB reduced/VBN (/( as/IN shown/VBN by/IN Doppler/NN ultrasound/NN )/) the/DT patient/NN underwent/VBD percutaneous/JJ transluminal/JJ angioplasty/NN (/( PTA/NN )/) using/VBG a/DT kit/NN for/IN coronary/JJ angioplasty/NN ./.
